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A NPfci CHROMOSOMAL T RA NS L O C A T I O N  t/l;22/ /q2 5; ql 2/  IN A 17-
MONTH-OLD GIRL
A. SELYPES1 , Enikő SÚLYOM2 , S. TAKÁCS1 
D ö J Á L ,  Miskolc, Hungary
d e p a r t m e n t  of Pediatrics, County Hospital, Miskolc, Hungary
Received 5 December 1990
A 17-month-old girl with multiple anomalies and a de 
novo translocation of chromosomes 1 and 22 
(t/1;22/ /q25;ql2/) is described.
INTRODUCTION
The symptoms in patients with deletion of chromosome lq can 
be divided into three groups on the basis of the location of 
the deletion /10/,- as follows: group 1: distal lq /lq42-43— ^
lqter/ deletion syndrome; group 2: interstitial lq /lq24-25 — > 
q32/ deletion syndrome; group 3: proximal lq /lq21-22— 3>q25/ 
deletion syndrome.
In 1988, Dasouki et al./1/ reported an eight-month-old girl 
with symmetrical bilateral oblique facial clefts, a
calcaneovarus foot deformity, and a balanced chromosomal 
translocation t /1; 2 2/ /q25;ql2/.
In this report, we present a 17-month-old girl with a 
chromosomal translocation t /1; 2 2/ /q25;ql2/. Su-gui et al./9 
earlier found a male patient with a chromosomal translocation 
t/1 ; 15/ /q2 5;q24/ among couples associated with abortions or
stillbirth. Unfortunately, the symptoms of their patient 
were not described.
Akadémiai Kiadó, Budapest
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P AT I E N T S  AND METHODS
Case report:
E.V. (date of birth: 01.03.1988), a 17-month-old girl, was 
examined clinically and cytogenetically, because of her 
craniofacial dysmorphism and wrinkled skin. She was born at 
term after a normal pregnancy, to a 35-year-old G1 P0-1 mother 
and a 28-year-old father: they were healthy. The patient 
reported here was resuscitated at birth. Her weight at 17 
months (9.7 kg, 90 centile) was normal, but her movements and 
intellectual development were slightly retarded at the time of 
the investigation.
Cytogénie analyses were performed on conventional blood 
cultures /8/. GTG-banded slides were made according to the 
method of Seabright /7/. Forty mitoses of the patient and 
twenty mitoses of the parents were examined under the 
microscope. Karyotype analyses were carried out on ten mitoses 
of the patient and on five metaphases of the parents with the 
short version of ISCN /4/.
RESDLTS
Table I shows the symptoms observed in the proximal lq 
deletion syndrome /6, 10/, those in the intermediate lq
deletion syndrome /3, 5, 11/, those in a case with a t / 1 ;22/
/ q 2 1 ;q 12/ /1/, and those in our patient with a t / 1 ; 22/
/q25 ; q 12/ . It can be seen that all of the patients with the lq 
deletion proximal to the lq25 band had cleft lip and palate, in 
contrast with patients in whom the deletion lq was in band q25 
or distal to that.
Our patient exhibits craniofacial dysmorphism: rough
features, not only a flat and broad nasal root, but also a flat 
and broad nose, low-set auricles, and a large mouth. She has 
very loose, wrinkled skin, which is very conspicuous on the 
neck and the hands, and a slight branchydactyly (Fig,la and 
lb) .
She displays retarded ossification of the bones; her bone- 
age is similar to that of a 3-6 month-old child. All of the 
results of laboratory investigations (serum electrolytes; 
hematocrit; hemoglobin, glucose, creatinin concentrations; 
white blood cell counts; immunoglobulins; etc.) were in the
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TABLE I
Clinical symptoms in proximal lq deletion syndrome, in 
intermediate del lq syndrome, in a case of t /1; 2 2//q 21 ;q l 2 / , 
and in our patient with a t/1 ; 22//q25 ;q!2/
Symptoms Syndrome
1 2  3 4
Craniofacies 
microbrachycephaly +
microcephaly + + +
cleft lip and palate + + +
round face + +
high forehead +
low-set ears + + +
micrognathia f +
upper epicanthic folds 
soarse, fine hair 
sparse eyebrows 
short nose 
microphthalmia 
rough features 
flat and broad nose
+ +
+
+
+
+
+
+ +
large mouth
Brain and intelligence 
epilepsy
profound motor and men-
+
+
tal retardation +
normal brain parenchima 
severe motor and mental
+
retardation
Abdomen
+ +
hernias 
Genitalia 
genital anomalies 
Limbs
+ + 
+ +
small hands and feet +
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T a b l e  I C o n t .
Symptoms Syndrome
1 2 3 4
clinodactyly of the
fifth fingers + +
brachydactyly + + 4 -
calcaneovarus foot
deformity +
retarded ossification
of the bones +
Other abnormalities
exotropia +
anisocoria +
hypothyroidism 
growth hormone defi-
+
ciency +
cardiac defects +
bilateral ocular
hypoplasia +
loose, wrinkled skin +
-'-proximal lq deletion syndrome (del/l//q21-q23 q25/ ) /Schinze 
and Schmid 1980; Taysi et al. 1982/
^intermediate lq deletion syndrome (del/l//q24-q25 q32/)
Turleau et al. 1974; Koivisto et al. 1976; Garver et al. 1976/
 ^t/ 1 ; 22//q21 ;ql2/ /Dasouki et al. 1988/
^t/l;22//q25;ql2/ /our patient/
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Fig. lb. The hands of the patient
Fig. la. Our 17-month-old patient
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normal ra n g e .
The partial karyotype (Fig. 2) demonstrates the 
translocation t/1 ; 22/ /q25;qll/ observed in all the mitoses 
examined of the patients. The parents were cytogenetically 
n o r m a l .
1 22
Fig. 2. The partial karyotype shows the balanced translocation 
t/1 ; 22//q25;ql2/ of our patient
DISCUSSION
Figure 3 shows the deleted segments in patients with 
proximal, intermediate, and distal deletions of lq. It seems 
that the intermediate del lq syndrome must be divided into two 
groups: into the proximal intermediate del lq / q 2 4 ^ q 3 2 /
syndrome, and the distal intermediate del lq / q 2 5 — ^q32/ 
syndrome. The patient with the proximal intermediate del lq 
syndrome had cleft lip and palate /11/, in contrast with the 
patients with distal intermediate del lq syndrome, who were 
without cleft lip and palate /3, 3 and our patient, if she has
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''■proximal lq /q21 -q22-^q25/ deletion syndrome 
^proximal intermediate lq /q24-^q32/ deletion syndrome 
•^distal intermediate lq / q 2 5 ^ q 3 2 /  deletion syndrome 
^distal lq /q42-43-^qter/ deletion syndrome 
arrow: the breakpoint in our patient
Fig. 3. Schematic representations of the deleted segments in 
various lq deletion syndromes
microdeletions in band lq25).
In the present case, the "balanced translocation" is 
associated with an abnormal phenotype. Microdeletions at the 
breakpoints can cause abnormalities in the phenotype /1, 2/. In 
our patient, the possibility of microdeletions cannot be 
excluded, however the symptoms in the patient are rather 
unspecific.
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Hundred children of 64 fathers with testicular 
tumour treated from 1979 on at the National Institute 
of Oncology, Budapest were studied. Three groups were 
formed on the basis of the time of conception. 59 
children were born before the illness of the fathers, 
19 during the 9 pretreatment months and 22 during or 
after combined chemotherapy.
Family anamnesis, perinatal and gestational data 
were listed, thereafter physical, laboratory, 
immunological, psychiatric, and, if required, 
radiological examinations were made.
No difference was detectable in the somatic and 
psychiatric status of the three groups, development was 
well balanced, corresponding to age. Protocols of the 
combined chemotherapy applied and incidence of 
anomalies, malformations, malignancies and other 
diseases were recorded. Their incidence was similar in 
all three groups though frequently this was higher than 
that of the normal population. Often cumulated 
incidence of severe congenital malformations was found 
in the group conceived after concluded therapy where 
twice as many girls were born as boys. The interval 
between conception and the end of therapy was 
established in the case of children conceived during 
and after therapy. This was shortest in the case of 
healthy children, the number of healthy children 
conceived during cytostatic treatment was also 
remarkable.
Further compilation of data and individual evaluation 
of case reports is recommended.
Akadémiai Kiadó, Budapest
12 Mária Babosa et al.
A b b r e v i a t i o n s  :
Ca-e : 
Cc:
T :
T-a :
S :
S + C a - e : 
S + T :
Embryonal cell carcinoma 
Choriocarcinoma 
Teratocarcinoma 
Teratoma adultum 
Seminoma
Seminoma + Embryonal cell carcinoma 
Seminoma + Teratocarcinoma
VP В : Vinblastine + Bleomycin+Cisplatin
VACAO: Vincristin+Adriamycin+Cyclophosphamide+Actinomycin-D
AMV : Adriamycin + Methothrexat + Vincristin
VAC: Vincristin + Adriamycin + Cyclophosphamide
INTRODUCTION
The incidence of testicular tumours is greatly increased 
among males aged 20 to 35 years (6-7/10 0000/years) /41/. As a 
result of recent advances in the concept of combined therapy, 
based on histological-clinical parameters /4, 13, 52, 55/, 
their mortality rate was reduced /16/, and depending on the 
stage of their status, a major part of them might even be 
considered fully recovered /42/.
Now, beyond the improvement of therapeutic results, further 
aspects have to be considered, whether the presence of 
testicular tumours in fathers and their treatment with 
irradiation or chemotherapy constitutes a problem for advising 
them to have children.
In addition to the well-known short-term side effects of 
chemotherapy affecting the patient it may also impair the 
genetic material or may even trigger new malignant processes 
/27, 29/. Studies on long-term effects /45/ draw attention also 
to further pathological somatic alterations /12, 24/.
As most of the recovered patients are young, several papers 
were published about the procreative power /30/, sexual 
behaviour /53/ and parency /1/ of males as well as children 
conceived by these patients /11, 46/, though their deductions 
were highly variable.
The aim of the present study was to investigate whether 
congenital malformations are induced in children of fathers 
with testicular tumours submitted to combined chemotherapy and 
irradiation. The main accent was made on genetical disorders 
depending on children's conception time.
Children fathered by men 13
P A T H  NTS AND METHODS
Patients
This cohort represents data of 100 randomly selected
children whose father had testicular tumour (Table I). This 
trial was performed on children in a blind study. The groups 
were classified depending on the time of conception as follows 
(see Table II).
In groups I and II 9 months were taken into consideration 
because of threefold termine time the maturation process of 
germ cells (53, 11). In total, there were 31 siblings, of them 
15 had sibling before the treatment and was only one pair born 
after the treatment.
The fathers had histologically confirmed unilateral 
testicular tumour (Table I) and were treated between 1979 and 
1988 at National Institute of Oncology Budapest managed after 
orchidectomy by VACAO, VACAD + irradiation ( ^  ), VPB or 
exceptionally VPB+other combination.
Lymphocyte subpopulations of healthy children of the same 
sex and age (18 children) served as control in data processing.
Methods
Upon admission to the clinic the patients were informed about 
the aim of study. Ten patients (16 children = 13%) refused to 
participate, while 64 males were admitted with 100 children. 
Detailed family, pregnancy and perinatal anamneses were 
prepared. For examinations carried out on the children see 
Table III.
During the processing of test data the parameters of 
children born to healthy fathers (group I) were compared to 
those conceived immediately before the onset of the disease 
(group II) and to those born during or after chemotherapy 
(group III).
The rate of anomalies and disorders were presented as the 
incidence calculated in index population in comparison to 
national rate. -At the evaluation of the time between 
termination of therapy and conception mathematical means were 
calculated. The investigation of lymphocyte subpopulations of 
children fathered by men treated for testicular cancer seems to 
be a very interesting, up to the present unclarified problem.
During the analysis of lymphocyte subpopulation ratios 
Student's "t" test was applied to determine the extrapolated 
range, in possession of the distribution of normal data /5/. 
The data of children conceived during and after therapy were 
demonstrated in this system.
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TABLE I
Distribution of offspring fathered by men treated for 
testicular cancer
Groups, examined depending on children's 
conception time 
I II III 
More than 9 months During or 
9 months before before after Total 
onset of treatment the start of therapy
therapy
A. Histological diagnosis of fathers
S 9 1 1 + 1+ 11 + 1 +
S anaplast. 2 - - 2
Ca-e 24 + Í 5 8 37 +1+
T 5 4 3 12
S + Ca.— e 3 + Í 4 - 7 + 1 +
S+T 3 - 2 5
Ca-e+T 5 3 5 13
Ca-e+T+S 6 1 - 7
T+Cc - 1 1 2
Rhabdomyosarcoma - - 1 1
B. Pregnancys sequence
1st pregnancy 31+f 9 8 48 + 1 +
2nd pregnancy 13 + Í 5 11 + 1 + 29 + 2 +
3rd pregnancy 7 4 1 12
4th pregnancy 3 1 - 4
5th pregnancy - - - -
6th pregnancy 1 - - 1
no sign. 2 - 1 3
C. Mothers' age
<  20 years 3 - - 3
20-25 years 26 + 1+ 7 11 44 + 1 +
26-30 years le + lf 7 6 + 31 + 1 +31-35 years 7 4 2 + 1 13 + 1 +
У ’ 3 5 years - 1 - 1
no sign. 3 - 2 5
D. Offspring age
1 year - 1 5 + 1 + 6 + 1 +
1- 3 years 14 + 1+ 8 8 30 + 1 +
4- 6 years 16 + 9 6 31
7- 9 years 12 + 1 1 1 14 + 1 +
10-12 years 8 - - 8
13-15 years 5 - - 5
>■ 15 years 2 - - 2
E. Offspring sex
male 25 + 1+ 9 6 + l + 40 + 2 +
female 3 2 + 1+ 10 15 57 + 1 +
57 + 2 + 19 21 + 1 + 97 + 3 +
+ dead child
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TABLE II
Groups and number of children according to conception time
Groups of children Number of children
I . More than 9 months before 
the initiation of therapy
59
I I . 9 months before the initiation 
of therapy
19
I ll. During and after therapy 22
TABLE III
Examinations carried out on children and their number of
offspring
Examinations carried out on children Number of children
Physical examination 96
Bloodgroups for the identification 
of paternity 20 (in III )
Laboratory test 51
Radiological examination (bone-age) 21 ( in III )
Abdominal ultrasound investigation 57
Immunological analyses (Behring, BMA) 18 (in III )
Wartegg-and anxiety test 62 (age 3 ye a r s )
No tests were performed on a single child in group III who 
d ie d.
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RESULTS
Age, diagnosis and treatment of fathers
Fig, 1, Table I show the age distribution and diagnosis of 
the fathers of the children studied. One third of the patients 
was 26 to 30 years old and a major part of them (35/64) had 
been submitted to VPB treatment at 4 to 6 occasions due to 
embryonic carcinoma. The paternity of recovered patients could 
not be excluded on the basis of blood tests.
Number of
Fig. 1. Age of men treated for testicular cancer, either 
г- I : at the birth of offspring conceived before therapy, 
wnrm\ or at the birth of offspring conceived during and 
after chemotherapy
Gestational, perinatal anamnesis
Analyzing the pregnancy pattern of individual groups (Table 
I) in the first two groups the children were coming from the 
first pregnancy while most of those who were born after 
concluded therapy came from the second pregnancy. This 
observation was closely associated with the dramatic increase 
in the incidence of induced abortuses after the diagnoses 
became known (9/13) (Table IV) while earlier spontaneous 
abortuses had been the predominant pattern (5/8).
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No difference was detectable between the 3 groups either as 
regards gestational or obstetric anamneses except for a single 
feature: premature delivery. Most of the premature infants
(3/19) were conceived during the 9 months preceding therapy. In 
89 of the 100 children studied the gestational period was in 
the range of 39 to 42 weeks.
Reviewing perinatal anamneses there was one feature
deserving attention, the incidence of physiological jaundice; 
in each of the three groups (3/59, 2/19, 3/22) though with 
varying frequency. Symptoms suggesting cerebral haemorrhage or 
microcephaly were observed in two children born before
castration. A newborn with persistant ductus Botalli was 
conceived 7 months before the onset of therapy while atrial 
septal defect and spine bifida/anencephaly were found in 
children conceived during the posttreatment period. If properly 
cared for, patients with valvular disease remained in normal 
condition. A single 6 weeks-old infant with neurological defect 
has died.
Mother's age and familiar anamnesis
Age of the mother, diseases and causes of deaths of grand­
parents as well as of brothers and sisters were recorded. The 
age of most mothers in all 3 groups was in the range of 20 to 
25 years, there was a single mother who was older than 35 years 
at delivery (Table I). In the line of both parents malignancies 
had the highest incidence (28/100) followed by cardiovascular 
diseases (22/100) and diabetes of the elderly (16/100).
Sex, age and somatic development of children
The group of 100 children studied consisted of 58 girls. The 
incidence of girls conceived during and after therapy was 15/22 
(Table I). It demonstrates the age distribution of children and 
percentual data of their development was observed, too. 
Compared to the balanced percentual weight and length curves of 
newborns at birth four fifth of the population studied was in 
the range of 10 to 90% in all three groups. 1/3 to 1/5 of them 
were born with a length higher than 90%, considered the limit 
of the normal range. Data recorded in 1989 show that 4/5 to 
9/10 of the percentual weight and 3/4 to 9/10 of the percentual
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TABLE IV
Loss of offspring due to different causes in families with
testicular cancer
Before onset 
of disease
Within months of 
start of therapy 
and the birth of 
offspring
After 
the birth 
of offspring Total
Spontaneous
abortion 5 1 2 8
Artef icial 
abortion 2 9 2 13
Still birth 0 0 0 0
Postnatal
mortality 2 0 1 3
(cause) Wilms tumour spina bitxda
neopl.of the brain and anencephaly
TABLE V
Perinatal data of children fathered by testicular cancer
patients
Groups
Groups, examined depending 
conception time 
More than 9 9 months 
months before before 
treatment treatment 
I II
on children's
During and 
after 
treatment 
III
Total
Total
of children 59 19 22 100
examined
Gestation time
7  39 weeks 54 15 20 89
37-38 weeks 4 1 1 6
<  37 weeks 1 3 1 5
Birthweight
^  2500 g 5 2 1 8
2600-3400 g 11 2 3 16
3500-4400 g 41 14 17 72
^  4500 g 2 1 1 4
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length of the children mostly aged 3-8 years and born before 
the illness of the father, or aged 2-5 years and born during 
the pretreatment months or aged 0.5-5 years and born during or 
after therapy were within the normal 10 to 90% range. There was 
no significant difference in the birthweight of children in 
groups I , II and III (Table V). The bone age of all children 
listed in the III. group was normal.
Congenital anomalies, malformations, malignancies and other 
acquired syndromes
The incidence of congenital anomalies was not higher in the 
population conceived during the pretreatment months, during and 
after therapy compared to those of the first group (Table VI).
However, as regards congenital malformations, the occurrence 
of heart diseases and neurological disorders should be 
mentioned in groups II and III.
At the assessment of minor anomalies (Table VII) and con­
genital malformations in two children, conceived during the 
24th posttreatment month, the cumulated incidence of congenital 
malformations was observed.
Reviewing the incidence of malignancies (Table VI) two 
children, born when their fathers were not ill yet, died due to 
Wilms' and cerebral tumour at the age of 8.5 and 2.5 years, 
resp. There were also malignancies in the offsprings conceived 
after concluded therapy: the 4 - months -old child of a man
treated for embryonic carcinoma had neuroblastoma but remission 
was attained by combined chemo- and radiotherapy. At present 
the child is 2 years old, untreated and symptom-free.
In the following the causal effect of the interval between 
conception and therapy as well as the effect of cytostatic 
agents was studied (Table VII).
Two fathers submitted to VACAD and VACAD+radiotherapy had 
children with anomalies. Analysing the incidence of congenital 
malformations and malignancies it was found that most of the 
patients received VPB therapy. Most of the fathers (12/14) 
whose children were declared healthy (14/22) have also been 
treated according to the VPB protocol (Table VII). The mathe-
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TABLE VI
Occurrence of congenital anomalies and other disorders 
in children conceived by testicular cancer patients
National
Groups examined depending Total rate+
on children'
Groups_______________________i_
Total of children 
examined 59
A. Occurence of
minor anomalies
hernia umbilical 1
nevus (over 1 cm) 2
alopecia (localised) 1
inner epicanthal folds 3 
clinodactily 2
hypertelorism 2
flat occiput 1
prominent occiput 2
B. Occurence of congenital 
abnormalities
atrial septal defect(ASD)- 
horseshoe kidney 
patent ductus arteriosus - 
microcephaly
spina bifida+anencephaly -
strabismus cong. 2
inguinal hernia cong. 3
dysplasia of hip 2
undescended testis 3
hydrocele testis 2
micrognathia 
teleangiectasia 
nevus flammeus 4
C. Occurence of malignancies
Wilms' tumour 1
neuroblastoma
neoplasm of the brain 1
D. Other disorders
conception time 
II III.
(control)
19 22 100 1000
- - 1 0.98
- - 2 2.74
- 1 2 1.10
1 Iх 5 2.35
- Iх 3 0.39
1 1 4 4.41
- - 1 0.88
- 3 6.96
- дХ X 1 0.95
- дХХ 1 0.40-0.8
1 - 1 0.86
1 - 1 0.10
- 1 1 1.63-1.0
- 1 3 26.25
1 - 4 12.10
- - 2 2 7 . 5 3
- 1 4 8.0
1 - 3 8.0
1 - 1 0.03
1 - 5 30.0
1 7/10^/year 
1 1 7/10 /year
1 23.9/10a/yea
bronchitis obstr. 10 4 2 16
malnutrition 5 2 2 9obesity 2 3 _ 5kyphosis 4 3 2 5
anemia (iron deficiency) 7 3 2 12
atopic dermatitis 2 2 _ 4
lymphadenopathy (benign) - 1 - 1
+ see references/7 ,8 ,54/
X the same child (epicanthal folds + clinodactily) 
XX the same child (ASD + horseshoe kidney)
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TABLE VII
Healthy children and offsprings fathered by men treated 
for testicular cancer
Disorders
Occur­
rence Sex
Fathers
histology
Time from completion 
of treatment to 
Treatment conception
(month) means 
(month)
A. Minor anomalies
alopecia 1/22 F Ca-e VACAD+irr 24
epicanthal
folds 1/22 F* Ca-e+T VACAD 24 22.75
clinodactily 1/22 Fx Ca-e+T VACAD 24
hypertelor. 1/22 F T+Cc 6 VPB 19
B. Congenital malformat ions
ASD 1/22 pXX Ca-e 7 VPB 24
horseshoe
kidney 1/22 Fxx Ca-e 7 VPB 24
spina bifida+
anencephaly 1/22 Mxxx S AMV+5 VPB 89
strabismus 32.0
congen. 1/22 F Ca-e+T 6 VPB 24
undescended
testis 1/22 M Ca-e 6 VPB 22
CMalignancies
neuroblastoma 1/22 F Ca-e 4 VPB 9
D. Healthy children F S+T VACAD+4 VPB 18
F Ca-e 4 VPB 30
M T 4 VPB 55
F Rhabd.sc VAC during therepy
F Ca-e+T 4 VPB 32
M Ca-e 4 VPB 16
F Ca-e+T 5 VPB 15 21.0
M Ca-e 6 VPB during therapy
F Ca-e 6 VPB 30
F T 6 VPB 18
F T 6 VPB 33
F s AMV+5 VPB 23
M S+T 6 VPB 24
M Ca-e+T 6 VPB 6
xxx dead child
X the same child (epicanthal folds+clinodactily) 
XX the same child (ASD+horseshoe kidney) 
irr.= irradiation 
M= male 
F= female
юNi
Fig. 2. T cell subsets.
A. CD4/CG8 ratio and
B. CDj/CDjg ratio in children fathered during and 
after chemotherapy by men treated for testicular cancer 
X = prospective mean of healthy control
%-interval = distribution of healthy control data
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matical mean of the intervals between the end of therapy and 
conception was shorter (21.0 months) in the case of healthy 
children compared to the malformed ones (anomaly: 22.75 months, 
malformation+malignancy: 32 months). Even healthy children were 
conceived during therapy.
Immune status
The study could be evaluated in the case of 18 children of 
group III. Helper T/suppressor T or Pan Т/Рап В ratios were 
plotted in the assumed scattering range of healthy controls 
(Fig. 2). The helper/suppressor ratio was beyond the 68% 
scattering range in the case of 4 children but only one was 
less than 1.0 (0.98). Only a few children (2/18) had Pan T/Pan 
В ratios in the range of 68 to 95%.
Psychic maturity
Psychic status was assessed by family patterns, Wartegg and 
anxiety tests applied differentially according to age. Two 
boys, one of them of group II, had adaptation difficulties and 
retarded development of speech. The major part of the 
offsprings (70/100) however, had an open, adaptive, creative, 
optimistic personality with emotional and mental maturity 
corresponding to their respective age. Only a single child was 
pathologically anxious, full of stress and uncertainty with 
strong mother fixation probably due to the rather disorderly 
relationship of its parents. Mother fixation was a dominant 
feature recurring in about 20% of the children (mother in the 
center in pantalons, rather muscular, with a hat or sometimes 
glass in hand).
DISCUSSION
The increased survival rate due to successful therapy is 
unfortunately accompanied by unexpected side effects, too /29/. 
This is especially the case in patients with testicular 
tumours. The increasing rate of remissions /16, 42/ with 
concomitant preservation of procreative ability /30/ may lead
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to children with potential retardations, malformations /46/.
In agreement with the literature /16, 41, 42/ the data 
compiled in the field of testicular tumours demonstrate that 
young fertile males are the most affected population group, 
particularly the recovered 26-30 year old ones (Fig.1).
Though most of them had already a child before the diagnosis 
of the tumour, the chances of those born after successful 
therapy are most important.
Several papers review the pregnancy of mothers who suffered 
from malignancies /15, 17, 56/, the fate of their children /39/ 
and some even attempt to follow them up for prolonged periods 
of time /3, 44/. There are studies of pregnancy outcome after 
treatment during childhood or adolescence for neuroblastoma 
/6/, ALL /36, 20, 48/, Hodgkins' disease /19, 25/ and Wilms' 
tumor /31/. Case reports in infants of women treated for ALL 
have documented minor /37, 20/ and major congenital anomalies 
/36/, none has been diagnosed with any type of childhood cancer 
/37, 36, 20/. Beyond the articles mentioned in the introduction 
only two papers /28, 49/ report in detail about children born 
to fathers with testicular malignancies /25/. Several other 
studies /36, 20/ reported pregnancy outcome in men after 
treatment of patients for ALL. None has been diagnosed with 
congenital anomaly or childhood cancer. The current data do not 
suggest an increase in the spontaneous abortion and in the 
females/males ratio /20/. Some stress the high probability of 
abnormalities in the children of fathers with testicular 
tumours submitted to radiotherapy /46/ while others advise them 
after remission induced by chemotherapy to have children /49/. 
In fact the question is still open in the literature as well 
for the patients.
From the social point of view it has great importance that the 
number of artificial abortuses increases when the patient is 
informed about the diagnosed malignancy, since they are afraid 
of a potentially malformed child.
In agreement with literature data /56/ the number of 
premature births became higher in mothers who have learned 
about the condition of their husband during pregnancy /32/.
Similarly to the data of Senturia /49/ referring to the age
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□f mothers no difference was detectable between the groups born 
before castration and after treatment.
Comparing the observations on the growth and development of 
children born after combined cytostatic therapy with the 
respective literature data /22/ and with Hungarian growth 
standards they remained within the range of normal development. 
No skeletal retardations were recorded in children conceived 
during and after the chemotherapy of fathers with testicular 
tumour unlike children whose parents with Hodgkin's disease 
were submitted only to radiotherapy /25/.
The relationship between severe congenital malformations 
disease and therapy is reviewed by several authors /11, 22, 28, 
46/. At the evaluation of data the incidence of malformations 
in the population /7, 8/ the in vitro and in vivo teratogenic 
effect of the cytostatic agents applied /26, 33/ as well as 
drug exposure and conception times /49/ were considered.
Investigating the relationship between therapy and 
congenital malformation in children conceived by fathers 
treated according to the VACAD protocol, primarily anomalies 
were found while after successful VPB therapy /4/ severe 
cumulated malformations (valvular disease, spina bifida, 
anencephaly, etc) were recorded in addition to the large number 
of healthy children (14/22) though congenital anomalies (17/59) 
and malformations (24/59) were also found among the offspring 
conceived before the illness.
The role of cytostatic agents in carcinogenesis is well 
known /40, 54/ but the relationship between combined 
chemotherapy and neuroblastoma /13, 50/ recorded in children 
conceived in the 9th posttreatment month may be subject to 
doubt if the Wilms' /9/ and cerebral tumour /2/ found in 
offspring born before the disease of fathers is considered.
Unlike the results of Senturia /49/ difference was found in 
the interval between concluded therapy and conception of 
progeny. The mathematical means of healthy children were lower.
Cytostatic therapy in pregnant mothers induced frequently 
chromosome aberration in the offspring /47/ while no chromosome 
analysis of children conceived during or after the treatment of 
fathers with testicular tumour was found in the literature
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beyond our earlier paper /23/.
In our study chromosomal aberrations were recorded in 
children conceived during and after termination of the 
treatment, but no significant differences were found between 
control and "treated" offspring groups /23/.
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An extremely rare clinical syndrome on a 7-year-old- 
girl is presented. Besides isolated glucocorticoid 
insufficiency, achalasia and alacrimia disturbance of 
the lipid metabolism was also detected - being a 
special feature of this case. The details of the 
endocrine workup is discussed, providing clues for the 
possible pathomechanism.
The correct diagnosis and specific therapy is of 
utmost importance in the everyday life of the patient.
INTROOUCTI ON
Isolated glucocorticoid deficiency or selective ACTH
insensitivity is a rare disease. Increased skin pigmentation 
and feeding difficulties may appear in early infancy, but the 
symptoms are manifested typically in the second year of life, 
as hypoglycaemia and recurrent attacks of vomiting. Spasms and 
coma may also occur. Low and non-stimulable serum cortisol 
values are characteristic together with elevated ACTH levels. 
There is no electrolyte aberration typical of hypadrenia; the 
aldosterone secretion is normal /2, 17, 25/. Familial
occurrence has also been described / 6 , 21, 22/. The association 
of this disease with achalasia /16/ is very rare, but even the 
co-occurrence of isolated glucocorticoid deficiency of the 
adrenal, achalasia and alacrimia (3 A syndrome) has been 
observed /11, 18/. No publication has been found that describes 
an accompanying lipometabolic disorder.
Akadémiai Kiadó, Budapest
32 Ágnes Várkonyi et al.
The report on our patient with isolated glucocorticoid 
deficiency, achalasia and alacrimia is considered interesting 
due to its rarity, the diagnostic difficulties and the observed 
shift in fat metabolism.
PATIENT AND M E T H O D S
Case report:
T.B. a girl, was born in 1977 from a first, uneventful 
pregnancy, at term, as a mature newborn. Her development was 
problem-free for several months. Following weaning with solid 
food, she began to have episodes of vomiting with a severe 
oesophageal character, which from the age of about 3 years 
occurred at every meal. After infancy, the skin and later the 
oral mucosa became markedly pigmented. From babyhood on she was 
fatiguable, adynamic, often prostrate, extremely neuropathic, 
depressed and inactive. Her growth was in the range 75-90 
percentile, but her weight was retarded, at 15-20 percentile.
At the age of 7 years, she was admitted to the Paediatric 
Department. Some days later, during the early morning hours, 
she had a severe attack of convulsions accompanied by loss of 
consciousness (a similar attack had not been experienced 
earlier), which proved to be of hypoglycaemic origin (blood 
sugar level: 1.7 mmol/1). Due to the appearance of the child, 
the possibility of Addison's disease had been suggested 
previously, but the normal serum electrolyte values and 
considerable hypopotassaemia observed in the ECG contradicted 
this. The low serum cortison level (1.2-3.4 yug/100 ml) and the 
high plasma ACTH value (291-330 pg/ml; normal: 20-80) obtained 
during the informative examinations supported, however, the 
possibility of an adrenocortical disease. At the same time, the 
renin and aldosterone levels were normal. On mobilization, the 
serum aldosterone level exhibited a 5-fold increase. On the 
administration of ACTH (2 /ug/kg body weight) i.v., neither the 
serum cortisol nor the serum aldosterone level showed any 
elevation. For a further evaluation of the function of the 
adrenal cortex, a theophylline load was applied: 6 mg/kg body 
weight theophylline was administered i.v. for 2 0  minutes, and a 
dose of 1 . 2  mg/kg body weight/hour was then given in i.v. 
infusion for 2 hours. The serum cortisol and serum aldosterone 
levels were controlled hourly for 4 hours, but no elevation in 
their values was observed (Table I).
Gastrointestinal symptoms were checked by X-ray contrast 
examinations. These demonstrated a spasm in the cardia with a 
dilated oesophageal body (Fig. 1). The oesophageal sphincter 
pressure was normal (12-30 mmHg).
Other findings: serum cholesterol: 10.8 mmol/1, 
triglyceride: 0.68 mmol/1, HDL-cholesterol : 1.24 mmol/1, 
(values in pathological range found repeatedly) LE-cell: 
negative, latex: ++. Serum Tj (2.0 nmol/1) and Тд (126.9 nmol/1
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TABLE I
Effect of a theophylline load in the 7-year-old patient
Sampling Cortisol Aldosterone
(hours ) (/jg/100 ml) (ng/100 m l )
1 3.4 3.9
2 2.2 4.3
3 2.0 3.8
4 1.6 3.7
values characterizing the thyroid gland function were normal. 
Ophthalmological consultation revealed a decrease in 
lachrymation. (At the age of 11, there was a complete lack of 
lachrymation) . During the diagnostic process, the life- 
endangering hypoglycaemia and the deficiency state due to 
nutritional disturbances necessitated the introduction of 
nasogastric nutrition, which resulted in a considerable 
improvement in the clinical state of the patient. To correct 
the glucocorticoid deficiency, substitution therapy with 
cortisone acetate (Adreson tablet) was started. Initially, this 
markedly improved the very severe symptoms of vomiting. The 
skin pigmentation also decreased. Later, however, the vomiting 
increased in severity again and a pneumatic dilation of the 
oesophagus became necessary; in accordance with recent 
literature recommendations /3/, surgery (Heller) was performed 
at the age of 10. As a symptomatological treatment of 
alacrimia, artificial tears have since been used regularly.
At the age of 11, the girl was still impuberal (height: 148 
cm; weight: 32.5 kg). Glucocorticoid substitution therapy was 
interrupted for 3 days, and a more detailed analysis of 
adrenocortical steroid hormones in the blood serum was 
performed. Cortison was determined by fluorimetry, other 
steroid hormones, their precursors and plasma ACTH by our own 
specific radioimmunoassay methods, and the binding capacity of 
steroid binding transport proteins by the binding of -5H- 
cortisol and -'H-dihydrotestosterone /8, 9, 14, 23/.
Preliminary steroid studies (low cortisol and high ACTH 
levels) suggested the possibility that the glucocorticoid 
deficiency was caused by the defect of one of the enzymes 
involved in steroid hormone biosynthesis. Thus, in addition to 
aldosterone and cortisol, the serum concentrations of their 
precursors (pregnenolone, progesterone and 17-OH-progesterone) 
were also determined in the basal state and 1, 2 and 4 hours 
following in i.v. ACTH bolus. As shown in Fig.2, an upright
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Fig. 1. Bariumswallow demonstrating typical finding of 
achalasia
position increased aldosterone secretion, but otherwise, the 
levels of cortisol and all investigated steroid precursors in 
the blood were extremely low. There was no increase in these or 
in aldosterone following the administration of ACTH. Likewise, 
pathologically low levels of testosterone and its precursors 
(dehydroepiandrosterone, dehydroepiandrosterone-sulphate, 
andostenedione) were detected. The serum oestradiol-17/9 level 
was in the normal prepuberal range. All these latter steroids 
were unresponsive to the administration of ACTH (Fig. 3). The 
binding capacities of serum steroid binding proteins ("Sex 
Hormone Binding Globulin = SHBG and "Corticosteroid Binding 
Globulin" = CBG) proved to be normal (Fig. 4).
A computer tomogram of the adrenal gland verified hypoplasia 
of the glands on both sides (National Institute of Vascular 
Surgery, Dr. К .Karlinger ).
To prognosticate the sexual-steroid secreting capacity of 
the impuberal ovaries, choriongonadotropin (Choriogonin inj.) 
was administered in a 3000 U/day dose i.m. for 6 days. This led 
to an elevation of some precursor levels in the serum (17-0H- 
progesterone: from 0.5 ng/100 ml to 40 ng/100 ml; androstenedione
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ALDOSTERONE CORTISOL
PREGNENOLONE
N= Normal values  
and ranges
Fig. 2. Serum levels 
precursors (у. в.,
of aldosterone, 
1 1  y.,2 )
cortisol and their
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TESTOSTERONE OESTRADIOL -17/b
N:  N o r ma l  values 
and  ranges
Serum levels of sex-steroids and their precursors 
(T. B., 11 y., 2)
Fig . 3 .
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Fig. 4. Binding capacity of sex-hormone binding globulin and 
corticosteroid binding globulin in serum (y_ g  ^ ;q  2.1 Ç)
from 4.0 ng/100 to 46 ng/100 ml), but no change was found in 
the levels of pregnenolone, progesterone, testosterone or 
oestradiol-17/3.
As glucocorticoid substitution therapy, at present she 
receives 2x25 mg cortisone acetate orally daily. In addition, 
for normalization of her hypercholesterinaemia, an appropriate 
diet and the administration of cholestyramine have been 
introduced.
DISCUSSION
Isolated glucocorticoid deficiency or selective ACTH 
insensitivity is a very rare disease. It is considered to be a 
hereditary, progressive, degenerative disease or a primary 
insensitivity of the adrenal glands /18,- 19, 22/. Its X-linked 
or autosomal recessive inheritance have been presumed / 1 0 /, but
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the latter is more likely /25/. According to Werder et al, 
damage of the mineralcorticoid function /4, 25/ may also
develop gradually. Some publications /16, 22/ stress the
importance of a higher than average body length as a symptom, 
which was most conspicuous in our case because of the retarded 
increase in body weight.
Achalasia itself in children is very rare: its frequency is 
1:10 000 in an average population /7, 20/ and less than 5% of 
the cases are observed under the age of 15 /3, 24/. It is a 
disease of unknown origin, characterized by a non-organic 
obstruction and an incapacity for relaxation of the distal 
segment of the oesophagus, and consequently dilation of the 
oesophagus develops. Its principal clinical symptoms are 
dysphagia, regurgitation of fluid and solid food, vomiting and 
a retarded increase in body weight. A disordered cholinergic 
innervation of the oesophagus is supposed. Its autosomal 
recessive hereditary predisposition is probable.
The first survey concerning the accumulated occurrence of 
glucocorticoid deficiency, achalasia and alacrimia was 
published in 1978 /18/ by Lanes et al /17/ who reported on its 
complication with a partial mineralcorticoid deficiency. 
Geffner et al /11/ detected the full syndrome in a patient aged 
3 1/2. It has not been explained yet how these diseases are 
c o n n e c t e d .
The ACTH insensitivity of the adrenals, the absence of ACTH 
receptors, or a steroid synthesis disorder may be assumed as 
causes of isolated glucocorticoid deficiency. Geffner et al 
/ 1 2 / suggested that a theophylline test may be useful in 
differentiating these possibilities. Theophylline acts by 
bypassing the ACTH receptors and inhibiting phosphodiesterase, 
which hydrolyzes cAMP. Theophylline therefore elevates the cAMP 
level directly and increases intracellular steroidogenesis. If 
theophylline elevates the steroid level, a receptor deficiency 
can be supposed. If theophylline is without any effect, an 
impaired intracellular synthetizing mechanism (as in our case) 
can by hypothesized.
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The computer tomogram of the glands contradicts the 
possibility of any enzyme defect in the adrenal cortex: a 
deficincy of the enzymes involved in steroidogenesis would lead 
to adrenal hyperplasia. With such a clinical picture, well- 
controlled glucocorticoid supplementary therapy may decrease 
the size of the glands, but produces no hypoplasia as observed 
in our patient. Our detailed steroid investigations definitely 
exclude hypadrenia based on an enzyme insufficiency. High serum 
levels of steroid hormone precursors prior to the enzyme block 
would indicate this etiology. In the serum of our patient, 
however, all the biosynthetic intermediates (pregnenolone, 
progesterone, 17-OH-progesterone) were found in pathologically 
elevated concentrations. It may be presumed that the first step
in the biosynthesis of steroid hormones (cholesterol--- ?
pregnenolone transformation), where the ACTH effect ought to 
prevail, is inhibited. The pathologically elevated ACTH level 
and the ineffectivity of ACTH therapy suggest a possible 
diagnosis of ACTH insensitivity. This may be due to a 
congenital lack of ACTH receptors or their insufficient 
function, or even to an unknown (possibly autoimmune) disease 
leading to atrophy of the zona fasciculate and the zona 
reticularis of the adrenal cortex, but not the zona 
glomerulosa. By stimulating the renin-angiotensin system, the 
erect posture of the patient may increase aldosterone 
secretion, as the function of this mechanism is independent of 
c A M P . Even a relatively small amount of precursor steroids may 
be enough to ensure as the serum aldosterone concentration is 
1 0 0 0  times lower than that of cortisol even in a healthy person 
/13, 15/. The above supposition might be confirmed by 
investigating the effect of i.v. angiotensin II, but we have 
had to forego this diagnostic method because of its potential 
danger /5/.
The normal levels of steroid binding proteins (SHBG and CBG) 
may be of interest because of the extremely low sexual steroid 
and glucocorticoid levels of our patient. Accordingly, the 
synthesis of the transport proteins in the blood is not 
regulated by the levels of steroid hormones alone (although a
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very low testosterone concentration may play a role in the fact 
that the binding capacity of SHBG has attained the upper limit 
of the normal range).
The increase in the levels of sex hormone precursors follow­
ing the administration of choriongonadotropin may promise that 
the ovaries will be able to synthetize their organ-specific 
hormones. More precise information could be obtained by apply­
ing FSH + LH sequentially, but we considered it unwise to prov­
oke early puberty in a child who has not attained adult body 
height. Further follow-up observations of the patient will fur­
nish more data on the endocrine function of the gonad.
During examinations for an absorption disorder as causal 
factor of the retardation in weight, we tested the serum 
cholesterol level and found it unexpectedly high. 
Hyperlipoproteinaemia of type lia was diagnosed. In 
hypothyroidism, hyperlipidaemia of this type may occur 
secondarily / 2 1 /, but this etiological possibility was 
excluded. Associated with high-dose glucocorticoid therapy, 
hyperlipoproteinaemia of type IV may develop. At the beginning 
of observation, however, the patient was not given any steroid 
preparations and the later therapy consisted only of hormone 
substitution doses. Her mother was hyperlipoproteinaemia of 
type lia, detected because of xanthelasma formation round her 
eyes. Similarly detailed steroid hormone tests were performed 
on the mother but the results were completely normal.
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206 поп-selected children who had wheezy bronchitis 
before two years of age were observed in the first 
follow-up (1985) about 9 years after their clinical 
wheezy episode. Among them 31 patients (15%) showed 
bronchial hyperreactivity (B.H.) after acetylcholine 
challenge and 9 children became asthmatic. In the 
second follow-up (1988) 28 children who had B.H. and 
randomly 17 children who did not have B.H. 
participated. The prognosis of wheezy bronchitis is 
good, there was no new asthmatic child at this time. 
The B.H. was found to diminish only in 7 cases. During 
the last 3 years wheezy episodes developed only in 5 
asthmatic patients. The skin prick test (SPT) 
positivity did not change (26% versus 29%). The 
familial atopy in the group B.H. is higher (43%) than 
in the group non B.H. (23%) but the difference is not 
significant (X -1.72). No significant correlation was 
found between the familial atopy and SPT positivity. 
The familial smoking is higher in the group B.H. (78% 
versus 64%) but no significant influence on the B.H. 
(X -1.03) could be detected.
INTRODUCTION
Wheezing is common in infancy and early childhood, Brasher 
found about 10% under two years of age /1/ and in Hungary its 
frequency is similar /13/. Warner found wheezing in 10% of 
infants /10/. Clark and Godfrey mentioned that in spite of the 
very similar symptoms the wheezy bronchitis is not equal with 
bronchial asthma /2/. On the other hand, wheezy bronchitis is 
one of the both ends of "asthmatic scale" after Williams and 
McNicol's opinion /11/. Wheezing can develop in the case of
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different diseases (cystic fibrosis, bronchial anomalies, 
vascular ring, heart failure, foreign body, etc.). In the cases 
of repeated wheezy episodes attention should be paid to 
bronchial asthma.
In our study the following questions had to be answered:
1. What kind of prognosis do those children have who have had 
wheezy bronchitis before two years of age?
2. Whether bronchial hyperreactivity can be detected in them 
and how does it change?
3. What connections can be detected between prognosis and 
familial atopy, skin prick test positivity and familial 
smoking?
To answer these questions we carried out a two-step follow­
up of children who were earlier treated with wheezy bronchitis 
at our Department. The criteria of wheezy bronchitis was: 
during a febrile respiratory tract infection taken place before 
two years of age wheezing with respiratory dyspnea could 
be detected. By clinical examination hyperinflated lung, 
wheezing and rhonchi were found. X-ray picture also showed 
hyper inflated lung.
M AT ERIALS AND M E T H O D S
Patients material
In the first follow-up (1985) 206 children were examined, 
who were treated for wheezy bronchitis at our Department in the 
time period of 1974-76. The children were unselectedly invited 
some 9 years after their clinical treatment. The mean age was 
11 years, 139 boys and 67 girls. In the second follow-up 
(1988 45 children participated:
1. Group B.H.: 28 children who had B.H. in the first 
follow-up, mean age 14.5 years,
2. Group non B.H.: 17 randomly selected children, who 
did not have B.H., mean age 14.1 years.
For the comparison of the acetylcholine challenge results 
data of 30 healthy children having had no atopy, no repeated 
lower respiratory tract diseases, and no other kinds of chronic 
diseases were used.
Method
The anamnestical data were registered on questionnaires 
which were planned for our follow-up. Physical examination of 
children was done.
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Skin prick tests (SPT) were carried out on the forearms of 
children according to the prescription of manufacturer Bencard 
with the following allergens: Dermatophagoides pteronyssinus, 
cat, dog, ragweed, grass mix, tree mix, flower and shrub, 
moulds: А^з, M^ q , Mi^. After 15 minutes urtica 3-5 mm diameter 
as 3+, greater than 5 mm and with pseudopodium as 4+ was 
appreciated.
Bronchial challenge was carried out with 0.5% acetylcholine 
breathing for 2 minutes on tidal level from ultrasonic 
nebulizer (TUR-USI 50). The control was phys. saline solution. 
The output of the ultrasonic nebulizer reached a steady state 
after 8-10 minutes of working: 1.35 ml +_ SD 0.11 ml/2 minutes, 
accordingly the challenge was started after 1 0  minutes of 
nebulising. The FEV^ and PEF values were determined before and 
after 3 and 5 minutes of acetylcholine inhalation by SPo^ 
spirograph. The degree of bronchospasm was expressed as the 
percentage fall of FEV^ and PEF. The criteria of positive 
challenge - the bronchial hyperreactivity - was a decrease 
over 20% of FEV^ or PEF.
The PC 2 0  value was calculated from FEV^ results. The 
challenge was done on symptomfree children, who had not 
respiratory tract infection in the last 4 weeks.
In the mathematical analysis we used the Pearson test and 
the level of significancy was at p < 0.05.
RESULTS
/
At the time of the first follow-up 9 of the 206 children 
proved to have asthma (4%), while at the second follow-up no 
new asthmatic was found. Wheezy episodes disappeared in 189 
children (92%) by 7 years of age. At the second follow-up 
(1988) during the last 3 years wheezy episodes continued only 
in 5 of the asthmatic patients.
At the first follow-up the bronchial challenge showed a 
positive result in 31 (15%) of 206 children. At the second
follow-up 7 out of 45 reacted positively upon bronchial 
challenge. In the control group no child had positive reaction 
on 0.5% acetylcholine solution. The change of FEV^ and PEF mean 
values are demonstrated on Table I. The value of PC 2 Q did not 
change in the asthmatics, however, it did increase in the 
Group B.H., as shown in Table II.
Skin prick test positivity was experienced in 35 (17%) of
206 children, while at the second follow-up 13 (28.8%) of 48 
(in this group the previous SPT positivity was 26%). At the 
second follow-up there was no difference in SPT positivities of
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TABLE I
Changes of PEF and FEV^ values after 0.5 
percent acetylcholine challenge
mean
PEF%
decrease
FEVX%
Group B.H.
1985
1988
-27.3 
- 1 2 . 2
-26.9
-14.9
Group non B .H.
1985
1988
- 8  . 5 
- 6  . 2
- 6 .1 
-7.2
Control - 6 .3 -4.9
TABLE II
Changes of PC 2 0  values
Control F ollow-up
I . II
Ail patients 2.01 (30) 1 . 2 0 (206) 0.79 (45)
Asthmatics - 0.49 (9) 0.47 (8 )
Non-asthmatics - 1 . 26 (197) 0.92 (37)
Group B .H . - 0.37 (28) 0.67 (28)
Group non B .H . - 1.52 (17) 1.29 (17)
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Group B.H. and Group non B.H. (28 vs 29%). By the end of the 
follow-ups the SPT remained negative in 28 children, while 
positive in 8 (Fig. 1): the SPT of 4 patients changed from
positive to negative, while 5 changed inversely, from negative 
to positive. One of the last ones developed drug allergy, the 
others did not show allergic symptoms.
Family atopy (bronchial asthma, atopic eczema, allergic 
rhinitis) appeared as follows:
First follow-up (206 patient.s) 38%
Second follow-up (45 patients) 37.7%
Group B.H. 43%
Group non B.H. 23%
Familial atopy occurred more frequently in the Group B.H. 
than the Group non B.H., however the difference is not 
significant (X 2 = 1.72). No significant correlation could be
found between the familial atopy and SPT positivity X2 =0.18 
(Fig. 2).
At the second follow-up the effect of familial smoking upon 
bronchial hyperreactivity was also studied. Families of 45 
children included smokers in 73%. The ratio of smokers in the 
Group B.H. was 78%, while in the Group non B.H. it was 64%, 
giving a non-significant difference X 2=1.03 (Fig. 3).
DISCUSSION
In the course of the two-step follow-up of non-selected 
wheezy bronchitis children the disease showed favourable 
prognosis. 92% of the children had no more wheezy episodes by 
the age of 7 years, similarly to Selander's results /9/ 
according to which 80% of the children became symptomfree by 
the age 6-11 years. Park and co-wokers / 8 / investigating a 
large child population after wheezing disease prior to 5 years 
of age found 2% of the children to be asthmatic. At a follow­
up 10 years after wheezing Foucard and Sjöberg /4/ detected 22 
asthmatics from 80 wheezy children. In our patients the 
frequency of asthma was 4% and this ratio did not change by the
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Patients
1988
Fig. 1. The SPT positivity (3+ or 4+) and its change
Patients
positive negative
Fig. 2. The familial atopy and SPT positivity
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Patients
Fig. 3. Familial smoking and B.H.
time of the second follow-up, i.e. no new asthmatics could be 
discovered.
In the course of acetylcholine challenge 15% of the patients 
exhibited B.H. which is a higher frequency than that found in 
the healthy population / 6 /. In pubertal age however, the B.H. 
showed a decrease. At the second follow-up only 7 of 28 
children had positive results indicated also by the increase of 
PC 2 0  values which did not change in asthmatics. Asthma is known 
to improve or "heal" during puberty.
Godfrey and Griffiths detected SPT postitivity (3+ or 4+) in 
33% of healthy children /5/, while Cserháti et al in Hungary 
only in 7% /3/. During the follow-up of wheezy bronchitis 
Foucard and Sjöberg registered 7% SPT positivity /4/. The SPT 
positivity found 17% in 206 children seems to be higher than 
that of the healthy population, and this ratio is even higher 
at the second follow-up (28.8%), but here all the asthmatic 
children were also present. The SPT positivity of children 
taking part in both follow-ups did not change as a whole. There 
were, however, individual changes, some of them changed from 
positive to negative, also inversely. SPT positivity showed no 
significant correlation with familial atopy.
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Several data can be found on the harmful effect of smoking. 
Liard and co-wokers observed wheezy bronchitis in infants of 
smoking mothers significantly more frequently compared to non- 
smokers' infants /7/. At present we studied the effect of 
passive smoking on B.H. and found that parental smoking did not 
influence the frequency of their children's B.H.
Furthermore, in a two-step follow-up of non-selected wheezy 
bronchitis children we are going to confirm Jackson's statement 
"All that wheezes is not asthma" /12/.
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The ALL-BFM 8 8  RF > 1.7 treatment of high malignancy 
ALL patients in remission was monitored at the 4th week 
of Protocol I. The qualitative and quantitative 
processing of parameters indicating cellular 
transformations by light and electronmicroscopy was 
performed in lymphocytes separated from peripheral 
blood drawn at scheduled times of therapy.
The immunophénotype of sample lymphocytes was 
determined by indirect immunofluorescent techniques, by 
listing the percentual level of CD2, CD3, CD4, CDg, 
CD jq surface antigens.
The incidence of infections, confirmed clinically 
and bacteriologically, was recorded. The parameters of 
the patients were compared to those of healthy 
children.
In the group of patients with high malignancy in the 
intensive period of ALL-BFM 8 8  RF > 1.7 therapy the 
incidence of cells rich in organelles, dense granules 
and vacuoles was significantly (p < 0.05) higher 
compared to the control cells, poor in structures. 
During the weeks of induction and after the 
consolidating combination with VM-26+ARA-C the 
expression of surface antigens of the lymphocytes was 
reduced.
That means that up to the introduction of 
maintenance treatment the presence of surface antigens 
remained below the range of normal deviation.
These data obtained during monitoring revealed that 
the morphological and functional integrity of cells was 
damaged in patients with high malignancy ALL during 
intensive therapy, though only temporarily.
Akadémiai Kiadó, Budapest
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INTRODUCTION
The favorable results obtained in ALL therapy of children 
/ 1 1 , 2 1 / are due to the combined intensive chemotherapy and 
radiotherapy /23/ applied in patient groups differentiated on 
the basis of risk factors /2 , 2 0 , 2 1 , 26, 28, 29/.
However, there is a group of patients with poor prognosis 
ALL-diagnosed on the basis of both qualitative and quantitative 
parameters / 8 , 12, 14, 16/ - who have a rather low life 
expectancy even today, because of early relapses and their 
nonresponsiveness to therapy /12, 30, 33/.
It was the aim of the study to investigate the cells 
separated from the blood samples of patients with high 
malignancy but presently in remission, i.e. to monitor the 
regeneration of normal lymphocytes appearing during combined 
cytostatic therapy and to observe the clinical pattern of 
changes occurring at cellular level. The present study focuses 
on the changes of morphology and immunophénotype of the 
lymphocytes, and of the associated clinical aspects of patients 
with high malignancy ALL induced by BFM - 8 8  therapy.
PATIENTS AND M E T H O D S
The analysis of morphological lymphocyte parameters (by 
light microscopical parameters) was drawn in peripheral blood 
samples from children with high malignancy during the ALL-BFM 
8 8  RF > 1.7 protocol at scheduled treatment times (in weeks: 2, 
9, 13, 21, 24, 29, 39, 44, 52). The electron microscopic 
analysis was performed from samples, fixed by Matutes' method 
/15/, 20 to 25 cells, chosen at random from each child on 
weeks 4 and 13, and evaluated on the electromicrograms with a 
semiautomatic planimeter, at 4000 to 12 000 fold magnification.
In addition to the routine hematological parameters (WBC), 
the immunophénotype of the lymphocytes was also determined /4, 
7/. Applying indirect immunofluorescent techniques, the 
percentual incidence of surface antigens (CD 2 , CD 3 , CD 4 , CDg 
CD^g-s was determined after counting 1 0 0  to 2 0 0  cells per 
s a m p l e .
At the same scheduled treatment time the incidence of 
infections, bacterial resistance data /3, 17/ as well as the 
antibiotic therapy applied /27/ were registered.
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During the study the blood samples of patients in remission 
were processed, therefore the monitoring of ALL patients was 
started in the 4th treatment week. The tests were always 
performed during the treatment-free period and at normal LDH 
levels /13/. The follow-up period was 52 weeks. In the 
Student's "t" test the expected control values (x) as well as 
the standard deviation range of normal values were listed by 
processing the data of 2 0  healthy children.
In the present study the therapy of 7 children with high 
malignancy ALL was monitored. In Fig. 1/A sex, age, risk 
factors /21/ and FAB classification /2/ of the patients 
designated by code numbers are listed. Patient No 501 with a 
large submandibular tumour and patient No 507 with a breast 
tumour were also included in this high malignancy group. With 
regard to immunological characteristics /26/, 3 were CALLA 
positive,2 T-lymphoma-like and one had T and В cell ALL.
The survival rate of patients is represented in Fig. 1/B. 
After a one year follow-up period, 3 of 7 patients are alive 
and their maintenance treatment is being continued. In 
agreement with the aim of the study only the data of patients 
in remission were processed which enabled the monitoring of the 
regeneration of healthy lymphocytes independently from the 
original diagnosis.
RESULTS
From the hematological parameters WBC remained at a 
lower level compared to the control throughout the treatment 
period (Table I).
Of the parameters monitored by light microscope the ratio of 
nucleic diameters, rate of basophilia, presence of granulation 
and vacuoles gradually approached normal mean levels during and 
after inductive therapy. However, the regular bean or kidney 
shape, characteristic of normal lymphocyte nucleus, was 
retained only during maintenance therapy in the majority of 
cells (Table II).
Electron microscopic monitoring was performed before the 
remission and before application of consolidating therapy 
(Table III). At the 4th week of induction and at the start of 
consolidating therapy the incidence of cells rich in organelles 
was singificantly higher (p < 0.05) compared to the healthy 
control cells, poor in structure. Comparing data measured on 
weeks 4 and 13 respectively, significant differences (p < 0.05) 
were found in the ribosome count, in the presence of
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A. Characterisation of the investigated patients
Code
number
Sex Age
(years )
BFM
(RF)
FAB
(L)
Immunological
characteristics
501 a* 7 0.82 Ll C-ALL
502 o'* 13 1.92 к "T"
503 o'* 1 2 1 . 48 L 1 T-lymphoma like
504 a* 3 1.75 4 C-ALL
505 4 9 1.84 L 2 "B"
506 O'4 1 1. 70 Ll/L 2 C-ALL
507 Ç. 2 1.03 L 1 Т-Lymphoma like
Survival of ALL (FR > 
1.7" protocol
1.7) patients treated by "BFM - 8 8
C. " AL L - 8 8  RF > 1.7" treatment protocol
Protocol I. Protocol M V-C Protocol II. Maintenance
Fig.l. A: Sex and age distribution of patients with high
malignancy ALL treated by "BFM - 8 8  RF > 1.7" and 
indicated by codes, their BFM and FAB 
classification and immunological diagnosis
B: Survival rate of high malignancy ALL patients
C: Scheme of therapy applied for the treatment of high
malignancy ALL patients ("BFM - 8 8  RF > 1.7") with 
scheduled sampling time
TABLE I
Hematological parameter (WBC)
WBC of patients with high malignancy ALL during treatment
Weeks 4 9 13 2 1 24 29 39 44 Healthy
control
Investigated
parameters
WBC 5.171 3.22 4.620 3.80 3.067 4.466 3.691 3.904 7.0429
(1 0 9 / 1 ) ^3.435 +1.434 ^2.234 + 0.163 +0.741 _+0 .5 91 j+0.2 2 7 ^0.097 ^2.5127
No of cases 7 6 5 4 4 3 3 3 2
КЛ
Monitoring the therapy of 
ALL
TABLE II U lCD
Parameters determined at scheduled time of therapy by light microscope using normal controls 
(ratio of nucleic diameters, presence of regular nucleic shape, rate of cytoplasma 
basophilicity, incidence of granulation, vacuoles)
Light microscopic findings in ALL (RF > 1.7) cases during treatment
Weeks 4 9 13 2 1 24 29 39 44 Healthy
controls
Features
Nuclear D^/Ü 2 0.8729 
+_0.0 5 31
0.790 
_+0.0629
0 .828 
i 0 .0 3 9 7
0.8367
i0.033
0.730 
i 0 .0294
0.7967 
i 0 .0544
0.7963 
i 0 .0441
0.765 
i 0 .0946
0.7884 
i 0 .055
Basophilic 
cytoplasm 
(per cent)
60.43 
+14.31
59.0 
il 9.73
44.60 
il 7.33
0 . 2 2 0  
i 0 .0283
27.0 
+ 9.21
15 . 33 
+ 1.12
28.0
i28.92
16.7 
i 2 . 98
29.36
i23.35
Azurophilic 
granules 
(per cent)
14.71 
i l l .54
10.4 
i l l .09
17.20 
il 2.69
0.4633
i0.264
8.33
i6.24
8 . 0 0
i4.32
20.53 
il 9. 8 0
18.54 
i l l .34
19.7 
il 2.25
Vacuoles 
(per cent)
0.771 
i 0 .0947
0.520 
i 0 .387
6 .6  
+1.36
0.0033 
i 0 .0047
7.33 
i 6 . 13
6 . 0  
i 8 .49
1 .0  
i 5 .91
1 .4 
i7.68
1.3 
il . 78
Regular nuclear 
outline 
(per cent)
37.57 
+21.16
55.60 
il 5.87
53.80 
i24.5
46.0 
i 2 5 .14
35.0
i9.2
32 . 33 
i 2 9 .85
32.0 
i3 4.43
47.53 
+ 21.15
63.87 
il 6 .74
No of cases 7 6 5 4 4 3 3 3 2 0
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TABLE III
Change of ultrastructural indicators (nucleus-surface ratio, ribosome, endoplasmatic reticulum, 
mitochondrium, dense granulation, vacuoles, Golgi apparatus) and their incidence, determined in 
the lymphocytes of high malignancy ALL patients on weeks 4 and 13 compared to the respective
data of healthy cells.
Transmission electron microscopic findings in ALL (RF > 1.7) cases
Weeks 4 13 Healthy control
Features
N/C ratio + 0.8729 +_ 0.0483 0.750 _+ 0.066 0.0794 _+ 0.1991
Ribosomes 
(per cent)
33.86 + 8.04 14.2 i  0.85 7.29 +_ 1.819
Endoplasmic 
reticulum 
(per cent)
30.43 +_ 14.61 13.0 i  9.8 32.9 +_ 8.32
Mitochondrium 
(per cent)
46.86 +_ 15.72 49.2 +_ 17.52 6.79 + 16.92
Large/dense 
granules 
(per cent)
36.86 _+ 20.87 28.0 +_ 18.72 2.09 _+ 5.32
Vacuoles 
(per cent)
21.29 +_ 15.93 15.0 +_ 15.87 0.16 +_ 0.87
Active
Golgi apparatus 
(per cent)
14.14 _+ 6.998 6 . 6  _+ 3.61 2.03 +_ 5.29
No of cases (n) 7 5 1 1
No of cells (n) 7x25 5x25 11x25
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endoplasmatic reticulum and Golgi apparatus. At the 
introduction of consolidating therapy Golgi apparatus and 
ribosomes were only rarely detectable compared to the cells 
with large nucleus rich in organelles, observed in the 4th week 
of the inductive treatment ( Fig. 2 /А) while the loose 
chromatin structure of the nucleus, the high incidence of 
mitochondria (Fig. 2 / В ), dense granules and vacoules remained 
u n c h a n g e d .
The expression of surface antigens of the lymphocytes, which 
are also characteristic phenotypes of healthy lymphocytes (9, 
19), was monitored during therapy together with the absolute 
lymphocyte count and rate of cells forming rosettes with sheep 
red blood cells (Fig. 3 /А).
It appears that up to the start of maintenance treatment the 
presence of surface antigens remained below the range of normal 
deviation .
A similar curve was obtained during the monitoring of the 
C D 3 marker. It should be stressed that the level of both 
markers was reduced in the 4th to 9th week of induction and the 
lowest level was detectable after the consolidating combination 
treatment with VM-26 + Ara-C (Fig. з/В).
The presence of the CD 4 antigen followed the trend of the 
two former markers, although it must be noted that a very low 
T-helper presence was observed beyond the inductive phase after 
the Protocol M (Fig. 4/A).
Values representing the rate of CDg marker bearing T- 
suppressors represented the exact "reciprocal curve" (Fig. 4/B) 
of the T-helpers while C04 and CDg both failed to attain the 
healthy mean value after the 44th week (Fig. 4/A+B).
The value expressing the ratio of the two former markers 
(x = C D 4 /CD8) became lower than the normal deviation range in the 
22th week of consolidation, but by the end of Protocol II., or 
during the maintenance therapy it reached the normal levels 
again (Fig. 4 /C).
The В cell specific CD^g surface antigen was hardly 
detectable in the second half of induction or after the 
VM-26+ARA-C Block of consolidation, on the 26th week (Fig. 5/A).
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Fig. 2. Cells separated from the peripheral blood of a child 
with high malignancy
ALL submitted to "ALL-BFM 8 8  RF > 1.7" therapy.
A: During the inductive treatment (week 4)
B: During the first week of consolidation (week 13)
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A
Fig. 3. A: CD 2 marker bearing cells forming rosettes with
sheep RBC
B: Rate of cells with CD 3 surface antigen at specific
time of therapy compared to controls (n = 2 0 )
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Fig . 4. A: T-helper cell levels with CD^ marker
B: T-suppressor cell levels with CDg antigen
expression
C: Ratio of the two markers compared to the entire
range of deviation compared to controls (n = 2 0 )
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A.
Fig. 5 . A: Specific C 0 1 9  marker expression of the В cell
during treatment
B: CDj /CD^j values at scheduled time of treatment with
the control data of healthy children (n = 2 0 )
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The change in the CD^g marker is indicated by the C D 3 /CD 1 9  
ratio (Fi g. 5 / В ) .
Confirmed by bacterial or clinical tests, and cytopenia 
associated with febrile episodes /3, 27/ during treatment,
revealed infections during the inductive phase, increasing 
repeatedly by the 2 2 nd and 26th week at the low marker levels 
mentioned, though during this period of therapy fever
complications were much less frequent (Tahié IV).
DISCUSSION
Intensive chemotherapy cures many children with ALL /5/. 
Encouraging results /30/ are reported in children with high- 
risk ALL /14, 16/ receiving modern chemotherapy /11, 12/.
As supported by recent data /22/ bone marrow transplants 
from twins in cases of high malignancy ALL proved to be 
successful in 60 per cent in first remission.
In the present study it was found that during the intense 
chemotherapy of patients with poor prognosis ALL, the 
parameters monitored by light microscope / 6 , 32/ reached the 
values of normal resting cells by the end of the induction, 
while electron microscopic investigation / 6 / confirmed 
properties characteristic for still immature cells. In the same 
cells the surface antigen expression, corresponding to the 
immune phenotype of healthy lymphocytes /19/, became only 
detectable by the end of the consolidating treatment.
It was this high malignancy which justified the 
differentiation of patients /9, 14/ during intense, high dose 
chemotherapy /25/, by simultaneously interrelating cytological, 
clinical information with phenotypes / 8 /, the efficacy of 
treatments being determined, in addition to the correctly 
applied supportive therapy /1, 24/, by the physiological 
tolerance of tissues /25/ and the drug susceptibility of 
lymphocytes /31/.
TABLE IV ONOn
Incidence of infections, confirmed by bacteriological and clinical tests, and of febrile episodes associated with 
granulocytopenia during the first 52 weeks of "BFM-88 RF > 1.7" treatment
_______  ALL-BFM 88 (RF >1.7) Protocol
Weeks 0 4 9 13 21 24 29 39
!.. vi' 'l' J- i
Protocol I Protoc.M. v-c 1 Protocol II
Granulocyte count
(109/1)
<0.5 + + + +  + + + +
< 0.1
Granulocytopenic episodes
With fever + + + + +
Total Antimicrobial
drugs
8
5
Bacteriologically 
documented infection
Upper respiratory tract 
Non haem, strept. + +
1
1
Urinary Tract
E.coli I 1 + +
Proteus J
E.coli + 1 +
CD
CDCDСГОСЛCD
Clinically
documented infection
Co
-T
ri
mo
xa
zo
l
Fever + ++ ++ ++ ++ ++ + +
Sinobronchitis +
Angina 
Tons.foil.
Stomatitis 
Number of
infection 2 2 2 3 1 2  2 1 1  1
Number of 
drugs
16 + -Htt- + + ++
2 + + +
1 +
2 + +
2
3 1 2  2 2 27
3 2 3 17 2 1 1 1 2
Os
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Papers reviewing the treatment results of high malignancy 
ALL recommend further controlled, prospective clinical studies 
/ 1 0 / to limit both the intensity and the duration of 
chemotherapy and improve relapse-free survival rates /18/. The 
results obtained justify continued extensive research in this 
area. Collecting further information /5/ on the lymphocytes of 
patients in remission during combined cytostatic therapy may 
furnish results which, later on, can be directly applied in the 
treatment of ALL patients.
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The author evaluates the usefulness of clinical 
features and some supplementary investigations in 
diagnosis of tuberous sclerosis in children. 52 
children ranging in age from 1 month to 14 years took 
part in the study. Usually depigmented naevi were the 
first sign of tuberous sclerosis and were seen in 98% 
of affected children. Epileptic seizures occurred in 
96% of patients, mostly during the first year of life. 
Axial computed tomography of brain seems to be very 
helpful in diagnosis of tuberous sclerosis in every 
age. Multiple periventricular calcifications were found 
in 98% of children. Two-dimensional echocardiography 
was especially useful in infants and children below 2 
years of age. Retinal hamartomas were found in 25% of 
children with tuberous sclerosis. In some cases these 
changes were revealed during the first year of age. 
Abnormal EEGs were found in 90% of recordings. The EEGs 
tended to improve with increasing age. In 25% of 
children one of parents was affected by tuberous 
sclerosis. The careful skin examination of both parents 
can be especially helpful in children with doubtful 
diagnosis of tuberous sclerosis.
INTRODUCTION
Tuberous sclerosis (TS) is an autosomal dominant disease 
known for over a century and recognized by characteristic 
hamartomas or benign growths in one or more organs, notably the 
skin, the central nervous system including the retina, the 
kidneys and the heart. Other organs or tissues that may be 
affected are lungs, spleen, liver, pancreas and 
gastrointestinal tract /17/.
Akadémiai Kiadó, Budapest
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The incidence was thought to be one in 100 000, but has 
been recently updated to suggest one in 10 000 /17/.
In 1908, Heinrich Vogt /28/ established the clinical triad 
of features for the diagnosis of TS consisting of seizures, 
mental retardation and facial "adenoma sebaceum". For years the 
disease was only suspected in those suffering from mental 
retardation and fits, but it is now known that the disorder may 
present with less than these classical findings as a "forme 
fruste" .
In the experience of Gomez /10/ all the three features of 
Vogt's triad were found only in 29% of patients with TS. 
Notoriously 6% of the patients had none of the symptoms of the 
triad.
Diagnosis of tuberous sclerosis in children is especially 
difficult. Most symptoms and lesions are absent at birth and 
develop with age. Therefore this study was aimed to analyse the 
usefulness of clinical features and some investigations in the 
diagnosis of tuberous sclerosis in children, particularly in 
early a ge.
PATIENTS AND METHODS
52 children with tuberous sclerosis (27 males and 25 
females) ranging in age from 1 month to 14 years were 
investigated in Department of Child Neurology in Memorial- 
Hospital Child's Health Centre in Warsaw in years 1984-1989. At 
admission there were 21 children below 2 years of age, 14 
children aged 2-5 years, 9 children aged 5-9 years and 8 
patients aged 9-14 years.
Only 18 children (35%) were referred to Child's Health 
Centre with the diagnosis of tuberous sclerosis. In the other 
children (65%) the main causes of hospitalization were drug- 
resistant epileptic seizures in 28 patients, cardiac defects in 
3 patients, brain tumours in 2 patients, intraocular tumour in 
1 child.
In each child thoroughful anamnesis was taken and particular 
stress was laid on the time of appearance of skin lesions and 
neurological features. Medical records concerning previous 
hospitalizations have been reviewed. Special attention was paid 
to familial anamnesis.
The health status of siblings, parents, grandparents, uncles 
and aunts has been questioned and particular attention was 
given to a history of mental retardation, seizures, brain or
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cardiac tumours, kidney cysts, pulmonary failure, renal 
angiomyolipoma, skin lesions including depigmented naevi, 
facial angiofibroma and shagreen patches.
Full pediatric and neurological examinations were carried 
out for each child and the following investigations were 
performed: psychological examination in all 52 children,
echocardiography in 29 children, computed tomography of the 
brain in 50 children, ultrasonography of the abdomen in 39 
children, electroencephalography in 52 children and 
ophthalmologic examination in 51 children.
Psychological investigation was based on anamnesis and 
following tests: Psycho-Cattell test, Terman-Merrill test and
Wechsler test.
Echocardiography was performed using apparatus Hewlett- 
Packard type 77020A. In retarded or agressive patients the 
examination was carried out after rectal administration of 
Thiopental Sodium.
Axial computed tomography of the brain was performed with 
apparatus Somatom 2 of Siemens.
Ultrasonography of abdomen was carried out with Echo-Camera 
SSD-280 LS of Aloka Co.ltd.
Electroencephalographic examination was performed mainly 
during sleep with apparatus Elema Mingograf of Siemens.
RESULTS
1. Dermatologic manifestations
Dermatologic features were an important part of tuberous 
sclerosis. Even in the neonatal period, lesions that were 
highly suspicious for TS could be recognized in some patients. 
With increasing age, additional lesions appeared and in certain 
cases the diagnosis of TS might be established even without 
performing any additional investigations.
Depigmented naevi were the most common skin lesions found 
in 51 children (98%) with TS. Usually, they were seen by 
parents in newborns (44 cases) or very small infants and were 
the first visible sign of TS. They were distributed in 
irregular way, mostly over the trunk and extremities and were 
rare on the face.
"Café au lait" spots were seen in 20 children (38%). In 19 
patients the parents noticed them in neonatal period.
Pringle's tumours pathognomonic for TS were revealed in 35 
children (67.3%). These lesions were identified in 29 children 
aged 3-5 years. They are very helpful in diagnosis of TS in
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children above 5 years. In this age group Pringle's tumours 
were found in 27 of 30 children (90%). In 4 children Pringle's 
tumours appeared below 2 years of age. During the puberty the 
lesions usually became more numerous and prominent. An average 
age of appearance of Pringle's tumours was 3.89jf2.10 years. In 
the group of 17 patients without Pringle's tumours, only 3 
children have finished 5 years and 10 children were younger 
than 2 years of age.
Shagreen patches were seen in 19 patients (36.5%), but only 
in 1 child below 2 years of age. These changes commonly 
appeared in older patients. Multiple smooth papules (molluscum 
fibrosum pendulum) on the neck, axillae or near flexures of 
limbs were noticed in 10 patients (19%). Forehead fibrous 
plaques and Koenen's tumours were found in very small groups 
forehead fibrous plaques in 7 children (13.5%) and Koenen's 
tumours in one girl of 12 years of age.
The incidence of dermatologic features is shown in Table I.
2. Neurologic features
The most frequent neurologic feature, epilepsy, was observed 
in 50 patients (96%). Usually, the epileptic seizures appeared 
between 4 and 6 months of life. In 27 children (52%) onset of 
seizures appeared during the first six months and in 35 
children (67.3%) during the first year of age. The most common 
type of first epileptic seizure was infantile spasms. Infantile 
spasms, as first type of seizures were observed in 24 of 27 
children below 6 months of age, in 7 of 8 children aged 6 
months-1 year and in 3 of 8 children between 1 year and 2 years 
of a g e .
Generalized hypotonia was seen in 17 children below 9 years 
of age. Spastic hemiparesis was observed in 11 children /21/.
3. Mental status
Mental retardation was one of the most frequent clinical 
features of patients with TS: 36 patients (70%) were known to 
be mentally retarded. Mental retardation was more severe in 
children in younger age groups. There was a clear correlation 
between the two most important neurologic symptoms of TS: the
TABLE I
Incidence of dermatologie features in children with TS
Skin lesion No. of patients
o,
(52=100%)
1. Oepigmented naevi 51 98
2. Pringle's tumors 35 67.3
3. "Cafe au lait" spots 20 38.5
4. Shagreen patches 19 36.5
5. Molluscum pendulum 10 19.2
6. Forehead fibrious plaque 7 13.5
7. Koenen's tumors 1 1.9
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seizures and the mental subnormality. The age of seizure onset 
and the presence and severity of the mental subnormality were 
directly related. In the group of children whose epileptic 
seizures appeared in the first year of age mental development 
was more severely delayed than in the group of older patients
(p < 0.01).
Almost all patients whose seizures began in the first six 
months of life, were mentally defective. Usually, the patients 
whose motor development was abnormal, were known to have 
seizures prior to failing to sit up, crawl or walk.
In 15% of children with infantile spasms some features of 
autistic behaviour were observed.
4. Ophthalmic findings
Retinal hamartomas were revealed in 12 children (23.5%). The 
most common type of retinal hamartoma was a relatively flat, 
smooth-surfaced, semitransparent lesion, which was seen in 9 
patients. In 3 patients there was calcified mulberry-like 
tumour and in 1 patient a lesion had morphologic 
characteristics similar to both previously described lesions. 
In 3 children retinal hamartomas were observed during the first 
year of a ge. 5
5. Echocardiography
Cardiac tumours were identified in 10 (6 males and 4 
females) of 29 children in échocardiographie examination. In 4 
cases the tumours were multiple. Tumours were more common on 
the left side of the heart (5 children) than on the right (3 
children), and were more frequent in interventricular septum (8 
children) than in the ventricular wall (2 patients) (p < 0.01).
Detectability of these tumours diminished with increasing 
age. The highest detectability was in children below 2 years of 
age. Cardiac tumours were found in 4 of 6 children (66%) in 
this age group.
Echocardiography was repeated in 5 of 10 children with 
cardiac tumours and in 2 of them the size of tumours did not 
change, but in 3 patients tumours disappeared or their size 
significantly diminished.
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6 . Computed tomography of brain
Computed tomography revealed many of the gross pathologic 
processes of cerebral TS (Table II). Calcified subependymal 
nodules were the most diagnostic CT findings. They were found 
in 49 of 50 children (98%). Computed tomograhpy did not reveal 
these changes in three children below 5 years of age during the 
first examination. Next CT demonstrated calcified subependymal 
nodules along the lateral ventricules in two of them.
Focal areas of increased attenuation involving the cortex 
and/or white matter appeared on ÇT in 25 patients (50%). In 14 
children (28%) hypodense tubers were seen. These lesions were 
observed in 38% of children below 2, and in 23% of children 
above 5 years of age.
Relatively often CT demonstrated a dilatation of the lateral 
ventricules (38% of children) and cortical atrophy (42%). These 
changes were seen more often in older children. In two patients 
CT showed brain tumours. Microscopically, subependymal giant 
cell astrocytomas were revealed.
7. Ultrasonography of abdomen
Ultrasonographic examination of abdomen was carried out in 
39 children and in 5 of them (13%) bilateral, hyperechogenic 
nodules were revealed. Usually, they were not troublesome to 
the patients. Physical examination of patients with TS provided 
little evidence of their renal tumours. Hamartomas of the liver 
were seen in 5 children (13%).
8 . Electroencephalography
EEG examination was carried out in all children. 13 of total 
number of 114 EEG recordings (11%) were normal (Table III).The 
most common abnormality - paroxysmal generalized activity was 
observed in 56 recordings (49%). There was exclusively
generalized paroxysmal activity in 29 recordings and in others 
it was accompanied by focal or lateralized abnormalities. 
Hypsarrhythmia appeared only in 10 recordings, usually in 
patients below 2 years of age. In 35 EEGs (30%) non-paroxysmal 
activity was observed.
In general, the most severe abnormalities, particularly with
•-Jœ
TABLE II
Cerebral findings revealed on computed tomography 
with tuberous sclerosis
in children
Cerebral finding No. of patients
0,
(50=100%)
1. Periventricular calcification 49 98
2. Other intracerebral calcifications 25 50
3. Cortical atrophy 21 42
4. Ventricular dilatation 19 38
5. Hypodense areas 14 28
6 . Brain tumors 2 4
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TABLE III
EEG findings in children with tuberous sclerosis
EEG finding No. ofEEG recordings
00
Normal 13 11
Hypsarrhythmia 10 9
Generalized paroxysmal activity 36 49
exclusively generalized 29 25.4
with focal or lateralized 27 23.6
discharges 27 23.6
Non-paroxysmal abnormalities 35 31
T o t a l  : 114 100
40
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retjard to epileptiform abnormalities, were seen in young 
children with early onset of seizures. With increasing age the 
abnormalities tended to decrease in amount and degree. There 
was statistically significant difference (p < 0.01) in 
appearance of these changes in children below and after 5 years 
of a g e .
In the group of children below 2 years of age hypsarrhythmia 
and paroxysmal generalized activity were revealed in 24 
recordings (73%). In children above 9 years of age, generalized 
paroxysmal activity appeared in 35% of EEGs.
There was a good correlation between the degree of EEG 
abnormality and the degree of mental retardation, with the most 
severe EEG abnormalities in patients with moderate or severe 
mental retardation. Children with infantile spasms and 
hypsarrhythmia showed a greater degree of mental retardation 
than children with other types of seizures or EEG 
abnormalities. Most of the patients with focal or generalized 
spike-and-wave discharges who had onset of seizures after 2 
years of age were only mildly retarded or had normal 
i n t e l 1igence.
Although epileptiform abnormalities were the most common 
type of abnormality, no one specific type of EEG pattern was 
seen in children with TS.
9. Family evaluation
In the group of 52 children with TS, each child had a 
thorough investigation of family history. The parents of 13 
children from 10 families were found to have TS. There were 5 
males and 5 females (Table IV)
Epilepsy was given in anamnesis in 6 parents. Thorough skin 
examination revealed depigmented naevi in 9 parents, facial 
angiofibroma in 7 parents, "café au lait" spots in 2 parents, 
shagreen patch in 1 and Koenen's tumours in 1 parent.
Computed tomography of brain was performed in 8 of 10 
affected parents and in all of them the characteristic 
periventricular calcifications were seen. In 8 parents 
fundoscopic examination was performed and no ophthalmic lesions 
were found. There were two families with 2 and 3 siblings 
affected by TS.
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TABLE IV
Familial cases of TS
N o
o f
p e d i ­
g r e e
S e x  o f  
a f f e c t e c  
p a r e n t
S k i n  l e s i o n s E p i l e p s y
C o m p u t e d  t o m o g r a p h y  
o f  t h e  b r a i n
1 . F d e p i g m e n t e d  n a e v i  
f a c i a l  a n g i o f i b r o m a  
, , c a f e  a u  l a i t "  s p o t s
p r e s e n t p e r i v e n t r i c u l a r
c a l c i f i c a t i o n s
2 . M d e p i g m e n t e d  n a e v i  
f a c i a l  a n g i o f i b r o m a
a b s e n t p e r i v e n t r i c u l a r
c a l c i f i c a t i o n s
3 . M d e p i g m e n t e d  n a e v i  
f a c i a l  a n g i o f i b r o m a
p r e s e n t n o t  d o n e
4 . F d e p i g m e n t e d  n a e v i  
f a c i a l  a n g i o f i b r o m a  
s h a g r e e n  p a t c h  
, , c a f e  a u  l a i t "  s p o t s  
K o e n e n ' s  t u m o r s
a b s e n t p e r i v e n t r i c u l a r
c a l c i f i c a t i o n s
5 . F d e p i g m e n t e d  n a e v i  
f a c i a l  a n g i o f i b r o m a
p r e s e n t p e r i v e n t r i c u l a r
c a l c i f i c a t i o n s
6 . F d e p i g m e n t e d  n a e v i p r e s e n t p e r i v e n t r i c u l a r
c a l c i f i c a t i o n s
7 . F d e p i g m e n t e d  n a e v i p r e s e n t n o t  d o n e
8 . M d e p i g m e n t e d  n a e v i p r e s e n t p e r i v e n t r i c u l a r
c a l c i f i c a t i o n s
9 . M d e p i g m e n t e d  n a e v i  
f a c i a l  a n g i o f i b r o m a
a b s e n t p e r i v e n t r i c u l a r
c a l c i f i c a t i o n s
1 0 . M f a c i a l  a n g i o f i b r o m a a b s e n t p e r i v e n t r i c u l a r
c a l c i f i c a t i o n s
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DISCUSSION
The cutaneous lesions are amongst the most important and 
most widely studied features of TS. Usually, depigmented naevi 
are the first sign of the disease and may be seen at birth or 
in first months of life. Few months later epileptic seizures 
develop. This coincidence of depigmented naevi, infantile 
spasms and mental retardation is very suggestive of TS.
The majority of patients with TS have depigmented naevi at 
the time of birth, although their presentation may be delayed 
by months or years. In my study parents noticed depigmented 
naevi in neonatal period in 44 of examined children.
The incidence of facial angiofibroma, the cutaneous lesion 
of great diagnostic significance is 47-100% according to 
different authors /3,10/. I found these lesions in 90% of the 
children more than 5 years old. Similar results were obtained 
by Sutterworth and Wilson /2/ and Nickel and Reed /21/.
Usually, facial angiofibroma appears between 3 and 5 years 
of age. It is rather seldom in children below 2 years. In one 
of the patients examined by Rogers /24/ the facial angiofibroma 
was present at birth.
The late appearance of facial angiofibroma needs very 
thoughtful verification. In the adolescent patient acne 
vulgaris may be very easily mistaken for angiofibroma, 
especially in the child with epilepsy.
Shagreen patches were noted in 36.5% of studied patients, 
but only in 1 child below 2 years of age. They become more 
common after the first decade of life /24/.
Forehead fibrous plaques and Koenen's tumours are regarded 
by many as pathognomonic for TS /10/. In my series these 
changes appeared in 13.5% of children respectively, and had 
only supportive value in diagnosis of TS.
There is a high frequency of epilepsy in TS patients. 
According to Gomez /10/ and Cendrowska et al /3/ epilepsy 
appears in 92% and 100% of patients respectively. In my study, 
96% of children suffered from epilepsy and in all 50 patients 
epileptic seizures appeared below 5 years of age.
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Seizures seldom begin in the first 8 weeks of life, but in 
most children the onset of seizures is between 4 and 6 months 
of life. 52% of patients in my series had first epileptic 
seizures during the first 6 months of life, and 67% of them 
during the first year of age. These results are similar to 
those found by Zaremba /31/ and Cendrowska et al /3/.
Epileptic manifestations appear with particular frequency in 
the form of infantile spasms. This kind of epileptic seizures 
was the presenting complaint in 89% of children below 6 months 
in my study and in 69% of the selected patients with TS 
reported by Pampiglione and Moynahan /22/ and in 68% of Hunt's 
patients /13/. During the course of TS the type of seizures 
changes .
The patients with onset of convulsions in early life are 
more likely to be mentally retarded. Almost all of the patients 
in my series, whose epilepsy appeared during the first six 
months of age were severely retarded. It confirms a strict 
correlation between epilepsy and mental subnormality. In the 
group of 160 patients examined in Mayo Clinic, Gomez /11/ found 
20 patients without epilepsy. All of them had normal 
intelligence.
According to Fleury /7/ the incidence of ocular findings in 
TS is about 40%, but there are very few studies in children. In 
my study the charasteristic ophthalmological lesions 
(hamartomas) were found in 23.5% of children. This relatively 
low percentage of revealed lesions may be explained by young 
age of examined patients.
Ocular findings are of diagnostic value, particularly in 
"formes frustes" (as they are sometimes found in the absence of 
Pringle's tumours) and in some children below 1 year of age.
The frequent association of TS and cardiac rhabdomyoma has 
been recognized for many years. Most information on these 
tumours has of necessity been related to morbid anatomy /6,16/ 
and there are only very few papers on frequency of cardiac 
involvement in such patients during life /9,25/.
Cardiac rhabdomyoma, although benign histopatologically, 
may be life threatening especially during the first year of 
life /4,20/. In the Fenoglio et al /6/ series of 36 patients
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with cardiac rhabdomyoma, 78% of the patients died during the 
first year of life and only 3 patients lived beyond age 5 
years. Commonly asymptomatic, cardiac rhabdomyoma may cause 
fetal obstruction of the cardiac outflow tracts, cyanosis, 
arrhythmias, cardiogenic emboli and cardiac failure secondary 
to myocardial involvement.
Echocardiographically cardiac tumours were revealed in 35% 
of examined children. Smith et al. /25/ found them in 58% of 
children and 18% of adults affected with TS. Tumours seem to be 
especially frequent in neonatal and infantile period. I found 
cardiac tumours in 4 of 6 patients (66.6%) below 2 years of 
age .
The higher incidence of these tumours in young children may 
be explained both by frequent deaths reported in these patients 
and spontaneous regression of cardiac rhabdomyomas observed by 
Alkalay et al. /1/ and Smith et al. /25/. Also in my series in 
3 children the cardiac tumours disappeared or diminished with 
increasing age. Because of high frequency of cardiac 
rhabdomyomas in small children, echocardiography seems to be 
extremely effective in diagnosis of TS in these patients.
Calcified subependymal nodules are the most frequent 
cerebral abnormality of TS. They were found on CT scan in 98% 
of children and in all children above 3 years of age in my 
series. In 3 younger children the first CT scan did not reveal 
any changes. Multiple subependymal nodules are regarded by many 
authors to be pathognomonic for TS /12/.
Intracerebral calcifications localized in white matter and 
cortex have been seen in 50% of children. They should be 
differentiated from those observed in toxoplasmosis and CMV 
infections.
Current study supports thesis proposed by Houser and Nixon 
/12/ that hypodense tubers may disappear with age. In my series 
they were observed in 38% of children below 2 and in 23% of 
patients above 5 years of age. The thesis that hypodense tubers 
change with age evaluating from hypodense through isodense to 
hyperdense tubers requires further CT follow up studies. 
Computed tomography should be periodically performed in all 
children with TS because of the danger of development of 
subependymal giant cell astrocytomas /14,15,19/.
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Ultrasonography of abdomen may reveal lesions mainly in 
liver and kidneys. Relatively low frequency of changes 
disclosed in this study (13% in kidneys and 13% in liver) may 
be connected with young age of examined patients. Sti llwell et 
al. /26/ observed angiomyolipomas of kidneys in 47% of patients 
and Van Baal et al. /27/ even in 60% of patients. Our recent 
follow up studies with applications of late generation 
ultrasonography revealed echogenic areas in kidneys suggestive 
of angiomyolipomas in about 40% of children /23/. Value of 
ultrasonographic examination in diagnosis of TS in children 
seems to be limited to "forme frustes" and cases in which the 
diagnosis is uncertain.
There is a high incidence of electroencephalographic 
abnormalities found in patients with TS. Only 10% of children 
in this study and 12% of patients reported by Westmoreland /29/ 
had normal EEGs. No characteristic EEG abnormality exists.
With increasing age, slow, but constant improvement of EEGs 
can be observed. In older patients there were less severe 
abnormalities than those seen in the young children /5/. It 
should be clear that the value of EEG lies in revealing latent 
epilepsy in "forme frustes" of TS or in allowing determination 
of the extent of cerebral involvement in diagnosed cases.
There was a good correlation between mental retardation and 
severity of abnormalities in EEGs.
The thorough examination of parents and siblings may be very 
helpful in establishing the diagnosis, especially in very young 
children with sporadic signs of TS /18,30/. Fryer /8/ suggested 
that careful examination of skin and ophthalmologic examination 
should be sufficient for diagnosis of TS in familial cases. In 
doubtful cases additional CT of brain should be offered.
Tuberous sclerosis, because of its variable expressivity may 
produce great diagnostic difficulties, especially in early age. 
The purpose of this communication is to evaluate the usefulness 
of some clinical features and laboratory investigations in the 
diagnosis of TS in children.
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MATERNAL WEIGHT GAIN AND BIR TH  WEIGH!
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The data of first 1000 non-malformed, mature 
(>_ 2500 g) singletons of participants in the Hungarian 
Family Planning Programme were evaluated. The mean 
maternal weight gain during pregnancy was 13 kg which 
was modified by the body weight of women. Maternal 
weight gain exceeded 13 kg in 54% of pregnant women. 
There was a positive correlation between maternal 
weight gain and birth weight which was calculated as 
26.6 g/kg.
INTRODUCTION
The results of previous paper /1/ suggested that a wider 
range of maternal weight gain than is currently recommended is 
associated with good pregnancy outcome. This finding is 
supported by a prospective Hungarian study /3/ complemented 
with an obvious positive correlation between maternal weight 
gain and birth weight.
PATIENTS AND M E T H O D S
The Hungarian Family Planning Programme /3/ (HFPP) was 
established in 1984 for the reduction of unsuccessful pregnancy 
outcomes. The purpose of this feasibility study was to check 
the efficacy of the combination of the so-called qualitative 
family planning methods within the primary health care. Couples 
who satisfied all 5 of the following criteria were eligible for 
participation in the HFPP: (i) age between 18 and 35 in 
females, (ii) no previous unsuccessful pregnancies, (iii) no 
delayed conception and infertility, (iv) no pregnancy as yet 
and (v) voluntary participation and promise of compliance.
Akadémiai Kiadó, Budapest
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The HFPP has 3 guiding principles. First, the checking-up of 
reproductive health which involves family history, case history 
of females including prepregnancy body weight and maternal 
height, exploration of psychosexual condition, examination of 
vaginal and cervical smears, sperm analysis, blood examination 
for serological status of rubella and HIV. Second, a 3 month 
preparation for conception: "protection of germ cells" 
(avoidance of smoking, alcohol, etc), stop of oral 
contraception, measurement of basal body temperature, 
periconceptional multivitamin supplementation, occupational 
history, check-up of dental status and the measurement of body 
weight. third, protection of early pregnancy, i.e., after the 
diagnosis of pregnancy during the first missed menstrual 
period, the hazards (e.g., occupational) to the fetus are 
avoided. Nutrition education is provided by a written 
guideline. After the fourth, the so-called 'good-bye' meeting, 
these women are referred to regional prenatal care clinics. 
Female participants get a certificate form which is filled out 
and sent back by them confirmed by their obstetricians at the 
end of pregnancy. It involves the maternal body weight before 
delivery and birth weight. Eight months later mothers and their 
children are invited for a detailed check-up examination and 
that time, among others, previous maternal and newborn weights 
are checked. Some cases are lost to follow-up, but these 
couples are visited at home in order to clarify their pregnancy 
outcomes. At the end of 1989, 2,723 pregnancy outcomes were 
evaluated. The number of drop-out cases was 36 (1.3%).
The data of the first 1000 liveborn singletons with birth 
weight of _< 2500 g and without congenital abnormalities were 
used for this analysis. Three and 11 women had maternal 
diabetes or any hypertensive disorder, respectively. The number 
of cesarean delivery was 92. The correlation between 
gestational time and maternal weight gain and sex will be 
analysed separately.
RESULTS
Table I shows the distribution of pregnant women before 
their deliveries by maternal weight gain. The mean maternal 
weight gain was just 13 kg and 75.2% of cases had weight gain 
between 8 and 16 kg (Fig. 1). Only 18.6% of females had lower 
weight gain than 10 kg. The maternal weight gain distribution 
does not fit the Gaussian normal distribution mainly due to the 
skewness of tails.
The mean maternal body weights were 58 kg and 71 kg before 
conception and before delivery, respectively. It means 18.3%
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TABLE I
Distribution of women and mean birth weight by maternal weight 
gain groups in 1 0 0 0  women
Maternal 
weight gain 
(kg )
Pregnant 
women 
N o .
Birth
X
weight
S.D.
1-3 5 2650 354
4 6 3033 375
5 8 3200 541
6 2 0 3217 345
7 28 3104 400
8 51 3177 434
9 6 8 3190 416
1 0 76 3262 391
1 1 8 8 3274 430
1 2 109 3302 357
13 1 0 2 3372 452
14 94 3412 455
15 92 3364 526
16 72 3356 374
17 38 3523 411
18 36 3433 497
19 19 3536 431
2 0 26 3562 374
2 1 2 1 3584 414
2 2 1 0 3925 410
23 8 3463 415
24 3 3150 278
25 6 3743 372
26-29 5 3470 396
Total 1 0 0 0 3340 442
чо
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Fig. 1. Distribution of maternal weight gain
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TABLE II
Maternal weight gain as a function of pregnancy body weight and maternal 
height. (The means are shown in brackets)
Body
weight
Height
V. (cm)
-159 
(156) 
No .
X
160-169 
(164) 
N o .
X
170-
(172)
No.
X
Total
(165)
N o .
X 4
-49 (47) 53 44 0 97
12.5 1 2 . 6 - 12.5 2 1 . 0
50-59 (54) 78 394 75 547
11. 7 13.0 13.3 1 2 . 8 19.2
60-69 (63) 14 149 117 280
12.3 13.3 13.8 13.5 17.6
70- (75) 3 32 41 76
17.0 12.4 13.4 13.1 14.9
T otal (58) 148 619 233 1 0 0 0
1 2 . 1 13.0 13.6 13.0 18.3
чО
чЛ
Maternal weight gain
чо
ON
Fig. 2. Correlation between maternal weight gain and birth weight of newborns
A.E. Czeizel et al.
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increase in maternal weight during pregnancy (Table II). 
However, the maternal weight gain was modified by prepregnancy 
body weight. The relative maternal weight gain was 21.0% in 
females having less than 50 kg and 14.9% with body weight over 
70 kg. The height indicated a less significant effect 
determined mainly by body weight. The maternal age did not 
modify significantly the maternal weight gain.
The distribution of mean birth weights as a function of 
maternal weight gain is also shown in Table I. There is an 
obvious correlation between these groups mainly after the 
exclusion of cases with very low (under 5 kg) and very high 
(over 21 kg) weight gains (r=0.87). However, this correlation 
is much lower at the analysis of all individual cases (r=0.25). 
The mean birth weight/maternal weight gain figure was
26.6 g/kg. After the reduction of birth weight from predelivery 
body weight the correlation was 0.14 between maternal weight 
gain and birth weight. The mean birth weight as a function of 
prepregnancy body weight and maternal height are shown in 
Table III and IV. The correlation between pregnancy body weight 
and birth weight is 0.30, while it was 0.05 between maternal 
height and birth weight.
DISCUSSION
The study of Abrams and Parker /1/ showed a wide variation 
in the weight actually gained by women with a good pregnancy 
outcome, i.e., a vaginal birth at term of a living healthy 
infant. Of the 4,674 women studied the mean maternal weight 
gain was 15 kg and nearly twice of cases exceeded the 
recommended maximum without any apparent ill effects. In 
Hungary the recommended maximum maternal weight gain is 
11-12 kg, while the desirable average is advocated as 15% of 
prepregnancy body weight. In this Hungarian material, about half 
of female participants represented a higher socioeconomic 
status based on their education ( 1 2  or more classes of school)
40со
TABLE III
Mean birth weight as function of maternal weight gain and prepregnancy body
weight
Body weight -49 50-59 60-69 70- Total
(kg) No . No . N o . N o . N o .M a t e r n a l ^ ^
weight gain X X X X X
(kg)
- 8 9 65 41 12 127
3119 3068 3194 3566 3156
9-12 43 207 76 15 341
3062 3252 3361 3507 3263
13- 45 275 163 49 532
3101 3346 3580 3693 3429
Total 97 547 280 76 1000
3085 3279 3466 3638 3340
A.E. Czeizel et al.
TABLE IV
Mean birth weight as a function of maternal weight gain and maternal height
Height
(cm)
M a t e r n a l \ ^ ^  
weight gairi'-^
(kg)
-159 
N o .
X
160-169 
N o .
X
170- 
No .
X
T otal 
N o .
X
- 8 22 80 25 127
2996 3207 3206 3170
9-12 62 211 68 341
3172 3263 3347 3263
13- 64 328 140 532
3310 3388 3580 3429
T otal 148 619 233 1000
3206 3322 3472 3340
vû
40
Maternal weight gain
100 A.E. Czeizel et al.
and 93% of females were primiparous. The mean maternal weight 
gain was 13 kg, and 54.1% of women exceeded the recommended 
maximum (12 kg). Our results have also confirmed the finding 
that the relationship between maternal weight gain is lower in 
women with higher prepregnancy body weight /4, 1/.
The birth weight seems to be one of the most sensitive 
indicators of fetal development. The correlation between the 
maternal weight gain and bairth weight is a good example that 
the current medical advice concerning the maximum maternal 
weight gain have little scientific basis. In Hungary the rate 
of newborns with low birth weight is extremely high, the 
decreasing rates were between 10.2 and 9.2% in the eighties 
/2/. Thus the change of the above unreasonable advice 
concerning the maternal weight gain may help to reduce the high 
proportion of low birth weight. Further studies are needed to 
determine the longterm effect of larger maternal weight gain, 
e.g., for the recovery of body weight after puerperal period.
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Linked marker haplotype analysis of 16 cystic 
fibrosis (CF)-affected children, 3 fetuses, 1 healthy 
child and their parents was. performed by restriction 
fragment length polymorphism (RFLP) for J3.ll, Met H, 
Met D, XV-2c, KM.19 markers. Polymerase chain 
reaction (PCR) to detect the main nutation of CF 
chromosome, a specific 3 base pair (bp) deletion 
( F s08) was a^so performed in 17 CF patients.
Allelic frequencies on analysed CF chromosomes were: 
J 3 .11/Taq I 1.0, 0.0, J3.ll/Msp I 0.44, 0.56, Met H/Taq 
I 0.73, 0.27, Met H/Msp I 0.80, 0.20, Met D/Taq I 0.75, 
0.25, XV-2c/Taq I 0.85, 0.15, KM.19/Pst I 0.17, 0.83 
for allele 1 and 2, respectively. Two markers, Met H 
and KM.19 were found to be in strong association with 
the CF mutation. The frequency of the íI F j q o  mutation 
on all 34 CF chromosomes was 0.65 (of which 0.73 was 
homozygous and 0.27 heterozygous for this deletion).
INTRODUCTION
Cystic fibrosis (CF) is the most common recessive single 
gene lethal disorder, having 1 in 32 carrier frequency and 1 in 
4000 newborn incidence in the Hungarian population. The 
disturbed function of exocrine gland epithelia is a common 
feature of the affected organs in CF patients. The inability of 
an epithelial chloride channel to respond to adrenergic stimuli 
and disturbances of its regulation is the basic defect of the 
disorder. Extensive genetic linkage analysis allowed mapping of 
the CF locus to the long arm of chromosome 7 (15, 27-29). This 
approach relied on the discovery that DNA is highly polymorphic
Akadémiai Kiadó, Budapest
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/30/. The restriction endonucleases cleave DNA at specific 
sites producing DNA fragments with different lengths depending 
on the distance of the restriction sites. Variation in the 
position of these sites in DNA of different individuals or 
between DNA contained in homologous chromosomes will produce 
differences of the DNA fragments after digestion (restriction 
fragment length polymorphism = RFLP). The RFLPs are inherited 
in a stable Mendelian fashion and could be regarded as genetic 
loci. These sequence variants are detected primarily by 
Southern blot analysis in which recombinant DNA probe defines 
the region of interest. Before the discovery of the CF 
transmembrane conductance regulator (CFTR) gene in 1989 /13, 
20, 21/ and the most frequent CF mutation ( F 5 g g deletion) 
inheritance of the disease could only be inferred via linkage 
analysis with nearby polymorphic DNA probes.
The CF gene resides in a region flanked by the following 
linked DNA markers: 7 cen ... CollAl - B79a - D7S18 - Met - XV- 
2c - CS.7 - KM.19 - Mp 6 d - CF - W32 - J3.ll - TCRB..7qter (1, 
2, 4, 10, 23, 24, 29/.
These markers reveal genetic polymorphism useful in linkage 
and haplotype analysis and permit also the CF diagnosis of 
first - trimester chorionic villus biopsies, provided that 
material from an index affected child is available. Linkage 
analysis is dependent on marker haplotype information from 
proposite DNA and the results are valid within the same family.
When our laboratory initiated the project in Hungary, the CF 
locus has not been cloned yet, therefore we followed the 
"classic" RFLP analysis i. e. linkage studies with three 
closely linked DNA markers to the locus Met H, Met D, J3.ll / 6 / 
and from the second CF family - examination, we completed the 
genetic analysis with two more tightly linked DNA markers (XV-2c 
and K M.19). We studied altogether 16 CF families who wanted to 
have another healthy child.
We examined also in 17 patients (all but two were new 
patients) the main CF mutation ( A F ^ g ß )  with polymerase chain 
reaction (PCR) which is a powerful new method to amplify 
specific DNA sequences several millionfold in a few hours. This
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mutation means a specific 3 base pair (bp) deletion resulting 
in the loss of a phenylalanine at amino acid position 508 of 
the gene product.
MATERIALS AND M E T H O D S
RFLP analysis: DNA was extracted from EDTA-anticoagulated
venous blood of 16 CF affected children, their parents, one 
healthy brother and chorionic villi of three fetuses at 7-12 
weeks of gestation, as previously described /14, 16/. 1 0  /ug 
high molecular weight DNA was digested with 2 U/,ug restriction 
enzymes: Taq 1, Msp I and Pst I, respectively. The samples
were electrophoresed in 0.7% agarose gel at 25 V overnight and 
blotted into nitrocellulose filters as described by Southern 
/25/. The blots were hybridized with the appropriate DNA probes 
labelled with the random priming method / 1 2 , 16/, using an 
Amersham kit, and exposed to X-ray film with an intensifying 
screen for 3-6 days.
Hybridization probes: Probes were DNA sequencies, J3.ll, XV- 
2c and K M.19 (kindly provided by Dr. R. Williamson, St. Mary's 
Hospital, London) and Met H and Met D (gifts of Dr. R.'White, 
University of Utah, Salt Lake City).
Comparison of the allele frequencies on CF and normal 
chromosomes was made by use of Fisher's exact probability test.
PCR analysis for Д  Fggg mutation:
The PCR for A F j g g  was performed as described by C.G. Matthew 
et al /17/. Reactions were subjected to 35 cycles (via PREM 
thermocycler) of denaturing at 94°C for 1 min, annealing at 
55°C for 1.5 min and polymerase extension at 72°C for 1.5 min. 
The two opposite genotypes (50bp fragment of normal and a 47 bp 
by fragment of mutant genes) could be differentiated on 1 2 % 
polyacrylamide gels. The fragments were photographed in 
ethidium bromide stained gels.
Clinical diagnosis: the CF diagnosis was always based on
sweat test, the pancreatic and pulmonary function were assessed 
on the basis of clinical and laboratory findings.
RESULTS
Taq I and Msp I RFLP at J3.ll and Met H loci, Taq I RFLP at 
the Met D and XV-2c loci and Pst I RFLP at the KM.19 locus were 
used for allele analysis (Table I). The genotype of each 
individual was scored for the two alleles by using code 1 for 
the longer fragment and code 2 for the shorter fragment in the
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TABLE I
DNA-analysis of CF families with linked probes
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Family probe enzyme father mother affected healthy fetus informativity
N ° child child
1. S. Z. J3.ll Taq I 1/2 1/1 1/1 - - partly inf.
J3.ll Msp I 1/1 1/2 1/2 - - partly inf.
Met H Taq I 1/2 1/2 1/1 - - inf.
Met H Msp I 1/2 1/2 1/1 - - inf.
Met D Taq I 1/1 1/1 1/1 - - uninf.
2. Z. T. J3.ll Taq I 1/1 1/1 1/1 - - uninf.
Met H Taq I 1/1 1/2 1/1 - 1/2 partly inf.
XV 2c Taq I 1/1 1/1 1/1 - - uninf.
KM 19 Pst I 1/2 2/2 2/2 - 2/2 partly inf.
3. H. T. J3.ll Msp I 1/1 1/2 1/2 - - partly inf.
Met D Taq I 1/1 1/1 1/1 - - uninf.
XV 2c Taq I 1/1 1/2 1/1 - - partly inf.
KM 19 Pst I 1/2 1/1 1/2 - - partly inf.
4. A. H. J3.ll Msp I 1/2 1/2 1/1 1/2 - inf.
XV 2c Taq I 1/2 1/2 1/2 1/2 - uninf.
KM 19 Pst I 1/2 2/2 2/2 1/2 - partly inf.
5. M. Sz. Met H Taq I 1/1 1/1 1/1 — — uninf.
Met D Taq I 2/2 2/2 2/2 - - uninf.
XV 2c Taq I 1/2 1/1 1/1 - - partly inf.
KM 19 Pst I 1/2 2/2 2/2 - - partly inf.
6. J. Sz. J3.ll Msp I 1/2 1/2 1/2 - - uninf.
J3.ll Taq I 1/1 1/1 1/1 - ; - uninf.
Met H Taq I 1/1 1/1 1/1 - - uninf.
Met D Taq I 1/1 1/1 1/1 - - uninf.
XV 2c Taq I 1/1 1/2 1/1 - - partly inf.
KM 19 Pst I 1/2 1/1 1/2 - - partly inf.
7. I. Cs. J3.ll Taq I 1/1 1/1 1/1 - - uninf.
8. E. V. J3.ll Taq I 1/1 1/1 1/1 _ — uninf.
KM 19 Pst I 1/2 1/2 2/2 - - inf.
9. T. M. J3.ll Taq I 1/1 1/1 1/1 — _ uninf.
XV 2c Taq I 1/2 1/2 1/1 - - inf.
KM 19 Pst I 1/2 2/2 2/2 - - partly inf.
10. T. T. XV 2c Taq I 1/1 1/1 1/1 — — uninf.
Met H Taq I 2/2 1/2 1/2 - - partly inf.
11. P. L. Met H Taq I 2/2 2/2 2/2 — — uninf.
Met H Msp I 1/2 1/2 1/1 - - inf.
J3.ll Msp I 1/2 1/2 1/2 - - uninf.
XV 2c Taq I 1/2 1/1 1/1 - - partly inf.
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12. E.B. XV 2c Taq I 1/2 1/1 1/2 - partly inf.
Met H Msp 1 1/1 1/2 1/2 - partly inf.
13. D. F. Met H Taq 1 1/2 2/2 1/2 - partly inf.
XV 2c Taq I 1/1 1/2 1/1 - partly inf.
14. M.Gy. J3.ll Msp I 1/2 1/2 1/2 - uninf.
Met H Msp I 1/2 1/2 1/1 - a - b inf.
Met H Taq I 1/2 1/2 1/1 - 1/1 1/2 inf.
XV 2c Taq 1 1/1 1/1 1/1 - uninf.
KM 19 Pst 1 1/1 2/2 1/2 partly inf.
15. M. P. Met H Taq 1 1/2 1/2 1/2 - uninf.
Met H Msp I 2/2 1/2 1/2 - partly inf.
J3.ll Msp I 1/2 2/2 2/2 - partly inf.
XV 2c Taq I 1/2 1/2 1/1 - inf.
16. Sz. V. KM 19 Pst I 1/2 1/2 2/2 - inf.
XV 2c Taq I 1/2 1/2 2/2 - inf.
Met H Taq I 1/2 1/2 1/2 " uninf.
Lengths of fragments 1 and 2 Allele frequencies for fragment 1 and 2
on CF and normal chromosomes
1. J3.ll Taq I 1= 6 kb 2= 3.2 kb 1.0. 0.0 0.92, 0.08
2. J3.ll Msp I 1= 4.4 kb 2= 1.9 kb 0.44, 0.56 0.53, 0.47
3. 'Met H Taq I 1=7 kb 2= 4.2 kb 0.73, 0.27 0.40, 0.60
4. 'Met H Msp I 1= 2.3 kb 2= 1.7 kb 0.80, 0.20 0.20, 0.80
5. Met D Taq I 1= 5 kb 2= 4 kb 0.75, 0.25 0.75, 0.25
6. XV 2c Taq I 1= 2.1 kb 2= 1.4 kb 0.85, 0.15 0.62, 0.38
7. XKM 19 Pst I 1= 7.8 kb 2= 6.6 kb 0.17, 0.83 0.67, 0.33
Probe with the closest association to the CF gene 
* p<0.05 , x p<0.01
informative: the probe shows unique picture for the CF child
partly informative: informative for only one parent
uninformative: the same picture for the CF affected child and its parents
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absence or presence of the restriction sites. In cases where 
one or other probes were found to be informative in the family, 
we did not go on with another probe. 32 CF chromosomes of 16 
affected children and 32 normal chromosomes of 32 compound 
heterozygote parents were surveyed for the linked haplotypes 
for parental CF chromosomes. Normal chromosomes of the parents 
were assigned by using the CF child genotype in each family. No 
significant difference was found in the frequencies of alleles 
1 and 2 of 33.11 (Taq I 1.0, 0.0, Msp I 0.44, 0.56), Met 
D/0.75, 0.25) and X /-2c (0.85, 0.15) probes on the CF 
chromosomes as compared with those on the normal chromosomes of 
the parents. The number of CF allele associated with the longer 
fragment at the Met locus was nearly twice (Taq I) or four 
times (Msp I) as many as for the normal allele. The shorter 
fragment at the K M . 19 locus was found to be two and a half 
times more frequent in the disease (CF) allele than in the 
normal allele (0.83 in CF versus 0.33 in normal p < 0.01).
Conversely: the other alleles associated more frequently 
with the normal chromosomes.
All but two CF families were fully informative by one probe 
or an appropriate combination of partly informative probes and 
polymorphisms. The informative probes presented unique allele 
picture for the CF affected child. The partly informative 
probes were informative for only one parent but not for the other one and 
the CF affected child. The uninformative probes presented the 
same allele picture for the CF affected child and its parents.
To the prenatal diagnosis each parent must carry a 
detectable CF allele. We performed 3 prenatal diagnosis on 
chorionic villus tissue (9-12 weeks after conception). Two 
fetuses were predicted by DNA analysis to be unaffected 
(although carriers) and one fetus to be affected. One of the 
two unaffected, but carrier children was born healthy, whereas 
the other and the affected one were twins and the parents 
decided on termination of the pregnancy.
The distribution of Fjgg deletion and other CF mutation on CF 
chromosomes in our 17 CF patients is found on Table II. Eight 
patients were homozygous for the Fjgg deletion, 6 heterozygous 
and 3 homozygous for absence of this deletion. The frequency of
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Table И.
Distribution of CF chromosomes with FS08 deletion and with 
other CF mutations in 17 CF patients
№
Patients
Mutation of CF chromosomes
A F  508 other
1 M/34 (H.T.) X X
2 M/45 (M.Sz.) X X
3 M/50 (A.R.) X X.
4 M/157 (G.G.) X X
5 M/192 (G.F.) X X
6 M/199 (A.B.) X X
7 M/84 (E.V.) X -
8 M/87 (T.M.) X -
9 M/163 (G.G.) X -
10 M/164 (G.G.) X -
11 M/166 (N.Sz.) X -
12 M/172 (V.P.) X -
13 M/173 (A.H.) X -
14 M/185 (A.S.) X -
15 M/83 (F.B.) - X
16 M/148 (B.V.) - X
17 M/122 (A.T.) - X
The frequency o f Д  F 5QQ mutation on 34 CF 
chromosomes is 0.65 lof which 0.73 homozygous 
for this deletion).
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ZI F^gg mutation on 34 CF chromosomes of 17 CF affected child 
is 0.65.
As shown in Fig. 1 the PCR products of the mutant and normal 
alleles are clearly distinguished from each other in samples of 
heterozygotes or homozygotes for Д  F^gg mutation. The first 
sample is homozygous for Л  Fjgg mutation shows single 47 bp 
long fragment. The second sample is heterozygous for the F^gg 
deletion showing a 47 bp and a 50 bp long fragment and a
4  3 2 1
Fig. 1.
Tne PCR for A F ^ g g  was performed as described by Matthew et al. 
/17/. The two opposite genotypes 47 bp fragment of mutant /F/ 
and a 50 bp fragment of normal /N/ genes could be 
differentiated in 1 2 % polyacrylamide gel stained ethidium 
bromide. A heteroduplex /Het/ with slower mobility in the gel 
originated from the normal and mutant sequences. The first 
sample is homozygous for, the A F 5 gg mutation, the second one 
heterozygous and the third and fourth samples have only normal 
sequences in this CF locus.
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heteroduplex between the normal and mutant sequences with 
slower mobility in the gel. Those CF patients who carry the 
A F j g g  mutation only on one of their chromosome 7 and the other 
chromosome 7 carries a mutation elsewhere in the CF gene are 
indistinguishable by this simple analysis from the healthy 
compound heterozygotes for the Д  Fjgg mutation. The normal 
homozygotes (3rt^  and 4 ^  sample) possess only 50 bp long 
fragments.
DISCUSSION
Our first analysis relied on an indirect approach that used 
D N A sequence polymorphisms and.linkage analysis. The linkage 
disequilibrium means that a particular allele for the RFLP is 
found with a substantially increased frequency with the mutant 
gene than with the normal gene.
Our haplotype data show a strong allelic association between 
CF and allele 1 for the Met H locus and allele 2 for the K M . 19 
locus as compared with the normal chromosomes.
Conversely, the other alleles seemed to be associated more 
frequently with the normal chromosomes. There are differences 
in the CF and the normal haplotype distributions in the various 
geographic regions and ethnic backgrounds /3, 9, 11, 22, 27/. 
Our findings confirm the allele frequencies on CF chromosomes 
with J 3 . 1 l / M s p  I reported by Vitale et al (0.42, 0.58) /27/, 
with J 3 . l l /  Taq I reported by Bates et al (0.92, 0.08) /3/, 
with Met H/Taq I reported by Bates et al (0.66, 0.34) /3/, 
Estivill et al (0.67, 0.33) /9/, but differ from data of Vitale 
et al (0.36, 0.64), Németi et al. /18/ Met H/Msp I allele 
frequencies of our CF patients confirm data of Bates et al 
(0.71, 0.29) but differ from results of Vitale et al (0.43,
0.57). The allele frequencies of our CF affected children with 
Met D/Taq I, XV-2c/Taq I are in agreement with those 
of Estivill et al (0.79, 0.21, 0.92, 0.08 respectively). The 
data with KM.19/Pst I confirm the ones of Santis et al (0.15, 
0.85) /22/.
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After the identification of linked ONA markers, a 
fundamental breakthrough in CF research was the localization of 
the CF gene. The cloning of the CF gene (approx. 250 kilobases 
(kb) long, its m-RNA is 6.5 kb) made possible the 
characterization of the mutations. It was found that a deletion 
of three nucleotides (CTT) in the central part of the first 
nucleotide (ATP) binding domain at position 508 results in 
omission of a phenylalanine from the cystic fibrosis 
transmembrane regulator (CFTR) protein (delta Fjgg mutation). 
The overall proportion of Д  F 5 g g in a worldwide survey was 6 8 % 
with a range of 40-80% /26/. In our patients 65% of CF 
chromosomes harbour this deletion.
At the diagnostic level analysis of the three base pair 
deletion will replace linkage analysis to a certain extent for 
appr. 50% of the couples when both parents are heterozygous for 
this deletion. In the remaining cases, the identification of 
the other mutations of CF gene and in some cases the closely 
linked markers would have role for marker information from 
proposites and parents.
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60 children with acute lymphoblastic leukemia were 
sequentially randomized at the time of diagnosis: 
Immunoglobulin (Endobulin, Immuno) was administered 
intravenously to 30 patients at a dose 100 mg/kg/week 
during the first 3 months, followed by 2x200 
mg/kg/month immunoglobulin during the 4., 5., 6 . 
months. No immunoglobulin was administered to the 
control patients. We studied the effect of 
immunoglobulin prophylaxis on the number of days with 
fever, number of cases with bacteriologically proved 
infections, length and frequency of antibiotic therapy. 
Our data confirm the efficacy of immunoglobulin 
prophylaxis during the intensive phase of leukemia 
therapy in children.
I NT RODUCTION
Intravenous immunoglobulin therapy has been proven to 
reduce the frequency of acute bacterial infections in patients 
with antibody deficiency diseases / 1 /, and recently it has been 
employed succesfully for the treatment of echovirus induced 
meningoencephalitis in an agammaglobulinémie patient / 2 /. 
Substitution therapy with IgG in patients with humoral 
immunodeficiency /3/ has been also attempted with promising 
insults. In adults with CLL, immunoglobulin administration 
resulted in fewer bacterial infections in a randomized trial 
/4/. However, frequency and severity of acute or chronic 
infections do not seem to be always directly correlated with
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the extent and pattern of immunoglobulin deficiency in these 
patients /5/.
Due to the high morbidity and mortality caused by infections 
in leukemic children, prevention is of great importance. The 
aim of our study was to examine the effect of immunoglobulin 
prophylaxis in children with leukemia in a randomized trial.
P AT IE NT S  AND M E T HO DS
In our study 30-30 patients with acute lymphoblastic 
leukemia were subsequently randomized for prophylactic 
immunoglobulin administration. The patients in the experimental 
group received 100 mg/kg Endobulin i.v. per week for three 
months, followed by 2x200 mg/kg in the 4., 5., 6 . months of 
tre a t m e n t .
The age, sex and distribution for BFM risk factors were 
similar in the experimental group and in controls (Table I).
TABLE I
Patients' characteristics
№ Distribution of 
patients
according to BFM
Sex Age (year)
Risk groups (mean)
Experimental group 30 low 19 ? 1 1 6.3
standard 6 0* 19
high 5
Controls 30 low 18 ? 13
standard 8 a* 17 6 . 0
We examined the duration of initial aplastic phase during the 
treatment, the number of days with fever (higher then 38°C), 
the number of bacteri о logically identified infections and the
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number and duration of antibiotic treatments.
Student's 1-test for paired samples was used for statistical 
comparison of the observations from the two groups of patients
/ 6 , 7/.
Ihe immunoglobulin level in the blood was examined in 2 2  
experimental and 21 control children by the method of Mancini 
/8/.
RESULTS
The duration of initial aplastic phase during the 
antileukemic treatment was similar in the experimental group 
and controls. Ihe number of days with fever was only slightly 
less in the experimental group, however, the number of 
cacteriologically identified infections was significantly 
reduced (Table II). Ihe number and duration of antibiotic 
treatments were lower in the experimental group during the 
immunoglobulin treatment (Table III).
Ihe serum level of IgG increased in more patients and 
decreased in less children in the experimental group during the 
first 3 months of treatment. Ihe change of the IgM and IgA 
serum level in the experimental and control group was not 
remarkably different (Table IV).
DISCUSSION
The great improvement in the survival in ALL is due to 
agressive multi-agent chemotherapy. However, treatment results 
are compromised by high occurrence of infections and related 
deaths during therapy. The high susceptibility of leukemic 
patients to different infections is caused partially by 
decreased immune response, due to the disease itself and to the 
intensive cytostatic/immunosuppressive treatment.
TABLE II
Infections and fever in patients with ALL during the first 12 months of therapy
№ □ays with 
fever
(mean/patient)
Microbiol. 
proved 
infections 
(mean/patient)
Unproved
infections
Total №  
of infections
Experimental 30 1 1 . 1 0.53 1.63 2.16
group
Controls 30 1 2 . 0 1.13 1. 73 2 . 8 6
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TABLE III
Antibiotic treatment during the first 6 months of treatment
Endobulin How frequently 
(mean/patient)
Duration of antibiotic 
treatment (days) (mean/patient)
Experimental group 3.6 27.2
Controls 4.16 31.63
Antibiotic treatment during the second 6  months of treatment
How frequently 
(mean/patient)
Duration of antibiotic 
treatment (days) (mean/patient)
Experimental group 2.9 22.33
Controls 3.6 29.66
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TABLE III/А
Distribution of diagnoses and aetiology of bacteriologically proved
infections
Experimental group 
(Endobulin treated)
Controls
Infection № Isolated pathogens № Isolated pathogens
Septicemia 8 6 S. aureus 1 2 7 Klebsiella
2 Klebsiella 3 S. aureus
2 coagulose-negative
staphylococci
Respiratory 5 5 S. aureus 14 5 S. aureus
tract 2 coagulase-negative
staphylococci
3 S. pneumoniae
3 Klebsiella
1 E . coli
Urinary tract 2 1 Enterobacter 7 3 E. coli
1 P. mirabilis 3 Klebsiella
1 P. aeruginosa
Skin - - 1 1 P. aeruginosa
Total 15 34
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TABLE III/B
Distribution of diagnoses of bacteriologically unproved infections
Experimental group 
(Endobulin treated)
Controls
Infection № №
F.U.O.* 2 14
Respiratory tract 47 37
Abdominal - 1
T otal 49 52
* Fever of undetermined origin
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TABLE IV
The change of immunoglobulin level during the first 3 months of ALL -treatment
IgG IgM IgA
Controls Experimental Controls Experimental Controls Experimental
group group group
Increased 1 6 4 5 - 4
Unchanged 8 8 6 6 11 6
Decreased 13 7 12 10 11 11
№  of Ig-untreated children: 22 
№  of Ig-treated children: 21
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The more intensive therapy, the more prolonged are the 
agranulocytopenic intervals, which proved to correlate with the 
frequency of bacteriologically confirmed sepsis /9/. Several 
leukemia study groups administer pooled immunoglobulin 
preparations to decrease infections, however, its efficacy was 
not proved yet in children's ALL in randomised trials. In 
adult's chronic lymphatic leukemia, an American randomised 
cooperative study proved recently the efficacy of the 
immunoglobulin prophylaxis /4/.
Hartlapp and coworkers found also less infections in a 
randomised study of 56 adults with seminoma and 32 with 
bronchial carcinoma treated with immunoglobulin during 
chemotherapy / 1 0 /.
The studies described in children were done with 
unsufficient patient selection. Nishimura and Fujii /11/ found 
a good effect in septicaemia by the combination of antibiotics 
and immunoglobulin. The efficiency rate in their material was 
71% against infections in children suffering from leukemia or a 
malignant tumor. The dose of immunoglobulin was 50-150 mg/kg 1- 
3x. However, it was not a randomised trial and the number of 
their patients was only 17. Matsumoto et al in leucopenic 
patients found a 50% efficacy rate, but it is also anecdotal, 
because the number of patients was only 1 2  / 1 2 /.
In our study the mean number of days with fever per patients 
and the mean number of bacteriologically unproved infections 
per patient showed no difference in the two groups, 
how ever,
the number of bacteriologically proved and total number of 
infections per patient was significantly lower in the 
immunoglobulin treated group. It is remarkable that control 
children got more frequently and more antibiotics, than the 
experimental group. The number of days with antibiotics during 
the first 6 months of treatment as well as during the 7.-12. 
months was slightly less in the group treated by immunoglobulin 
(27.2 versus 31.6; 22.3 versus 29.7).
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The results of our randomised study demonstrate that the 
prophylactic use of immunoglobulin during the initial phase of 
antileukemic therapy in children results in a decrease in the 
number of infections.
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This paper presents two brothers with incomplete 
expression of the Smith-Lemli-Opitz syndrome.
A definite diagnosis, made after the birth of the 
second child, could only be reached when the clinical 
features of both patients were combined.
INTRODUCTION
The Smith-Lemli-Opitz (SLO) syndrome, first described in 
1964 by Smith et al /12/ is an autosomal recessive condition 
characterized by a combination of severe psychomotor 
retardation and failure to thrive, microcephaly, hand and foot 
anomalies, typical facial appearance and genito-urinary 
abnormalities /5/.
In the absence of a specific marker, the diagnosis of this 
relatively common syndrome / 8 /, still entirely depends on its 
clinical manifestations / 6 , 1 0 /.
Therefore, in the case of incomplete expression of the SL0- 
syndrome, the establishment of the correct diagnosis can become 
virtually impossible and hence genetic counseling hazardous. 
Here we report on two affected siblings with a diagnosis only 
becoming apparent after the birth of the second child.
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CLINICAL R E P O R T S
Patient 1. M .R . , a 22-month-old boy was referred to evaluate 
his severe psychomotor retardation and for possible genetic 
counseling. The nonconsanguineous parents were healthy and 
under 30 years of age.
He resulted from his mother's second, uneventful pregnancy 
(the first pregnancy ending in a spontaneous abortion), 
terminated at 41. week with a Caesarian Section due to breech 
presentation. Weight at birth was 3100 gram. The infant needed 
intensive care in the perinatal unit because of severe neonatal 
apnea .
Feeding problems were still present after two weeks, when he 
was discharged.
At the age of nine months his condition was evaluated at 
several referral centres. An atrial septum defect (type II) 
was diagnosed, and further his discharge papers mention severe 
muscle hypotonia, a head circumference well below the tenth 
percentile (44 cm), a normal EEG, while an EMG and muscle 
biopsy showed signs of myopathy.
At the time of admission he was unable to sit or stand, there 
was a generalized muscle hypotonia, a left N. abducens paresis, 
normal reflexes difficult to elicit, without abnormal reflexes 
being detected.
Mild micrognathia, dyscrania, a retractile testis on the right 
side, with an inguinal testis on the other side were noted as 
well. A screening laboratory blood and urine work-up was 
negative, his karyotype appeared normal.
With no other anomalies detected his condition was designated 
cerebral palsy with psychomotor retardation due to perinatal 
hypoxia. Genetic advice to the parents was given accordingly.
Patient 2. M . B . , the one-month-old brother of the propositus
was referred to us for evaluation of his underdeveloped 
genitals. He was born after forcipal extraction, following an 
uneventful full-term gestation, weighing 3240 gram, Apgar 
score: 9/10. From birth on he had marked muscle hypotonia, 
feeding difficulties ensued and he had to be nourished by naso­
gastric tube.
At the age of one month his height (53 cm) was on the 25th 
percentile, the weight (3650 gram) just under this percentile, 
and his head circumference (35 cm) below the 10th percentile. 
The skull was asymmetric, with a broad nasal bridge, open 
metopic suture and ridging of the sagittal suture. Anteversion 
of the nose, micrognathia, small shoulders, a sacral dimple and 
hypertelorism of the mamillae were noted.
On auscultation a 3/6 systolic murmur was heard, but an 
echocardiogram - made two days after birth - revealed no 
abnormalities. The liver extended 3 cm below the costal margin. 
Besides a conspicuously small penis (13 mm), there was 
bilateral cryptorchidism with a hypoplastic scrotum.
Routine urine examination revealed a urinary tract infection 
with E. Coli. Renal ultrasound disclosed no abnormalities.
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TABLE I
Characteristics of patient 1 and 2, compared with reported 
frequency of clinical manifestation in SLO-syndromei.
Pt.l Pt.2 literature
Intra-uterine
decreased fetal movements / / 14*
birth weight less than 2500 g - - 33
prematurity less than 38 weeks - - 24*
breech presentation + - 13*
Post-natal
feeding difficulties + + 90*
failure to thrive + + 92*
Head
microcephaly + + 95
dyscrania + + 40
Facies
Eyes
epicanthic folds (1 ) + - 40
blepharoptosis (2 ) + 64*
strabismus (3) + - 40
miscellaneous - - 1 0
Nose
broad nasal bridge (4) + + 50
anteverted nares (5) + + 75
Mouth
gothic palate (6 ) - - 55*
cleft palate or uvula (7) + - 40*
wide alveolar ridges (8 ) - - 60*
Ears
low set or abnormal rotation (9) - - 33*
abnormal shape or size ( 1 0 ) - - 51*
Mandible
Micrognathia (11) + + 80
Facies suggestive for SLO
5 or more of the 11 facial
manifestations + - 85*
Genito-urinary
hypospadiasis - - 60*
cryptorchidism + + 50
microphallus - + 2 0
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Pt.l Pt.2 literature %
L imbs
post-axial polydactyly - - 23
soft-tissue syndactyly - - 65
Central Nervous System
severe mental retardation + / + 1 0 0 *
hypotonia/hypertonia + /- + /- 53/25*
EEG abnormalities + / 82*
Heart
congenital heart disease + / 2 0
Chest
narrow shoulders + + occ .
inter-mammillary index T - + occ .
Skeletal deformities
coxa valga + occ
wedge shaped vertebrae + -
Skin
sacral dimple + + o c c .
frequency reported by R. Gorlin in 1990 
* based on frequency reported in 1974 by V.P. Johnson 
+ = present 
- = absent 
/ = not assessed
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Repeated bloodtests showed transient elevation of liver-enzymes 
(SGOT 111 U/l, SGPT 79 U/l.TTGT 81 U/l), total serum bilirubin 
29.1 yum о 1/1, with a direct fraction of 23.8 yum о1/1. WBC: 44.000 
cells/cu mm, nucleated red cells: 8.800 cells/cu mm. FSH: 1.8 
mE / m l , LH: 9,6 mE/ml. Testosterone 0.8 nmol/1, after HCG- 
stimulation 2.3 nmol/1. The result of a screen for viral 
antibodies (Herpes, CMV and Rubella) was negative. Karyotype 
was n or mal.
Since an unequivocal diagnosis could not be made, his then 
4-year-old brother (patient 1) was also admitted. In Table I 
the above findings as well as newly found minor anomalies are 
summarized and compared with reported frequencies /4, 5/ of 
minor and major anomalies in the SLO-syndrome.
DISCUSSION
The diagnosis of multiple congenital anomalies syndromes 
that have no specific markers always carries some degree of 
subjectivity / 1 1 /, well illustrated by our, somewhat unusual, 
later detailed way of establishing the correct diagnosis.
When patient 1 was first seen, he showed three of the five 
characteristics of the Smith-Lemli-Opitz syndrome:
microcephaly, severe psychomotor retardation with failure to 
thrive and mild genito-urinary abnormalities.
Some of the manifestations that now make his facial appearance 
typical for the SLO-syndrome had not yet completely developed 
(ptosis, epicanthic folds) or escaped clinical detection (uvula 
bifida, broad nasal bridge, anteverted nares).
However, at the age of 22-months his clinical presentation was 
certainly not enough for the diagnosis of the SLO-syndrome, 
with its far reaching consequences regarding genetic 
counseling.
Patient 2, with hypogonadism and floppyness as characteristics, 
could not fulfill the above mentioned criteria for the SLO- 
syndrome either. At the age of one month it was too early to 
form an opinion about his psychomotor development, and his 
facial appearance was at least not yet suggestive for the SLO- 
syndrome. This gave him only 2 out of the 5 possible criteria. 
As none of these criteria is obligate or pathognomonic, the 
total clinical picture, resulting from a combination of these
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criteria should be the basis for the diagnosis /5/.
By combining the abnormalities found in the two brothers, we 
overcome the hesitation in the interpretation of minor 
dysmorphic signs /9/ (their appearance in both brothers is much 
more significant) and at the same time we gain criteria for 
the diagnosis: we now have a clinical picture at hand that is 
very suggestive for the SLO-syndrome, with four of the five 
criteria being fulfilled. Considering the wide phenotypic 
variability of the SLO-syndrome /11/ we regard our approach as 
jus tif i a b l e .
Furthermore, we can add one additional, hitherto unreported 
anomaly to the long list of reported anomalies: wedge shaped 
lumbar vertebrae in patient 1 .
Although their clinical presentation much differed (severe 
mental retardation versus hypogonadism), the two brothers had a 
similar, albeit incomplete expression of the SLO syndrome gene. 
On the SLO severity score /1/, devised by Bialer et al, patient 
1 would score 5, his brother (at this moment without complete 
evaluation of his cardiac condition) 2 points out of the 
maximum of 19 points.
This finding gives further support for the observation of 
consistency between affected sibs /1, 7/.
But if overall degree of severity is positively correlated with 
the degree of feminization of male genitals, polydactyly and 
cleft palate, as is suggested in the same article, our sibs 
cannot confirm this finding.
Patient 1 has a cleft uvula, patient 2 does not; Patient 2's 
genitals are far more feminized than the one's of patient 2 . 
The siblings presented in the article of Johnson /5/ (SLO 
score 3 resp. 2, with polydactyly causing the score difference) 
show marked familial concordance, while differing in 
polydactyly. Similar differences can be observed in the 
siblings reported by Blair et al /2/ and Curry et al /3/.
It would be interesting to know whether these three phenotypic 
correlations, established in the group of all 1 2 2  published 
patients, could also be found in the group of siblings, and 
whether the siblings were in general concordant for cleft
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palate, polydactyly and degree of feminization of genitals, as 
would be expected, given the consistency between affected sibs. 
A syndrome with a diagnosis entirely depending on its clinical 
picture and without pathognomonic features will always be at 
risk of being too often identified, or in the words of Winter
" ....  this is a much overdiagnosed syndrome." /13/
Regarding current preference for small families, however, 
our siblings clearly illustrate that the risk of 
underdiagnosing the SLO-syndrome, with its autosomal recessive 
inheritance and wide phenotypic variability, is as present as 
ever .
REFERENCES
1. Bialer MG, Penchaszadeh VB, Kahn E, et al: Female external 
genitalia and Müllerian duct dérivâtes in a 46,XY infant 
with the Smith-Lemli-Opitz syndrome. Am J Med Genet 28: 
723, 1987
2. Blair HR, Martin JK: A syndrome characterized by mental
retardation, short stature, craniofacial dysplasia, and 
genital anomalies occurring in siblings. J Pediatr 69: 457, 
1966
3. Curry CJR, Carey Ü C , Holland JS, et al: Smith-Lemli-Opitz
syndrome-type II: Multiple congenital anomalies with
pseudohermaphroditism and frequent early lethality. Am 0 
Med Genet 26: 45, 1987
4. Gorlin RJ , Cohen MM Jr, Levin LS (eds): Syndromes of the 
Head and Neck. Oxford University Press, 1990
5. Johnson VP: Smith-Lemli-Opitz syndrome: Review and report
of two affected siblings. Z Kinderheilk 119: 221, 1975
6 . Lachman MF, Wright Y, Whiteman DAH, et al: Brief clinical
report: A 46,XY phenotypic female with Smith-Lemli-Opitz
syndrome. Clin Genet 39: 136, 1991
7. Lowry RB: Editorial comment: Variability in the Smith-
Lemli-Opitz syndrome: Overlap with the Meckel syndrome. Am 
J Med Genet 14: 429, 1983
8 . Lowry R B , Yong S L : Borderline normal intelligence in the 
Smith-Lemli-Opitz (RSH) syndrome. Am J Med Genet 5: 137, 
1980
134 J. Karsten and G. Kosztolányi
9. Méhes K: Informative Morphogenetic Variants in the Newborn 
Infant. Akadémiai Kiadó, Budapest, 1988, p. 6 .
10. Opitz JM, Penchaszadeh VB, Holt MC, Spano LVM: Smith-Lemli- 
Opitz (RSH) syndrome bibliography. Am J Med Genet 28: 745, 
1987
11. Penchaszadeh VB: Invited editorial comment: The nosology of 
the Smith-Lemli-Opitz syndrome. Am J Med Genet 28: 719, 
1987
12. Smith DW, Lemli L, Opitz JM: A newly recognized syndrome of 
multiple congenital anomalies. J Pediatr 64: 210, 1964
13. Winter RM, Baraitser M, Somerville L: Syndrome Program 
(version 2.2), U.K. Medical Research Council and Institute 
of Child Health, London 1987
G. KOSZTOLÁNYI, MD
József Attila u .7. 
H-7623 Pécs, Hungary
Acta Paediatrica Hungarica 32 (2), pp. 135-148 (1992)
SEVERE H Y P O G LY CA EM IA  AND C AR DIOVASCULAR AUTONOMIC D YS FUNCTION 
IN TYPE I D IA BE TI C  CHILDREN T R E AT ED  WITH INTENSIFIED 
CONVENTIONAL INSULIN THERAPY
L. BÁRKÁI, L. MADÁCSY, Ildikó VÁMOSI
II Department of Pediatrics, Postgraduate Medical University,
Miskolc, Hungary
Received 18 July 1991
To assess the relationship between severe 
hypoglycaemias and autonomic dysfunction, five 
cardiovascular tests (resting heart rate, 
hyperventilatory arrhythmia, standing/lying heart rate 
ratio, orthostatic decrease in blood pressure, and 
increase in blood pressure during sustained handgrip) 
were performed in a 1-yr prospective study of 34 
insulin-dependent diabetic children treated with 
intensified conventional insulin therapy (ICIT). There 
were twelve severe episodes in 7 diabetic children, and 
the remaining 27 patients had no severe hypoglycaemia. 
The hypoglycaemic group had a longer duration of 
diabetes than the nonhypoglycaemic group (5.4 SD 2.5 
years vs. 2.8 SD 2.2 years, p<0.02). The hyper- 
ventilatory arrhythmia in the hypoglycaemic group in 
comparison with the nonhypoglycaemic group was 
significantly decreased (before ICIT: 16.1 SD 3/min vs. 
24.4 SD 5/min, p <0.01 ; 1 yr thereafter: 17.3 SD 3/min 
vs. 26.0 SD 5/min, p<0.01). The hypoglycaemic group 
showed a pronounced orthostatic decrease in blood 
pressure compared to the nonhypoglycaemic group (before 
ICIT: 13.2 SD 4 mmHg vs. 6.0 SD 4 mmHg, p < 0 .01 ; 1 yr 
thereafter: 12.3 SD 4 mmHg vs. 5.6 SD 4 mmHg, p<0.01). 
Three or more abnormal cardiovascular test results were 
found in patients of the hypoglycaemic group who showed 
abnormal hyperventilatory arrhythmia and abnormal 
orthostatic decrease in blood pressure simultaneously, 
whereas such a coexistence was not found in the 
nonhypoglycaemic group. These observations may support 
the view that diabetic children and adolescents with 
autonomic dysfunction are susceptible to severe 
hypoglycaemia during ICIT.
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INTRODUCTION
Considerable evidence has accumulated that the frequency of 
complications of diabetes is associated with the degree of 
metabolic disturbance, primarily hyperglycaemia /1, 2, 3/. On 
the basis of this, during the treatment and care of diabetes 
the main purpose is to achieve the best metabolic control as 
well as the long-term assurance of normoglycaemia. It is well- 
known that conventional (twice a day) insulin therapy fails to 
restore in diabetic patients the finely regulated blood glucose 
levels of nondiabetic individuals. In the pediatric practice, 
out of recent applied new therapeutic insulin delivery systems, 
the intensified conventional insulin therapy (ICIT) is current 
for treatment of children with insulin-dependent diabetes 
mellitus. .According to the majority of authors, the patients' 
metabolic condition using this method of treatment can be 
improved / 4 , 5, 6/.
With the continuing application of ICIT, the question has 
been raised about an increased risk of hypoglycaemic episodes 
as a result of the efforts to achieve normoglycaemia in 
diabetic children. The frequency and severity of hypoglycaemia 
seem to be increased in those patient populations who attempt 
to achieve metabolic normality /7/. One assumption is that 
impaired glucose counterregulation may be responsible for
increased risk of hypoglycaemia ( 8 , 9/. On the other hand, an 
association between impaired defense mechanisms against 
hypoglycaemia and dysfunction of autonomic system has been 
suggested /10, 11, 12, 13, 14/. However, in this respect, the
clinical importance of disturbed autonomic function in
childhood diabetes is not yet clear.
The aim of our present study was to investigate the
relationship between serious hypoglycaemias and autonomic 
nervous system dysfunction in diabetic children treated with 
ICIT studied prospectively. With this purpose, we included only 
those episodes of severe hypoglycaemia that caused loss of 
consciousness or convulsions and required outside assistance.
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PATIENTS AND METHO DS
Patients
Thirty-four children with insulin-dependent diabetes 
mellitus who had been treated with ICIT for more than 1 year 
were considered for inclusion in this study. This represents 
more than 25% of the diabetic children seen in our clinic 
during this time. All patients have received two daily 
injections of highly purified porcine insulin (conventional 
insulin therapy with Actrapid MC and Monotard MC, Novo-Nordisk, 
Copenhagen, Denmark) since the onset of diabetes. Intensified 
conventional insulin therapy was started in this study 
population after an average duration of diabetes of 3.5 SD 2.5 
years. After the institution of ICIT each child received 
semisynthetic human insulin (Novo-Nordisk, Copenhagen, Denmark) 
injections four times a day: three times Actrapid HM Penfill 30 
minutes before meals by means of NovoPen, and Ultratard HM 
hypodermic injection at 10 P.M. Patients and their families 
received instruction in the management of their diabetes by a 
physician, a nurse, and a dietitian. Patients followed their 
usual diabetic diet, which consisted of 25% fat, 15% protein, 
and 60% carbohydrate given as three meals and three snacks. 
Patients were encouraged to test their blood glucose levels 
with reagent strips and reflectance meters two or three times 
daily (before breakfast and supper and at bedtime). Each child 
was taught to adjust the short-acting insulin dose according to 
the blood glucose concentration before the insulin injection. 
Close follow-up was performed at our clinic at 2-mo intervals. 
In cases of intercurrent illnesses or any problem, children 
were seen as often as once a week. In addition, they were 
requested to come to the clinic or contact the physician 
immediately in the event of severe hypoglycaemia. There were no 
clinical symptoms or anamnestic data indicating vascular 
complications or manifest neuropathy in any of the children.
Study design
The study was conducted prospectively over a 1-yr period. At 
each clinic visit, a detailed information was obtained for the 
children and their parents on any episode of severe 
hypoglycaemia that occurred in the interval since the last 
visit, in case this was not reported immediately after the 
episode. Children with one or more episodes of severe 
hypoglycaemia during the study period were compared to 
nonhypoglycaemic population. Comparisons between the two groups 
were made by comparing sex, age, duration of diabetes, 
fructosamine levels determined at each clinic visit, insulin 
doses, insulin antibody bindings and autonomic function tests. 
Informed consent was obtained from all subjects and their 
parents before the study.
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Autonomie_ function tests
Five cardiovascular tests were performed before the 
initiation of ICIT and 1 yr thereafter. Each diabetic child was 
examined - in the lying position - for the mean resting heart 
rate for a period of 1 min, for hyperventilatory arrhythmia 
(beat-to-beat variation) during five maximal inspirations and 
expirations, for increase in heart rate and fall in systolic 
blood pressure during 1 min standing after the lying position, 
and for rise in diastolic blood pressure after a 1 -min 
sustained maximal handgrip /15, 16, 17/. Heart rates were 
determined with a routine EGG device (Medicor ER 31-A, 
Budapest, Hungary) by R-R intervals in standard leads, for 
blood pressure measurements a digital blood pressure device 
(Omron HEM-400 C, Tokyo, Japan) was used.
To obtain a reference range of cardiovascular tests, 30 
healthy age-matched children were used as control group. 
Confidence limits of 95% (2SD) from means of control subject 
were considered as limits of normality. If the deviation from 
the mean in the control group exceeded 2SD, the values of the 
diabetic children were considered as abnormal /18/.
Analytic methods
Serum fructosamine was mesured by the Roche Fructosamine kit 
(Roche, Basle, Switzerland). The mean and SO for nondiabetic 
children was 2.0 SD 0.3 mmol/1. Fasting serum C-peptide 
concentration was determined by the Mallincrodt kit (RIA-mat C- 
peptide, Dietzenbach, FRG). The normal fasting value is 0.Ív- 
О . 99 mmol/1. Insulin antibody binding was estimated by a 
radiological method (Isotest, Budapest, Hungary,). Ihe upper 
limit for healthy subjects was below 2 0 %.
Statistical analysis
Data and results are expressed as mean and SD. Data were 
tested by Student's paired and unpaired t-tests or by Wilcoxon 
signed rank test and Mann-Whitney rank sum test when data were 
not normally distributed. The frequency of cases with the 
nonhypoglycaemic group was assessed by chi-square test with 
Yates correction.
RESULTS
Twelve hypoglycaemic episodes were recorded in 7 patients 
(hypoglycaemic group) and 27 children had no hypoglycaemia 
(nonhypoglycaemic group) during a 1-yr period of ICIT (Table 
I). Out of the 7 hypoglycaemic patients, one child had 3 
hypoglycaemic episodes, three children had 2 hypoglycaemic 
episodes, and three patients had 1 hypoglycaemic event. There
TABLE I
Clinical data of diabetic children studied (mean + SD)
Diabetic children 
nonhypoglycaemic hypoglycaemic 
group group
Total patients
п 27 7 34
Hypoglycaemia (events yr--*-) 0 > 1 0.35 +_ 0.3
Gender (M/F) 12/15 3/4 15/19
Age (years) 13.2 +_ 3.2 13.5 _+ 4.0 13.4 +_ 3.5
Diabetes duration at the 
institution of ICIT (years) 2.8 +_ 2.2 5.4 +_ 2.5* 3.5 +_ 2.5
Basal C-peptide (nmol l-*) < 0.1 < 0.1 < 0.1
Insulin antibody binding (%) 7.5 +_ 5.0 8.7 + 5.8 8.3 +_ 5.2
ICIT: intensified conventional insulin therapy 
* : p < 0.02
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were no significant differences in respect of sex distribution, 
age and insulin antibody binding between the two diabetic 
groups. At the time of institution of ICIT the hypoglycaemic 
group had a significantly longer duration of diabetes than the 
nonhypoglycaemic group (5.4 SD 2.5 years vs. 2.8 SD 2.2 years, 
p<0.02). All patients in the two groups had no detectable basal 
C-peptide secretion. After the initiation of ICIT a significant 
improvement of metabolic control was registered in both of two 
diabetic groups. Fructosamine concentrations and the mean daily 
insulin doses were similar in the two groups throughout the 
study period (Fig. 1). There was no difference in the average
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Fig. 1. Fructosamine levels and insulin doses in 
nonhypoglycaemic (ЦЦ) and hypoglycaemic ( Щ )  diabetic 
children during intensified conventional insulin therpy 
(ICIT)
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frequency of blood glucose measurement between the two groups 
(2.5 SD 0.3 estimations/day vs. 2.3 SD 0.4 estimations/day).
Results of five cardiovascular tests obtained at 1-yr 
interval did not differ significantly. The individual values 
for hyperventilatory arrhythmia and orthostatic decrease in 
blood pressure in the two groups of diabetic children are shown 
in Figure 2. The hypoglycaemic group showed a significantly 
decreased hyperventilatory arrhythmia (before ICIT: 16.1 SD 
3/min vs. 24.4 SD 5/min, p<0.01 ; 1 yr thereafter: 17.3 SD 3/min 
vs. 26.0 SD 5/min, p<0.01) and a pronounced orthostatic 
decrease in blood pressure (before ICIT: 13.2 SD 4 mmHg vs. 6.0 
SD 4 mmHg, p<0.01; 1 yr thereafter: 12.3 SD 4 mmHg vs. 5.6 SD 
4 mmHg p<0.01) compared to the nonhypoglycaemic group. There 
were no significant differences in the average values of
О
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before ICIT 1 yr thereafter
Fig. 2. Hyperventilatory arrhythmia and orthostatic decrease in 
blood pressure in nonhypoglycaemic ( O)  and 
hypoglycaemic ( ® )  diabetic children during intensified 
conventional insulin therapy (ICIT). (Horizontal bars 
represent mean values; hypoglycaemic vs
nonhypoglycaemic: p < 0 .0 1 )
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resting heart rate, standing/lying heart rate ratio, and 
increase in blood pressure during sustained handgrip when 
comparing hypoglycaemic group with nonhypoglycaemic group (data 
are not shown).
Abnormal cardiovascular tests were found in 6 of seven 
hypoglycaemic children and 13 of twenty-seven nonhypoglycaemic 
patients. Three or more abnormal test results were found in 5 
patients of the hypoglycaemic group and 1 of the
nonhypoglycaemic group. All the five hypoglycaemic patients 
having 3 or more abnormal tests showed abnormal 
hyperventilatory arrhythmia and abnormal orthostatic decrease 
in blood pressure simultaneously. Coexistent abnormalities in 
these two parameters were not shown in the nonhypoglycaemic 
group (5/7 vs. 0/27, p<0.001).
DISCUSSION
In our 1-yr prospective study, ICIT provides an optimized 
glycaemic control in insulindependent diabetic children. 
Although fructosamine levels approached normal in all patients, 
it tended to remain in the upper normal range. Almost 20% 
(7/34) of this study population showed 1 or more severe 
hypoglycaemic episodes in a single year. This hypoglycaemic 
group had a longer duration of diabetes at the time of 
initiation of ICIT, and a more expressed cardiovascular 
autonomic dysfunction than the nonhypoglycaemic group.
The incidence of severe hypoglycaemia in insulin dependent 
diabetes mellitus is controversal. Goldstein et al. /19/ 
documented that the severity of hypoglycaemic episodes was 
related to the degree of blood glucose control. In the first 12 
months of the Diabetes Control and Complications Trial, 
patients receiving intensive insulin therapy reported a 
threefold increase in severe hypoglycaemic events compared with
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those patients receiving conventional therapy 111. Furthermore, 
results from this diabetes trial suggest a relationship between 
the occurrence of severe hypoglycaemia and disease duration. 
Muhlhauser et al /20/ and Schiffrin et al / 6 , 21/ did not find 
a higher incidence of severe hypoglycaemia in intensively 
treated than in conventionally treated diabetic subjects. 
According to Canadian authors /22/ severe hypoglycaemia in 
diabetic children does not appear to be related to long-term 
blood glucose control. In our present study overzealous 
attempts to achieve normoglycaemia as cause of severe 
hypoglycaemia can be excluded because long-term control and 
insulin dosages did not differ in those with and those without 
severe hypoglycaemia. However, the occurrence of severe 
hypoglycaemia in our patient population treated with ICIT seems 
to be not frequent if we take into account that in a recent 
study by Daneman et al /23/, 31% of 311 children treated 
conventionally were found to have had at least one severe 
hypoglycaemic episode. Furthermore, some other studies on adult 
patients with less optimal blood glucose control reported a 
similarly high frequency of severe hypoglycaemia per year /24, 
25, 26/. Until recently, hypoglycaemia was considered as an 
acute event of inadequate diabetes management with no long-term 
consequences. However, recent studies document that 
irreversible brain damage or intellectual impairment may be the 
consequence of severe hypoglycaemia /27, 28, 29, 30/.
Neurological complications of diabetes mellitus have been 
well-known for a long time, including dysfunction of the 
peripheral (somatic) and autonomic nervous system. Neurological 
complications in the subclinical stage appear initially as 
reversible functional disturbances, but later, the clinical 
symptoms are irreversible having poor prognostic consequences 
/15/. Clinically, diabetic autonomic neuropathy can manifest as 
gastrointestinal, genitourinary, and cardiovascular symptoms, 
but it may cause troubles also in pupillary reflex response to 
light, secretory function of sweat glands, and in the 
physiologic defense mechanisms against hypoglycaemia /10, 14/. 
There are two components of the hypoglycaemia response affected 
by the autonomic system in both the normal and diabetic
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individual /31/. The first is the complex of clinical signs of 
declining blood sugar level, resulting from catecholamine 
release and the typical adrenergic symptoms. This phenomenon is 
known as hypoglycaemic awareness. The second component to the 
physiologic response to hypoglycaemia is biochemical in nature. 
With the decrease of blood glucose concentration to abnormally 
low levels, there is normally an increase in counterregulatory 
hormone (glucagon and epinephrine) secretion. This process is 
referred to as hypoglycaemic responsiveness. It is known that 
patients with insulin-dependent diabetes may lose either their 
hypoglycaemic awareness, hypoglycaemic responsiveness, or both 
/ 8 , 9, 32/. The mechanism for the loss of hypoglycaemic 
awareness and responsiveness is unclear. There is some evidence 
to suggest that central (hypothalamic) activation of 
counterregulation may be diminished in insulin-dependent 
diabetes /33/. Other studies suggest that a reduction in 
sensitivity of peripheral beta-adrenergic receptors is a factor 
causing loss of symptoms of hypoglycaemia /34/. It is possible 
that the induction of tight blood glucose control using 
intensified insulin therapy lowers the blood glucose threshold 
for the release of counterregulatory hormones in response to 
hypoglycaemia /35/, nevertheless, an association with increased 
insulin antibody binding has also been proposed /9/. Many data 
suggest that hypoglycaemia unawareness and unresponsiveness may 
be due to disturbed function of autonomic nervous system since 
parasympathetic and sympathetic innervation play role in 
glucagon and epinephrine secretion during hypoglycaemia / 1 0 , 
11, 12, 13, 14, 36/. Recently, concern has arisen that human 
(as opposed to beef or pork) insulin may cause more frequent 
and/or severe hypoglycaemia in association with reduced warning 
symptoms /40/. In our prospective study it was not aimed to 
analyse the difference in frequency of hypoglycaemia between 
conventionally and intensively treated patients (e.g. animal 
vs. human insulin periods), because of only retrospective data 
have been available on hypoglycaemia occurrence during the 
conventional treatment period. In spite of this, our results do 
not support the above mentioned concept, since there was no 
difference between hypoglycaemic and nonhypoglycaemic groups
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concerning type of insulin used before ICIT period. A very 
recent study also concluded that human insulin use is not 
associated with either increased frequency of hypoglycaemia or 
reduction in awareness of hypoglycaemia /41/.
According to previous studies, some extent of autonomic 
nervous system dysfunction may appear relatively early during 
the course of childhood diabetes /18/, and subclinical signs of 
autonomic neuropathy are demonstrable in a relatively 
considerable proportion of diabetic children and adolescents 
/37, 38, 39/. Our present study suggests that autonomic 
dysfunction may play a role in the development of some severe 
hypoglycaemias in diabetic children treated with ICIT,
especially, if the institution of this regimen happens after 
several years of diabetes duration. Nevertheless, further 
studies are necessary to prove the possible causal relationship 
between autonomic dysfunction and impaired defense mechanisms 
against hypoglycaemia in diabetic children.
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Serum sex hormone binding globulin (SHBG) 
concentration of children with obesity was measured and 
relationships between SHBG level and body mass index 
(BMI), waist hip ration (WHR), serum insulin, C- 
peptide, thyroid hormones (thyroxine - Тд, triiodo­
thyronine - T 3 / sexual hormones (testosterone - T, 
oestradiol - E 2 ) were investigated.
Significant negative correlations were found between 
SHBG concentration and BMI, serum insulin, C-peptide 
concentration; significant positive concentrations were 
found between BMI and serum insulin, C-peptide 
concentration. Thyroid hormone and sexual hormones did 
not associate with SHBG levels.
These results suggest that insulin hypersecretion 
has an important role in determining the reduction of 
SHBG production in obesity.
INTRODUCTION
Sex-hormone binding globulin (SHBG) is a circulating 
glycoprotein with a molecular weight of around 1 0 0 . 0 0 0  daltons. 
SHBG is thought to be synthetized in the liver; in the 
circulation its biological . function is the transport of sex- 
steroid hormones. SHBG bind testosterone (T) and oestradiol 
(E 2 ) with a high affinity and this binding is considered to be 
an important factor in determining the free, active 
concentrations of these hormones /3/. SHBG levels themselves 
are thought to be regulated by the concentration of androgens 
and oestrogens; the former inhibit, while the latter stimulate 
SHBG production /1, 3/. Thyroid hormones are also known
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to stimulate SHBG production: increased concentration of SHBG 
is seen in hyperthyroidism, while hypothyroidism is associated 
with decreased SHBG levels /18/. A recent investigation found 
that insulin inhibits SHBG production in -, human hepatoma cell line, 
suggesting an alternative regulating mechanism in SHBG 
production which is dependent on insulin levels /17/.
Obesity is commonly associated with low serum SHBG 
concentration in both adult- and childhood /4, 6 , 7, 14/. 
Although a significant negative correlation exists between 
serum SHBG and body weight /4/, the mechanisms involved are 
unknown at present. In this study, therefore, our aim was to 
define the factors determining serum SHBG concentration in 
childhood obesity.
PATIENTS AND METHODS
Thirty-nine obese children (15 girls and 24 boys) were 
considered in this study. Their age was 10.0 - 14.5 years 
(girls 13.1 +_ 2.1, boys 12.8 +_ 2.7). None had diabetes, other 
endocrinopathies or systemic diseases. None of them was taking 
any medicament. All girls had a normal menstrual history since 
their menarche, and all boys had secondary signs of puberty (P2 
P5). Body mass index (BMI: body weight, kg divided for 
height, m O  was calculated, the waist and hip girth were taken 
and their ratio (WHR) was also calculated to define the body 
fat distribution.
A single blood sample for hormonal determinations was 
obtained in the morning after an overnight fast. Serum SHBG was 
measured by the immunoradiometric assay (IRMA) of Farmos G. 
Ltd. Serum insulin and C-peptide determined by radioimmunoassay 
(RIA) kits supplied by Izinta and Serono. Serum thyroxin and 
triiodothyronine (Тд and Tj) were measured by RIA methods 
developed in our university. Serum T and E 2 were determined by 
dissociation enhanced lanthanide fluoroimmunoassay (DELPHIA) 
purchased from Pharmacia. All assays were performed in 
duplicate.
Statistical analyses were done with CBM computer programme.
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RESULTS
BMI and WHR values, fasting SHBG concentrations and the 
results of hormone measurements are demonstrated on Table I. 
BMI was slightly higher in the subgroup of the girls, whereas 
WHR was higher in the subgroup of the boys; the differences 
were significant (p < 0.05). Serum SHBG concentration did not 
differ significantly in the two subgroups, and no significant 
differences in hormone results were found between the two 
sexes. Therefore, the relationships between serum SHBG 
concentrations and other parameters were investigated in the 
united group.
Relationships between serum SHBG concentration and BMI, WHR 
values and hormone results are shown in Table II; the 
correlation coefficients are demonstrated. A significant 
negative correlation was found between BMI values and serum 
SHBG concentrations (r = 0.46, p < 0.01), WHR values and serum 
SHBG concentrations did not correlate. Negative correlations 
were found between serum insulin and SHBG concentrations, 
furthermore between serum C-peptide and SHBG concentrations 
(r = -0.33 and r = -0.34; p < 0.05).
No relationships were found between serum SHBG and Tj, Тд 
concentrations and, similarly, serum SHBG concentrations were 
not associated with T and E 2 levels. It is also demonstrated in 
Table II that strong correlations were obtained between BMI 
values and serum insulin levels, moreover, between BMI values 
and serum C-peptide concentrations (r = 0.55 and r = 0.54; p < 
0 . 01) .
DISCUSSION
Obesity both in childhood and in adulthood, is often 
associated with a decreased circulating SHBG concentration /4, 
6 , 7, 14/. In this study there was not any opportunity to 
compare the SHBG concentrations of obese children to the 
results obtained in the age matched healthy controls. In a
TABLE I
BMI and WHR values, results of SHBG and hormone measurements
(X + SD)
Parameters Girls Boys Girls and boys
(n = 15) (n = 24) (n 39)
BMI (kg/m^) 33.87 + 4.82 + 26.67 + 4.33 + 31.28 + 4.92
WHR 0.90 + 0.08 + 0.96 + 0 .07 + 0.94 + 0.08
SHBG (nmol/1) 16.97 + 7.60 21.48 + 17 . 36 19.75 + 14.45
Insulin (u/U /ml) 38.70 + 33.41 28.42 + 25.86 32 .19 + 28.87
C-peptide (ng/dl) 4.34 + 4.09 3.46 + 2.73 3.80 + 3.29
T 4 (nmol/ 1 ) 111.5 + 18.8 126.0 + 24 . 3 121.3 + 23.7
I 3 (nmol/ 1 ) 2.5 + 0.46 2.70 + 0.47 2.63 + 0.47
E 2 (pg/ml) 79.08 + 65.63 - -
( n = 1 2 )
T (pg/ml) - 692.4 + 515.2 -
(n = 13)
p < 0.05 (Student I-test)
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TABLE II
Correlations between BMI, WHR values, hormone 
results and SHBG concentrations
Correlations Г П P
BMI - SHBG -0.46 39 < 0.01
WHR - SHBG -0.08 39 NS
Insulin - SHBG -0.33 39 < 0 . 0 5
C-peptide - SHBG -0.34 39 < 0.05
T 4 - SHBG 0.24 39 NS
T 3 - SHBG 0.23 39 NS
T - SHBG 0.14 13 NS
E 2 -SHBG 0.12 12 NS
BMI - Insulin 0.55 39 < 0.01
BMI - C-peptide 0.54 39 < 0.01
WHR - Insulin 0.09 39 NS
WHR - C-peptide 0.07 39 NS
г = correlation coefficient 
n = number of cases 
p = strength of significance 
NS = non significant
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previous study SHBG concentration of healthy 11-14 year-old 
children was found to be 60 _+ 6 nmol/ml, and 40.4 _+ 11.8 
nmol/ml values were measured in a group of normal adults /11, 
14/. Therefore, our results are in accordance with data showing 
decreased SHBG concentrations in childhood obesity.
In the present study it was found that serum SHBG 
concentrations were negatively correlated with BMI values 
indicating the degree of obesity. Similar association between 
the degree of obesity and circulating SHBG levels was 
demonstrated by others both in childhood and in adulthood 
obesity /4, 6/. Significant negative correlations were found 
between serum insulin and SHBG, and between serum C-peptide and 
SHBG concentrations. The role of insulin in regulating SHBG 
production is supported by several data. Insulin hypersecretion 
is a common feature in obesity, and obese women with low SHBG 
level have significantly higher glucose stimulated insulin and 
C-peptide levels than those observed in obesity with normal 
SHBG level /14/. Furthermore, serum SHBG concentrations fall 
throughout the pubertal period and a close negative 
correlation exists between serum insulin and SHBG levels /8/ 
Recently it has also been demonstrated that insulin is able to 
inhibit SHBG production from cultured hepatoma cell lines /17/.
Beside serum insulin concentrations, C-peptide levels were 
also negatively correlated with serum SHBG levels. It is well 
known that insulin and C-peptide metabolism can differently be 
altered in obesity because of the decreased hepatic clearance 
rate of insulin and insulin resistance /10/. In our work, 
although the basal serum insulin and C-peptide levels were 
measured, equally strong correlations were found between serum 
insulin SHBG, and between serum C-peptide and SHBG levels. It 
can be suggested that insulin hypersecretion has the main role 
in determining the reduction of SHBG production. Therefore, the C- 
peptide/insulin ratio was not demonstrated.
The effect of thyroid hormones on SHBG production was 
demonstrated by several works /1, 12, 18/. Serum SHBG 
concentration is low in hyperthyroidism and it is elevated in 
hyperthyroidism /1/. Measuring the serum SHBG level can be used
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for assessing the peripheral effect of thyroid hormones /12, 
17/. In obesity serum Тд and Tj levels are generally found in 
the normal range, although nutritional factors can influence 
thyroid hormone (mainly on Tj) levels /5/. In our work normal 
thyroid hormone levels were measured in obese children and 
there was not any association found between serum thyroid 
hormones and SHBG concentrations.
It is well known that oestrogens increase SHBG levels and 
androgens decrease them /3/. It was also demonstrated that 
serum SHBG concentration was not elevated in androgen 
insensitivity, and cyclicity cannot be demonstrated in SHBG 
concentrations during menstrual cycle /9, 13/. In our work E 2  
and T measurements were performed only in a few cases; sexual 
hormone levels and serum SHBG concentrations did not associate.
Previous data have indicated that high insulin level is 
associated with increased overall and upper body obesity /15/. 
For this reason WHR was calculated. However, WHR did not 
associate with serum insulin, C-peptide levels and SHBG 
concentration. This finding can be explained by the fact that 
the WHR may be inappropriate in puberty, since pelvic widths 
may change rapidly /2/ and this index reflect the variation 
rather than adipose tissue distribution.
Our results suggest that decreased serum SHBG concentration 
cannot be explained by the changes in thyroid and sexual 
hormones in obesity; insulin level has a fundamental role in 
determining the reduction of SHBG production.
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Applying proton-induced X-ray emission authors 
investigated the hair trace element contents in 10 
children with acute celiac disease after 3 to 6 and 12 
months long gluten-free diet; in 9 children with cystic 
fibrosis and in a control group (6 children) of the 
same age.
There was no difference in Cu, Fe, Ca, Cl values 
between the examined groups.
The Zn contents of the hair are significantly low in 
the group with acute celiac disease after a short-term 
diet and also in the group with cystic fibrosis, the 
data approach the normal range only after a year's 
d i e t .
The significant rise of hair potassium contents is 
well indicated in patients with acute celiac disease 
and this rise may be due to the destruction of cell 
cuticles. In case of cystic fibrosis there is no 
significant rise of hair potassium value.
INTRODUCTION
In the course of our former examinations it was observed 
that children suffering from celiac disease, having clinical 
symptoms but not yet having been placed on a diet, typically 
have hair without any luster.
The diameter of these children's strands of hair and the 
cuticle erosion score were significantly different from those 
of the control group even after 3 months' dieting.
In order to understand the biochemical reasons behind these 
micromorphological differences, the Zn, Cu, Fe, K, Ca, Cl
Akadémiai Kiadó, Budapest
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contents of the hair of children suffering from celiac disease 
were examined first in the acute period of the disease, then at 
various times during the glutenfree diet. The results were 
compared with the trace element contents of the hair of healthy 
children and children with cystic fibrosis.
G,
a t fi rst  biapsy
Cu
Fe
Ca
Cl
К
Zn *
g 2
3-6 months 
gluten-free  diet
NS
G3 Control
12 months 
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p <  0.05 ---------------------
-------- - NS
p <  0.01 
p <0.01 —  NS
Fig. 1. Hair trace element content of children with celiac 
disease compared to healthy controls
M AT ERIAL AN!) METHOD
The hairs were removed from the frontal third of the crown 
and they were analyzed at 4 cms above the root. The groups of 
the examined children were the following: Group 1 was made up 
of 10 children aged from 1.5 to 10 years. Their hairs were 
examined at the time of the first intestinal biopsy. The same 
patients made up Group 2 as well after being on a glutenfree 
diet for 3 to 6 months. In Group 3: the same children were 
examined after being on a glutenfree diet for 12 months. 9 
children suffering from cystic fibrosis (3 to 12 years of age) 
made up Group 4. Group 5 was the control group of 6 healthy 
children within a similar age bracket.
The examinations were carried out by using proton induced X- 
ray emissions (PIXE) /5, 13/. The hairs were exposed to a 
concentration of protons of 2.5 MeV energy. As a result of 
this, the trace elements in the hair emitted radiation 
characteristic of them. Using a semiconductor Si/Li, the energy 
of the radiation was detected. This energy determined the
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elements while its intensity determined the elements' 
concentrations. The spectrum gained this way was assessed with 
the help of a computer. The differences in the thicknesses of 
the strands of hair were corrected by a correlative sulphur 
atom, as the inner standard, which correlates with the mass of 
hair. A x^ test was used for the statistical analysis of the 
data .
RESULTS
There was no difference between the groups concerning their 
Cu, Fe, Ca, Cl values.
The Zn contents were lower (16.6^10.78; x4SD, P<0.01) 
compared to the control groups (56.2^16.6; x_+SD) and the group 
of patients who had been on diet for 3 months (23.9^12.59; 
X + SD, P<0.01 ). After a year on diet this difference was not
observable any longer (40.4j+27.2; x>5D). The Zn value in the 
hair of patients with cystic fibrosis was also significantly 
lower (34.9+19.35; x+SD) than that of the control group 
(56.22^16.6; ЗГ+SD, P < 0 .05 ) .
In the groups of patients suffering from celiac disease and 
cystic fibrosis, the serum Zn values were at the low end of the 
normal range and they were not in correlation with the Zn 
contents of the hairs.
The potassium contents of the hair in patients with celiac 
disease were significantly higher compared to the control group 
(p<0.05) and during the diet it indicated a downward tendency.
The increased potassium values measured in the hairs of the 
group with cystic fibrosis (14.5^12.78; x^SD) did not differ 
significantly from those of the healthy children, but this 
increased value was significantly lower than that of the group 
with celiac disease.
D IS CUSSION
The analysis of hair trace elements is a wellestablished 
method of assessing the nutritional conditions of the organism
TABLE I
Determination of hair elements of children with celiac disease and cystic
fibrosis (* p < 0.05, ** < 0.01)
Cl K Ca Fe Cu Zn
Gl X
+ SÖ
219.747
265.042
45.88*
39.30
25.067
8.82
14.545 
4.74
31.04
1.455
19.59** 
10.78
g2 Xj^SD
109.77
83.127
32.12 
31 . 66
24.295 
14.22
13.634
6.994
3.207 
1.13
23.974** 
12.599
G3 Xj^SD
123.71
56.89
16.16 
8.007
23.86
15.94
20.517
14.477
14.643
18.54
40.484
27.826
G4 X^SD
260.401
191.34
14.49
12.73
30.005
48.548
9.233
4.610
5.465
3.145
34.91*
19.35
g 5 X+ SD
263.035 
216.38
7.978
4.218
19.087
5.211
12.498
4.874
5.424
2.020
56.222
16.65
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/4, 12, 16/. Different hair preparations, hair-dyes and also 
the environmental conditions have an effect on the measured 
data /8/ and the trace element contents of the hair change at 
various distances from the hair-root. The trace element 
contents of the hair vary significantly in infancy /9/, so the 
data can only be compared with those of children within a 
similar age bracket. The determination of hair trace elements 
measured at the same distance from the hair-root in children of 
the same age (whose hair was treated similarly), however, gives 
information on long-term metabolic processes of the organism 
/ 10/.
It has become familiar from publications that very often 
there is no correlation between the Zn contents of the hair and 
that of the plasma /1, 11/, since the plasma always indicates 
the acute values of the day, therefore more suitable for 
detecting permanent effects. Our studies as well as those of 
others have long revealed that Zn deficiency detected from 
serum as yet in patients with acute celiac disease can be 
considered as a result of a chronic process, which is also 
reinforced by low Zn contents of hair.
Apart from many other factors, Zn deficiency also 
contributes to slow development and any other symptoms of 
patients with celiac disease.
However, the significant increase of hair potassium contents 
in acute celiac disease is a new result.
Alkali and halogen elements do not link with tissue proteins 
/13/, the significantly high potassium value may be due to 
increased cell destruction and only after a long diet can this 
value approach the normal range. There is no such significant 
rise in hair potassium contents in patients with cystic 
fibrosis. The signs referring to inner metabolic disturbances 
should be further investigated.
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This study was performed as a part of a longer research 
programme on urinary tract smooth muscle layer in 
children. All the children whose samples were 
investigated underwent surgery for urinary tract 
malformations. Specimens were taken from different 
segments of upper urinary tract during surgical 
intervention. Specimens were investigated by either in 
vitro motility tests or electron microscopy or both of 
them. Basic patterns of tissue strips were recorded 
after incubation of varying duration and then tested by 
administering neurotransmitter agents like 
noradrenaline and acetylcholine-bromide. Microstructure 
of samples were examined electron microscopically. 
Investigations were performed in order to find 
correlation between microarchitecture and motility 
patterns of urinary muscle wall. Factors influencing 
urinary muscle motility, characteristic features of 
impaired musculature and its possible regeneration are 
discussed too. Microhistological deteriorations inhibit 
spontaneous smooth muscle motility but muscle 
contractility proved by administering noradrenaline and 
acetylcholine-bromide remained in some extent. Taking 
into consideration that smooth muscle is able to 
regenerate and rebuild close contacts pediatric surgeon 
and urologist should spare kidney parenchyma as far as 
it is possible.
INTRODUCTION
Two-three decades ago microhistology of urinary tract smooth 
musculature and its nerve supply were made clear by electron 
microscopy at that time and later, factors exerting influences 
on smooth muscle contractibility were investigated. Moreover a
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lot of examinations were performed by electron microscopy to 
discover impaired structure of urinary tract smooth muscle 
layer of patients suffering from urinary tract malformations. 
For this reason the present study's aim is to find correlations 
between motility patterns gained by organ bath tests and 
microstructural features observed by electron microscopy on 
upper urinary tract samples obtained from children at surgery.
Two types of investigations were performed in this study:
a) "in vitro" motility tests in tissue bath
b) electron microscopic examinations.
Samples were taken from different segments of 28 children's 
upper urinary tracts during surgical intervention (Fig. 1). 
Children's ages range from 2 weeks to 13 years with a mean of 
19 months. All of them suffered from urinary tract 
malformations and underwent either reconstructive surgery 
(ureteropelvic plastics, ureteroneocystoplastics with or 
without shortening and tailoring, urinary diversions and 
undiversions) of nephroureterectomies, or heminephrectomies 
with ureterectomies. Main data are listed in Table I.
Removed specimens underwent motility or electron-microscopic 
or both investigations depending on the availability of skilled 
technical assistance (Table I).
For in vitro motility investigations specimens were cut into 
strips of 2 cm in length and 0.5-0.7 cm in width to be thin 
enough to allow diffusion of neurotransmitter agents to all the 
muscle cells and free of adherent fat and adventitial tissues 
in order to avoid self excition of the muscle cells through 
their own vegetative nerves. Strips were continuously moistened 
with Tyrode solution during preparation and incubation. For 
stable patterns incubation occurred at 4°C for one, 24, 48 and 
72 hours. Samples incubated longer than one hour were obtained 
from the same sites of patients' upper urinary tracts as 
duplicates, triplicates, etc. Strips were mounted in water 
jacketed organ bath: 46 of 89 strips after one hour, 29 after 
24 hours, 11 after 48 hours and 3 after 72 hours of incubation. 
Strips were suspended under 1 gram tension and connected to a 
transducer for recording contractions. Tissue bath was filled 
with 10 ml Tyrode solution, thermostated at 37°C, aereted 
continuously with 95% oxygen and 5% carbon dioxide. 
Contractions were provoked directly by administering
neurotransmitter agents to organ bath fluid. As 
neurotransmitter agents noradrenaline (Noradr) and
acetylcholine-bromide (Ach-Br) were administered in increasing
X q л V l n - 6
administration organ bath was washed out and filled with fresh
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/ . У  / Л  ±  и  ,
After each
3.94x10”6 , 
7 37xlCT6 
TABLE I
Distribution of patients and their samples investigated by motility tests
and electron microscopy
Diagnosis No. of patients Sites of samples No. of samples
investigated by investigated by
motility electron motility tests motility electron
tests microscopy and electron tests microsco
microscopy
Stenotic pyelo- 3 2 5 calyx 10 3
ureteric junction pyelum 18 9
pyeloureteric junction 7 4
ureter-upper 6 3
middle-segment 7 2
lower 6 2
Stenotic uretero- 2 3 3 pyelum 1 2
vesical junction pyeloureteric junction 1 1
ureter-upper 1 1
middle-segment 4 2
lower -stenotic 5 2
-non stenotic 3 2
V e s i с о - u r e t e г о - 1 1 1 pyelum 2 -
renal reflux ureter-upper 1 2
middle-segment 1 2
lower 4 2
Duplex kidney 1 1 2 pyelum 2 2
and ureter ureter-upper 2 2
middle-segment 3 4
lower 3 3
Other - 2 1 ureter-upper - 1
malformations middle-segment - 3
lower 2 3
Total 7 9 12 89 57
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Fig. 1.Sites from where samples were taken for in vitro
motility tests and electron microscopic examinations
Tyrode solution. Stable patterns of strips and effects by 
administering neurotransmitter agents were recorded by RAOELKIS 
pen recorder.
Samples in sizes of about 2x1x1 mm blocks were taken from 
whole thickness of walls of ureters, pyelums and calyces for 
electron-microscopy. To be fresh enough specimens were cut off 
immediately after cessation of blood supply and immersed in 24 
phosphate buffered glutaraldehyde (pH 7.2), postfixation 
occurred in 1% phosphate buffered osmium tetroxide (pu 7.2) 
then samples were dehydrated in graded ethanol and embedded in 
DURCOPAN (Fluka AG). Ultrathin sections were cut, mounted on 
copper grids, stained by uranil acetate and leadcitrate, and at 
last examined under either JEOL 100-B or JEOL 100-C electron- 
microscope .
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RESULTS
At first stable patterns of strips were observed in tissue 
bath then contractions induced by Noradr and Ach-Br were 
tested. Statistical analyses of our materials could not be done 
because data failed to show any condition to analyse at all, 
and conclusions could be drawn from our observations only for 
surgical practice and follow-up.
Spontaneous long lasting rhythmic and slow contractions were 
observed during testing strips obtained from either unimpaired 
or mildly deteriorated pyelums and ureters. (Fig. 2 A, B, 4 C, 
6 A , В , C ) .
Specimens removed from dysplastic ureters and ureters with 
seriously deteriorated muscle microstructure exhibited no 
spontaneous rhythmic contractions when testing them in organ 
bath (Fig . 3).
All strips taken from calyces, pyelums, pelviureteric 
junctions, and upper middle ureter segments but those from 
dysplastic ureters contracted by administering Noradr to 
organ bath fluid after 1 and 24 hours incubation (Fig. 4 A, B, 
C, □, E).
No strips contracted after 72 hours of incubation. Only two 
samples contracted by administering Noradr to organ bath fluid 
after 48 hours of incubation, both of them were from middle 
ureter segments. None of all above mentioned specimens 
contracted when administering Ach-Br.
Strips obtained from non-stenotic ureterovesical junctions 
contracted by administering both neurotransmitter agents used 
in this study (Fig. 5 A, B).
Stenotic ureterovesical segments did not contract at all.
It can be ascertained:
Strips taken from pyelums and pelviureteric junctions had 
higher contractions than those from calyces and ureters of the 
same patients.
The more concentrated Noradr was administered the more 
extensive contractions were achieved in all strips. That means 
contractions were dose-rela-ted as well as in some extent 
those depended on microstructure of smooth muscle layer (Fig. 6 
А, В, C).
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Pt. No. A
Dg: u r e t e r o v e s i c a l  s t e n o s i s  b . s .
Spe c i m en :  l o w e r  part of the r i ght  ure ter  
In cu b at io n  t im e  : 1 h
II
T washi ng
10s
Fig. 2.A. Patient (Pt.) No. 4. Between two contractions 
provoked by administering Noradr into tissue bath 
fluid slow rhythmic contractions of a strip taken from 
lower segment of mildly deteriorated ureter are seen 
(b. s . = both sides)
DISCUSSION
Transport of urine along the upper urinary tract depends on:
a) quantity of excreted urine stimulating peristalsis
b) microhistological architecture of urinary tract muscle
layer considering intact close contacts which are responsible 
for intercellular impulse transmission (3 , 4 , 6 , 7, 8 , 11, 23 , 25,
32, 33).
c) influences of vegetative nervous system on urinary 
tract smooth muscle cells (4, 7, 12, 24, 27, 28, 30, 31, 32, 
35, 36, 37).
d) locally released prostaglandins co-ordinating
intercellular impulse transmission /1, 2, 5, 7, 29, 44,
45, 46/.
e) damages of inner coat of protective transitional
epithelium due to local microtraumas resulting in entry of 
urine and exposure of the contractile elements to
nonphysiological environment /47, 49/,
Fig. 2.В. Electron micrograph shows slightly increased collagen (c) 
and collagen fibres (cf) amid muscle cells (s). Smooth 
muscle cells are linked by close contacts (large arrows). 
Mildly impaired muscle layer (X4000)
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Fig. 3. Pt. No. 24. Very seriously damaged musculature of the pyelic 
wall. Smooth muscle cells are disconnected by large amount 
of collagen fibres. No close contact is seen at all. 
Perishing muscle cell (p) and fibroblasts (f) point out: the 
muscle layer has been damaging for a long while (X4000)
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Pt. No 20
D g : u r e t e ropel V ic s t e n o s i s  I s .
Spec im e n : ca  ly X wall 
Incubât  ion t inne : 1 h ,
I
T w a s h i n g
I I
I I
t T
Noradr. Noradr.
-6 -6 
3 94* 10 M 1.97 *10 M
, Fig. 4.A. Pt. No. 20. Contractions of moderately impaired 
calyx wall
Pt. No 20
Dg: u re te  ropelvic s t e n o s i s  I s 
Spécimé n. py e l um wal l  '
Incubat ion t ime :  1h T washing
I I 1
▼ T »
Fig. 4.В Contractions of moderately damaged pyelum wall
Fig. 4.E. Unimpaired smooth musculature of the middle ureter 
segment (X4000)
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Pt. No. 20
Dg :u re te ropelvic  s t e n o s i s  I s 
Spécimé n : m iddle part of the  ureter  
Incuba tion t ime:  1h
( twash ing
I ' I
t  ▼ T
Noradr.  Noradr. Noradr.
11.82 *10’6M 7.88*10’6M 3.94*10’ 6M
Fig. 4.C. Spontaneous and induced contractions of unimpaired 
middle ureter segment (l.s. = on the left side)
Pt. No. 10
Dg:duplex k idn ey  I s .
Spec imen : u re t e ro ve s ic a l  junct ion of  the upper 
s e g m e n t  ure ter
Incubation t ime:  24 h
I
I
T w ash in g
I I 1 I
1 T
Ac h-Br  
3.68* 106M 
*
10s
Fig. 5.A. Pt. no. 10. Distended ureterovesical junction of 
duplex kidney's upper segment ureter shows no 
spontaneous contraction but contracted by 
administering both of neurotransmitter agents used in 
this study
Fig. 4.D. Moderately impaired smooth muscle micro structure is
characterized by increased intercellular collagen and 
collagen fibres disjoining smooth muscle cells. Close 
contacts are seen sparsely. (X4000)
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Fig. 5.В Seriously damaged muscle microstructure. Large amount of 
collégén fibres are seen and close contacts are found very 
sparsely. Muscle bundles are not totally destroyed (X4000)
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Pt, No. 13
Dg :ure terope lvic  s tenosis  
Specimen : pye lu m wall
r.s.
Incubat ion time: 1 h
1 1
I
▼ washing
1 1 
t  i
Noradr. N oradr.
3 94« 10'6M 1. 97 X 10‘6M
10s
Pt. N o . 13
Dg : ur e te rop el vie s t e n o s i s  r.s.
Spéci m e n : u re t e rope I vi c jun ct ion
Incu ba tion 1i me : 1 h ,
I
t  washing
! I
» t
Noradr. Noradr, Noradr. Nora dr.
Fig. 6.A,B. Pt. No. 13. Dose-dependent contractions evoked by 
administering Noradr (r.s. = on the right side)
Fig. 6.C. Mildly deteriorated smooth muscle layer of the pelvic 
wall (X4000)
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f) endo- and exotoxins of uropathogenic bacteria influencing 
peristalsis directly or indirectly /48/.
Human urinary tract musculature consists of smooth muscle 
cells forming muscle bundles. Muscle cells are separated by 
thin sheets of connective tissue elements and muscle bundles 
are demarcated by collagen fibres. Smooth muscle cells are 
joined by close contacts (gap junctions, nexus close contacts, 
nexuses, tight contacts, close approaches). Close contacts are 
200 nm in width and in this region cell walls lie in close 
apposition with no intervening basement membrane (Fig. 2 B, 4 D, 
E and 6 C). Close contacts are electric and metabolic coupling 
sites of low resistance /3, 19, 33/.
Pacemaker cells in minor calyces and pyelum wall are 
reactive to tension in calyx and pyelum and co-ordinate 
peristalsis along upper urinary tract. There are "P" "pale" 
smooth muscle cells in the ureter wall, they are thought to be 
pacemaker cells too. /8, 13, 14, 15, 16, 17, 18, 19, 26, 27/.
Smooth muscle cells receive nerve supply from vegetative 
nervous system. One nerve-ending stimulates indirectly about 
one hundred muscle cells and stimuli spread through close 
contacts from one cell to another without decreasing /3, 37/.
Smooth muscle cells are transformed into myofibroblasts and 
fibroblasts by increasing tension inside urinary tract. 
Fibroblasts produce collagen fibres /18, 20, 21, 22, 23, 34, 
39/. Furthermore dérivâtes of urinary tract infections worsen 
the situation by inducing muscle cells to produce elastin and 
collagen /23, 49/. Hereby the microstructure of the muscle 
layer deteriorates and close contacts are disrupted resulting 
in the smooth musculature's loss of its co-ordinated function. 
The seriousness of impairments vary and can be classified as 
mild, moderate, serious and very serious damages /20, 39/.
Recent research made clear that deteriorated urinary smooth 
muscle layer can regenerate. Regeneration means that increased 
fibres and intercellular collagen and elastin disintegrate, 
muscle cells rebuild close contacts by extending cytoplasma 
processes /10, 11, 38, 40/.
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Lastly muscle dysplasia should be mentioned: this is a 
congenital malformation inside the smooth muscle cells. Myosin 
fibrils are not found in the cytoplasms. Ureter of this type of 
anomaly is not able to transport urine at all /41, 42, 43/.
CONCLUSIONS
This study has shown that structural changes extending 
throughout the upper urinary tract muscle layer inhibit 
spontaneous motility, but muscle strips can be induced to 
contract directly by administering neurotransmitter agents in 
tissue bath fluid. It means that smooth muscle cells preserve 
contractibility except those having no contractible fibrils
i.e. myosin (thick filaments) in cytoplasma.
Taking into consideration that smooth musculature is able to 
regenerate and rebuild close contacts to some extent, it can 
therefore be said that pediatric surgeons and urologists should 
try to spare kidney parenchyma as much as it is possible.
Application of the above mentioned in vitro findings to 
pediatric surgical and urological activity: they serve as 
additional but very important factors in deciding whether to 
perform and what type of surgical intervention is necessary in 
children's maldeveloped urinary tracts.
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A retrospective analysis of the HLA-DR antigens was 
performed at the DRheta DNA locus by the means of 
restriction fragment length polymorphism (RFLP) in the 
case of a two-times kidney transplanted paediatric 
patient and in 16 adult kidney donor recipient pairs in 
order to prove the importance of DNA molecular analysis 
in those cases where the serological identification is 
poor. The child and her grafts (first from her mother, 
the second from a cadaver donor) carried the DRw6 an­
tigen which serologically can very poorly be defined. 
According to DR serotyping before transplantation both 
the child and the cadaver kidney proved to be 0R5,6, 
while the DNA analysis revealed mismatches; the child 
possessed the two subtypes: 13b3 and 14a of the DRw6 
antigen only and none of the 0R5, the cadaver kidney 
proved to belong to the DR4 antigen group instead of 
DR5, and furthermore to a different subtype of the DRw6 
(13a3 ) than the recipient. The DNA analysis of other 16 
adult donor-recipient • pairs also underlined the 
importance of the DRbeta RRLP analysis in cases where 
the transplantation antigens could be poorly defined.
INTRODUCTION
The antigens of the HLA-D region have been implicated in the 
regulation of the immune response and allograft rejection in 
clinical transplantations. Fortunately, partial matching 
between donor and recipient may be sufficient to achieve high
Akadémiai Kiadó, Budapest
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graft survival rates in the presence of immunosuppressive 
therapy .
The influence of HLA-DR matching on cadaver graft survival 
is more pronounced than that seen with A, 0 matching. Recent 
advances in molecular biology make possible to characterize 
different antigens according to the individually characteristic 
cleavage sites for certain restriction endonucleases of their 
genes. Restriction Fragment Length Polymorphism (RFLP) 
analysis of the HLA-DR gene has been developed into a powerful 
tool for genomic tissue typing /1, 2, 5, 18/. It has been 
suggested that this methodology can detect donor-recipient 
incompatibilities, which may be important in influencing the 
graft function.
The serological methods fail to easily discriminate between 
the subtypes of DR 2 (DRw 15, DRw 16), DR 3 (DRw 17-*-, 172 , 18), 
DR 4 (41 , 42 ), DR 5 (DRw 111 , 112 , 121 ’ 122 ), DRw 6 (13a1 , a3 , 
a^, 1 3 b 1 , 13b2 , 14a, 14b) and DR 7 (71 , 72 ) antigens.
Several studies demonstrated /7, 8, 14/ that the kidney 
graft survival in DRw6-positive patients was significantly 
lower than in DRw6-negative ones. In contrast these reports, 
Hoitsma et al. /9/ found no significant differences in overall 
renal allograft survival between DRw6-positive and negative 
r e c i p i e n t s .
The richness of the subtypes of DRw6 antigen can not be 
discriminated by serotyping. In a girl with two kidney 
transplantations and in adult patients also, we reviewed the 
HLA-DRj-jg^-g matching, the number of rejection episodes and the 
allograft outcome in order to highlight the usefulness of the 
RFLP analysis in kidney transplantation. We decided to compare 
the pretransplant HLA-DR serology with the DR^g^g-DNA-analysis 
and the number of rejection episodes in 8 adult donor-recipient 
pairs selected by compatibility for DRw6 antigens, and in 8 
pairs selected for other antigens.
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PATIENTS AND M E T H O D S
N.A. 12-year-old girl was introduced into the chronic 
haemodialysis and renal transplantation program because of a 
chronic renal failure originated from a Henoch-Schönlein 
nephropathy. She had got her first kidney graft from her 
mother. The mother's HLA antigens were: A: 2,11; B: 22,35; DR: 
3.6; the patient's were: A: 2,11;, B: 22,x; DR: 5.6. This graft 
had to be removed 1.5 year later because of a chronic rejection 
and acute vascular rejection. The child's second kidney 
transplantation was performed on 19. August 1988 using a 
cadaver kidney (HLA-A: 2,11; -B: 5,14; -DR: 5,6). This graft 
had to be removed 1 month later because of an accelerated 
vascular rejection and chronic rejection. The HLA serotyping 
(HLA-A, -B, -DR) was carried out by a standard 
microcytotoxicity assay /16/. ABO compatibility, sharing at 
least two HL-A,B antigens and one DR antigen, as well as a 
negative T-cell cross-match test, were the prerequisites for 
allograft transplantation. The patient and her grafts were 
analysed by DNA-DRbe-j-a and DQ^g^-g-RFLP technique after 
transplantation using Southern blot analysis /15/. DNA was 
extracted either from frozen donor spleen or from recipient 
peripheral leukocytes /10/. Genomic DNA was digested with Taq 
I, Bam HI, Bgl II, Pst I, Eco RI, Hind III restriction 
endonucleases, electrophoresed in 0.7% agarose gel and blotted 
onto a nitrocellulose membrane /11/. Nitrocellulose membrane 
was hybridized with •52P-labelled cDNA probes (6): p-II-beta-1 
(DQbeta^ and p-II-beta-3 (D^beta^ (kindly provided by Dr. P. 
Peterson, Uppsala).
Eight adult donor-recipient pairs selected by compatibility 
for DRw6 antigen (Group A) and 8 donor recipient pairs selected 
by compatibility for other DR antigens (Group B) were also 
examined by DNA-DRbetg-RFLP analysis. The number of rejection 
episodes and graft survival was also determined.
All patients had been on maintenance dialysis before the 
kidney transplantation. All grafts for the adult 
transplantations were taken from cadavers.
The initial immunosuppressive regimen was triple therapy: 
cyclosporine 12 mg/kg (later decreased, monitored with TDX), 
méthylprednisolone 1 mg/kg (decreasing after the 3rd day) and 
Azathioprine (below 150 mg/day). The rejection episodes were 
treated with high-dose steroid therapy (500 mg 
méthylprednisolone daily, for 3-5 days) followed by the steroid 
recycle. The rejection episodes were confirmed by the clinical 
course and histopathology.
Statistical evaluation was performed with Student's t test.
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RESULTS
The child had got a maternal graft matching for one antigen 
each of all HLA-loci. At the DR locus the 14a subtype of the 
DRw6 antigen was of maternal origin. The second DR antigen by 
RFLP analysis revealed a discrepancy with the DR5 serotyping 
(13t)l, another subtype of 0Rw6) (Table I). This graft survived 
1.5 year and had to be removed because of a chronic rejection. 
She had altogether four rejection episodes. The second kidney 
graft was found serologically compatible at DR antigens (DR 
5,6), but this proved to be incorrect by RFLP analysis (cadaver 
graft had 4*, 13a-5 antigens). There was also a discrepancy in 
the serologically not determinable DRw6 subtypes (donor: 13a , 
recipient: 13b*, 14a) (Table I). This graft survived 1 month,
the number of rejection episodes was one, the graft had to be 
removed because of an accelerated vascular rejection and a 
chronic rejection. In the case of adult kidney 
transplantations, the results of the serological HLA-DR typing 
as compared to the RFLP analysis the number of rejection 
episodes and the allograft outcome in Group A (8, serologically 
DRw6 compatible donor-recipient pairs) versus Group В (8 donor- 
recipient pairs, selected by compatibility for other than DRw6 
antigens) were as follows:
1. The number of mismatches by the DR^g^-g-RFLP was
significantly higher in Group A than in Group В (p = 0.001).
2. The number of rejection episodes was slightly higher in 
Group A (2.9+1.6) than in Group В (1.5j^0.53), , (p = 0.04).
3. The two-year graft survival was 25% in Group A, while 88% in 
Group В (Table I ).
DISCUSSION
Nowadays the DNA-RFLP analysis has demonstrated that the 
polymorphism of the HLA-D region genes is greater than 
suggested by the results of the conventional serological and 
cellular techniques.
This method can reveal donor-recipient mismatches which may 
be important in influencing the graft function. The HLA-DRbet a- 
typing of renal allograft patients and donors and its 
correlation with pretransplant serotyping have been examined in 
г number of laboratories (3-4, 12-13, 17, 19).
The polymorphism detected by RFLP analysis of Taq I enzyme 
digested D N A , hybridizes with DRbeta cDNA probe correlates 
quite well with the phenotypic polymorphism recognized by 
serology and mixed lymphocyte culture.
All tile recognized serologic DR spe-cificities, DR1 to DRwl8 
can be distinguished by RFLP analysis except for DR72/9 /2/. 
However, using Hind III/DRbeta RFLP the distinction of 72 
(DQw9, Dwll) can be achieved.
However, DR serology can not discriminate the subtype 
specificities of DR2, 3, 4, 5, w6, 7 antigens, and, this is of 
special interest in the case of DRw6 because of its numerous 
(seven at present) subtypes. Identification of DRw6 splits as 
13a*, 13a-* etc. required Taq I/DRj-ig^-g-RFLP and also examination 
with more restriction enzymes and DQ^gta probe, so as to be 
informative due to the linkage disequilibrium between DR and DQ 
loci (1-2, 4-5).
Our paediatric patient proved to have this poorly 
determinable DRw6 antigen. At her pretransplant serotyping one 
out of two DR antigens was categorized incorrectly (DR5).
Two subtypes of the DRw6 antigen have been found by RFLP: 
13b-*- and 14a, the latter being of maternal, the former (13b*-) 
of paternal origin, respectively.
We emphasize this situation because of the "high responder" 
status of the recipients having DRw6 antigen, well-known from 
some laboratories /8, 14/.
The possible association of the allograft survival with the 
HLA-DNÄ-RFLP-matching of the kidney donor-recipient pairs has 
been demonstrated in cases of transplantations to adults.
Many factors may influence the graft outcome, including the 
HLA-matching, immunosuppressive therapy, sex and blood group of 
the recipients, presensitisation, etc. No single factor plays a 
predominant role and the relative effect of each factor may be 
difficult to demonstrate.
Opelz, G. et al /12/ found that eliminating the typing 
mistakes from the determination of HLA-DR antigens, the success 
rate of HLA-matched cadaver transplants in nearly as good as 
that of HLA-matched sibling transplants. They showed that the 
high typing error rate was responsible for many unexpected 
transplant failures, but they have not examined separately the 
DRw6 selected donor-recipient pairs.
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TABLE I
Serological and DR^g^g-RFLP analysis and allograft outcome in adult 
renal transplanted donor-recipient pairs (Group A and Group B) and 
those of a child with two successive grafts
No. 1Datients serol.
Group A
HLA-DR
serol. DNA 
match. RFLP* match.
Allograft outcome 
No. of rej. graft 
episodesxx survival+
1 D 5, É 1 13a1, 14a 1 4 1 yr
R 6 13a3, 14a
2 D 6 1 8, 13a4 0 2 >2 yr
R 6 10, 14a
3 D 5, 6 1 n 1 13a4 0 1 2 yr
R 6, 7 71, 13a1
4 D 6, 7 1 15,, 72 0 2 1. ) yrR 6 13a3, 13a4
5 D 5, 6 1 13a1, 14a 0 5 1 yr
R 3, 6 10, 171
6 D 6 1 8, 13a4 0 5 1 yr
R 5, 6 ll1, 7/9
7 D 1, 6 1 1, 14a 0 3 2 moR 2, 6 ll1
8 D 6, 7 1 72. 15 0 1 2 wk
R 6 13b1, 9
Kidney graft to a child++
child 5, 6
1
13b1, 14a
1 4 1.5 yr
1st graft 3, 6 14a, 18
2nd graft 5, 6 2 4l, 13a3 0 1 1 mo
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TABLE I. Cont.
1 D 1 1 1, 9i 1 1 3 yrR 1 1, A1
2 D 2, 6 1 15 16 
71, 16
1 1 >2 yr
R 2, 7
3 D 2 1 A1 16 
13a1,15
0 1 >2 yr
R 2, 6
4 D 2, 5 1 Hj. 15.A1, ll1
1 2 >2 yr
R 4, 6
5 D 1, 7 1 1, 7/9 1, 13a1
1 1 >4 yr
R 6, 7
6 D 1, 7 1 1, 7/9 1» 41
1 2 2 yr
R 1
7 D
R
2, 6 
2, A
1 1Ab, 15 
41, 15
1 2 >1.5 yr
8 D 2, 5 1 12, 15 1 2 >2 yr
R 2 15
Legends to Table I
Group A: 8 donor-recipient pairs selected by compatibility for DRw6 
antigen
Group В: В donor-recipient pairs selected by compatibility for other 
DR antigens
D = donor, R = recipient
RFLP = Restriction Fragment Length Polymorphism
*: DNA-RFLP matching less in Group A versus Group В (p= 0.001)
**: slightly more rejection in Group A versus Group В (p = 0.04)
+: Two-year graft survival less in Group A versus Group В (25% vs
88%)
++: diverse serological and DNA-RFLP data together with poor graft
survival
Group В
HLA-DR Allograft outcome
No. Patients serol. serol. DNA No. of rej. graft
match. RFLP* match. episodesxx survival+
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The polymerase chain reaction (PCR) amplifies DNA sequences 
several millin-fold so within a few hours we can characterize 
the genes of the transplantation antigens. This makes PCR a 
valuable method in clinical practice for improving the success 
rate of kidney transplantations, especially in the presence of 
DRw6 antigen. Even if performed retrospectively, detection of 
mismatches by RFLP can be of predictive value concerning 
allograft rejection.
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BOOK REVIEW
Physician's Guide to Sunscreens. Ed. by N.J. Lowe Marcel 
Dekker, Inc. 1992, New York, 232 pages, 24 illustrations, 
tables
The reader can take a very well proportioned and edited book 
into his hand, the 15 subchapters within the 4 main chapters 
are written by the best American professionals within those 
specific fields, with the exception of the 7th subchapter which 
A.R. Young (London) has written on 5-Methoxypsoralen containing 
sunscreens. At the back of the book a concise table of selected 
American skin and lipstick sunscreens along with their trade 
names, manufacturer and sun protector factor (SPF) can be 
found. This is a selection of products with a SPF of 15 or 
above, as these meet the requirements of present day, according 
to the latest scientific findings. In the introduction the 
editor expresses the importance of wide spread enlightening on 
the connection between skin cancer and severe sun exposure. 
Besides this, accelerated skin aging also suggests the necessity 
of sunscreens everyday use, on our environmental catastrophe 
close earth, in the state of growing ozone holes. The second 
chapter deals with photobiological aspects, the third with 
sunscreen ingredients and formulations. The fourth main chapter 
discusses the biological evaluation of sunscreen products. 
According to past examinations just the cancer causing effects 
of UVB wavelengths, which make up a minimal part of sunrays, 
had been proved. In 198B it was proved for the first time that 
the UVA wavelengths (315-400 nm) are also carcinogen. As UVA 
occurs in a significantly large amount in sunrays, furthermore 
it reaches human skin through cloudy skies, it is important to 
know that this type of wavelength is the most important from 
the point of view of sun caused skin damage. It causes damage 
to the collagen and blood vessels within the dermis, as shown 
in L. H. Kligman and A. M. Kligman's chapter. A series of 
histological and electron microscopic examinations also proved
200
that skin aging caused by light can be well differentiated from 
the atrophic phenomenon of elderly people sunscreened skin. 
Pathak, a professor from Harvard University analysed the skin's 
natural sunscreening mechanisms. He convincingly proved how 
much the skin's pigment content, according to which human-skin 
can be divided into VI types, can determine the occurrence of 
not only basalomas but also the still almost incurable 
melanoma. R.S. Stern (Harvard) established that the protective 
effect of sunscreening agents related to every geographical 
place and risk group result in a similar percentage of tumor 
reduction. When using sunscreens their side effects should be 
taken into account. Their occurrence is more predominant with 
those products with a higher sunscreen factor, as they are 
prepared from a combination of more materials and furthermore 
they are of a high concentration. Mainly contact sensitisation 
effect and more seldom photocontact allergy have been recorded. 
This problem, however, occurs in about 1-2% altogether. The 
monograph's special value is that for the reader who is not 
acquainted with photobiology it is also clear that every 
Caucasian person needs sunscreen. The proof that a considerable 
part of the radiation which is harmful to our health and later 
also responsible for cancer are endured during our childhood, 
is considerably striking. For this reason I strongly recommend 
the book for pediatricians and pediatric dermatologists.
J. Mátyás Baló
ED IT O R I A L.
Acta Paediatrica Hungarica published a paper entitled "Effects 
of prostaglandin E 2 on the newborn respiratory system" written 
by E. Princzkel, L. Vojcek, L. Karmazsin, LG. Lampé (Debrecen 
Medical University), AC. Turnbull (Oxford) in Vol. 31. number 
3, pp 337-355, 1991. In March 1992 Professor Karl 0. Hittelman, 
Ph.D., Associate Vice Chancellor, University of California, San 
Francisco informed the editor of Acta Paediatrica Hungarica 
that with all probability plagiarism has been committed by the 
above -» mentioned article, being entirely identical with the 
original earlier paper of Guerra FA, RD Savich, LD Wallen, CH 
Lee, RI Clyman, FE Mauray and JA Kitterman "Prostaglandin E2 
causes hypoventilation and apnoe in newborn lambs" issued in 
Journal of Applied Physiology, 64 (5): 2160-2166, 1988. The 
reviewers of manuscript did not know about the Dr Kitterman's 
paper, thus the editor could not prevent the plagiarism. 
However, upon the letter of Professor Hittelman, immediate 
measures were taken and the alleged charge was investigated by 
the Ethical Committee of Debrecen Medical University. 
Unfortunately, the investigations of Professor L. Kovács, Vice 
Rector of University confirmed the act of plagiarism. 
Appropriate steps against Drs. E. Princzkel and L. Vojcek 
"authors" of the paper have been taken: they have been 
dismissed from the University. Professors Lampé and Karmazsin 
did not know about the previous paper of the Kitterman group 
and thought that the experiments had been carried out in 
Oxford. Drs Princzkel and Vojcek declared that Professor 
Turnbull who was their professional host in Oxford did not know 
anything about the manuscript and its submission to the Acta 
Paediatrica.
Together with the decision of the Ethical Committee of the 
Debrecen University and the issuing of this editorial we regard 
this regrettable case as closed.
M. Miltényi 
editor
U N I VE RS IT Y  OF CALIFORNIA, SAN FRANCISCO
School of Medicine Cardiovascular Research Institute 
San Francisco, California 94143-0130
Prof. Dr. M. Miltenyi, Editor June 10, 1992
Acta Paediatrica Hungarica 
Bokay Janos u . 53.
H-1083 Budapest 
Hungary
Dear Prof.Miltenyi :
My co-authors and I thank and commend the officials of 
Debrecen Medical University and Acta Paediatrica Hungarica for 
their rapid and thorough investigation of this sad and 
unfortunate incident and for their definitive action to rectify 
the situation. The responses of the University and the journal 
are tributes to the ethics and integrity of our colleagues in 
the Hungarian scientific community.
Joseph A. Kitterman, MO 
Cardiovascular Research Institute 
University of California 
San Francisco, California
ESPE CLINICAL FELLOWSHIP IN PEDIATRIC ENDOCRINOLOGY
T h e E u ro p ean  S ocie ty  fo r  P e d ia tr ic  E n docrino logy  h a s  e s ta b lish e d  a  C linical 
F ellow sh ip . T he aim is  to  p rom ote th e  developm ent of p a tie n t c a re  a n d  c lin ical 
r e s e a r c h  in  p e d ia tr ic  en d o c rin o lo g y  in  E u ro p e . T h e  program m e is  p r im a rily  
d e s ig n e d  fo r  E u ro p ean  C e n te rs  w here  th e  p o ss ib ilitie s  fo r  tr a in in g  in  p e d ia tr ic  
en d o c rin o lo g y  a re  n o t av a ilab le  in  th e  home s itu a tio n . T h e  fellow ship  c o n s is ts  of 
a 1 -to  2 - y e a r  c lin ical tr a in in g  in  a  E u ro p ean  C e n te r  w ith  lo n g s ta n d in g  t r a d i t io n  
of ex c e llen c e  in p e d ia tr ic  e n d o c rin o lo g y . A p p lica tio n s fo r  a  s h o r t- te rm  fe llow sh ip  
aim ing to  im prove q u a l i ty  in  th e  m anagem ent of a  sp ec ific  p e d ia tr ic  e n d o c r in e  
problem  will a lso  be ta k e n  in to  c o n s id e ra tio n . F inancia l su p p o r t  will b e  su f f ic ie n t 
fo r  a  fam ily . T h e  d ea d lin e  fo r  ap p lica tio n  ( i . e .  subm ission  of th e  com pleted  
ap p lica tio n  form ) is  August 15, 1992 (p o s tm a rk e d ) . T he fellow sh ip  will b eg in  
e f fe c tiv e ly  in  S p r in g ,  1993.
F u r th e r  in fo rm ation  an d  ap p lica tio n  form s can  be o b ta in ed  from  th e  ch a irm an  
of th e  fellow sh ip  com m ittee a t  th e  fo llow ing a d d re s s  :
P ro f . J . - P .  BOURGUIGNON 
D ep artm en t o f P e d ia tr ic s
C . H . R .  de la  C itade lle  
B o u lev a rd  du  12e d e  L igne 1 
В -4000 L ièg e , Belgium
P hone : 3 2 -41 -25 .65 .58  
F ax  : 3 2 -41 -25 .65 .58  *
* T h is  program m e is  sp o n so re d  b y  A re s -S e ro n o .
For over a year a female infant affected by Wolman disease and treated  by 
the dietary treatm ent described below survived far beyond the 3-4 months 
predictable life span. Although otherwise normal, with time she developed EFA 
(essen tia l fatty acid deficiency) which can be, and is now, treated by an 
estab lished  procedure which is not antagonistic to the dietary treatment.
T he treatm ent consists of strict cessation of breast feeding and strict 
avoidance of foods containing any fats and oils (triglycerides and cholesterol 
e s te rs). Formula feeding should be аз free as possible of neutral lipids, but 
should contain all vitamins.
In order to avoid dermatological complications and stunted growth due to 
tF A  deficiency, about 10 microliter (1/100 of ml) of sunflower oil should be lightly 
rubbed, once daily on the skin of one arm in infants below 5 kgs in body weight. 
Infants 5-10 kgs in weight should be treated  by daily doses of 20-25 tnl. In 
bigger c h i l ie n  the dose should be about 2 mg/day/kg body weight. The site of 
oil sm earing should be alternated on consecutive days between arms, forearm s, 
thighs and  legs.
At present it is not known whether this percutaneous administration of EFA 
should continue uninterrupted, or if 3-4 weeks of treatm ent should be followed by 
interm ission of 1 or more weeks. It is proposed that this point should be tested  
by experience in different cases.
In order to be able learn about best treatm ent modalities from a sizable 
y o u p  of patients, it is suggested  that treatm ent of patients and its effects be 
reported  to  me every 3-5 months. A report in the nam e of all participants (after 
consultation, of course) will be published in due time. Alternately, pediatricians 
of a country or an area can combine their efforts and resu lts and publish them 
independently. Also in this case , I would be grateful for information about the 
cases , which information will be considered confidential.
Prof. Em. Moshe Wolman 
Department of Pathology 
Tel Aviv University, Sackler Faculty of Medicine 
69978 Tel Aviv, Israel
April 1, 1992
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UNIDENT IF IE D  MULTIPLE CONGENITAL A BN ORMALITIES IN TWINS. 
A POPOLATION-BASED H U N G A R I A N  STUDY
Júlia MÉTNEKI1 , Ilona PAZONYI2 , A. CZEIZEL1
^Department of Human Genetics and Teratology, WHO Collaborating 
Centre for the Community Control of Hereditary Diseases, 
National Institute of Hygiene, Budapest, Hungary 
^Department of Probability Theory and Statistics, L. Eötvös 
University, Budapest, Hungary
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Of 1038 index patients with multiple congenital 
abnormalities, 34 were twins. This 3.3 per cent is 
higher than the Hungarian birth rate of about 2.1 per 
cent. However, after the exclusion of cases with 
congenital abnormality association of low birth weight 
newborn infants and with genital anomalies of the male, 
the twin birth rate was 1.8 per cent. Thus, the 
unidentified multiple congenital abnormalities have no 
common cause with twinning.
INTRODUCTION
There is now a growing amount of evidence indicating that 
the frequencies of congenital abnormalities (CAs) may be higher 
in twins /e.g., 9, 10, 12, 14/. The general observations are
the following: / i/ for CAs due to general origin, the
concordance values decrease in the order: monozygotic twins 
(MZ), dizygotic twins (DZ) and singletons; for those due to 
polygenic origin, the concordance values are in the order: 
CAs|Y|2 >CAsg 2 = CAs singletons /9, 15/ / ii/ deformations occur 
more frequently as a consequence of uterine constraints in both 
MZ and DZ twins /4, 7, 11/ and /iii/ in MZ twins, there is an 
excess of two groups of CAs; the first of these are part of the 
MZ twinning such as conjoined twins, some amorphous twins and 
some early embryonic field defects (e.g., caudal regression-
Akadémiai Kiadó, Budapest
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sirenomelia, holoprosencephaly /14/. The second group is 
related to and caused by differences in vascular interchanges 
between MZ twins (e.g., differences in vascular supply, reverse 
flow, vascular disruptions leading to limb defects, hemifacial 
microsomia etc. /15/.
Data suggestive of higher frequencies of multiple congenital 
abnormalities (MCAs) in twins have also been reported in the 
literature, but the differences appear to be small and non­
significant /15, 16/. However, to our knowledge, the question 
of whether MCAs have some causal factors in common with 
twinning has not been systematically explored. Since twinning 
represents a special situation in which a number of factors 
(including spatial constraints in the uterus, shorter gestation 
period, low birth weight, etc.) play a role, it was thought; of 
interest to undertake a population-based study to investigate 
whether there exists a causal relationship between twinning and 
unidentified MCAs.
MATERIAL AND M E T H O D S
A multiple congenital abnormality (i.e., concurrence of two 
or more CAs in the same individual) is the end result of errors 
in two or more different morphogenetic processes. A population- 
based MCA evaluation program (within the framework of the 
Center for Congenital Anomaly Control) has been in existence 
in Hungary since 1973 the overall objectives of which are / i/ 
to accumulate data on CA-syndromes and CA-associations which 
are of value in prognosis and genetic counseling and / ii/ to 
provide sensitive indicators of teratogenic and mutagenic 
factors in the environment. To achieve these objectives, 
efforts are continuously made to improve the validity and 
completeness of registration of MCAs and to increase the rate 
of identified MCA-entities. Details on how the program operates 
are given in reference 5.
The MCA Registry comprised 2733 cases with unidentified MCAs 
between 1973 and 1980. Our plan was to study on 1384 cases, 
i.e., 50.6 per cent of the study material. A specially designed 
post-paid questionnaire with an explanatory letter was mailed 
to parents in 1982 and 1983. Mothers were asked to inform us 
about numbers, dates and outcomes of all their pregnancies and 
the health condition of their children. To be certain, we 
requested all medical documents concerning their pregnancies 
and their children's CAs. We accepted only those questionnaires 
in which every question concerning the CAs in first degree
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relatives, especially those in sibs was correctly answered. 
When there were problems with the response, district nurses 
were asked to visit the families and seek clarification. /1/ 
109 letters (7.9 per cent) proved to be undeliverable. /2/ In 
the remainder of the cases where there was no response, another 
questionnaire and letter were sent and we asked for the help of 
the district nurses in order to obtain the data of these 
families. However, 166 parents (12.0 per cent) either failed or 
refused to respond. Some of their children lived in foster 
homes or with foster parents. /3/ 71 cases were excluded from 
further analysis. / i/ Eight cases were registered twice. / ii/ 
Some misclassifications and a few misdiagnosis of MCAs were 
detected later, i.e., after the notification by clinicians in 
31 cases. /i i i/ Finally a nosological diagnosis was achieved by 
detailed clinical examination of different experts later 32 
cases. (At the time of notification these recognizable MCA- 
entities were not identified.) Thus, the study sample involved 
1038 children (including 34 twins) with unidentified MCA. In 
this approach, index cases, i.e., affected twins were 
designated as twins "A".
The birth data collected by the Hungarian Central 
Statistical Office for total births and healthy twins (1973- 
1980) and by Budapest Twin Registry (1970-1979) /13/ were used 
by some comparative analysis. For statistical evaluation of the 
data chi-square statistics (Х2гУ]) (with Yates' correlation), 
the Fisher's exact test (Fç ) and t-test (with Welch 
modification for non-normal distribution of birth weights (tw ) 
were employed.
RESULTS
There were 34 twins in the study sample of 1038 cases with 
unidentified MCAs and this gives an occurrence rate of 3.28% 
which is significantly higher than the national figure of 2.06% 
for the study period (28 593 twins in 1 388 525 births; X2 of 
7.6; 0.05 > p < 0.01). Their MCA profiles and birth weights are 
given in Table I. It can be seen that oout of the 34 twins, one 
was a concordant twin-pair (these were conjoined twins), 2 were 
semi-concordant (i.e., one component CA was found in twin "B") 
and the remainder were discordant (i.e., predominantly only the 
index twin "A" was affected; note there were 3 cases 3 "8" 
twins affected in this group). Thus, out of 33 (the conjoined 
twin pair is counted as one), there were 6 affected "B" 
children, giving a rate of a 18.2% /6/33/.
The sex-ratio of index twins is 0.545 (18 males out a total
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of 33) and this corresponds to what has been known from studies 
of MCAs /5/. The sex-ratios for twins of unlike-sex and of 
like-sex are, respectively, 0.778 and 0.458. However, among 
twins "A" of the unlike-sex group, the number of affected 
females is less than expected; among affected twins "B", there 
is a male preponderance (sex ratio of 0.667).
A careful examination of the birth weights given in the last 
two columns of Table I will show that, within given pairs, 
these figures are generally similar, irrespective of whether 
the "B" twins have CA or not. In Fig. 1, the estimated mean 
birth weights of the index twins ("A") with MCAs with those of 
"B" twins with and without CAs are compared. Additionally, 
comparable data for other newborn groups are also presented. As 
can be seen, the mean birth weights increase from 1457 g for 
"B" twins with CA to 1782 g for the "A" twins with MCA to 1876 
g for the "B" twine without CA. All these mean birth weights 
are lower than that (2280 g) for healthy twins (Budapest Twin 
Registry) and lower still relative to those of singletons with 
and without C A .
§ Study__groyps.
a, twin'A" with MCA
b, twin"EP with CA
c, twin'fe" without CA
Control populations
d ,  twin without CA 
( Budapest)
e ,  singleton with CA 
(Hungary)
f ,  singleton without CA 
( Hungary)
H----------»-groups
a b c  d e t
Birth weight(g) 
3000- -
2000--
1000
Fig . 1
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Tests of significance in mean birth weights gave the 
following values:
/ i/ "A" twins with MCAs versus healthy twins from the
Budapest Twin Registry: (group a_ versus group c[ in Fig. 1) t = 
8.76; P << 0.001.
/ ii/ "B" twins without CA versus healthy twins (group £  and
£): t = 4.68; P < 0.001.
/ i i i/ Affected versus поп-affected singletons (groups £  and 
f_) : t = 24.3; P << 0.001.
For zygosity determination the most desirable method would 
be the examination of the actual genotype. However, it was not 
possible to do this in the majority of our cases either at 
birth or later because of the large number of stillbirths and 
perinatal deaths. It is well known that Weinberg method is 
applicable only to large populations. Nevertheless we attempted 
to use it for the estimation of zygosity in 33 twin pairs 
studied (Table III). The numbers of observed DZ and MZ was 18 
and 15, respectively in the study sample. The observed number 
of MZ was higher than expected /11/, however, the difference 
was not significant (P = 0.45 > p > 0.05) because of small
number of cases.
Our data permit an analysis of the common genetic component. 
All twin pairs are classified as like-sexed or unlike-sexed 
pairs. All unlike-sexed twin pairs are dizygotic. However, 
dizygotic pairs are equally likely to be like-sexed or unlike- 
sexed. The remaining like-sexed twin pairs are considered to be 
monozygotic. The numbers of concordant, semi-concordant and 
discordant pairs with MCA in unlike-sexed and like-sexed groups 
are shown in Table IV. As will be clear, there are no 
significant differences in the concordance between monozygotic 
and dizygotic twins. It would therefore seem that common 
genetic factors do not play a significant role in the origin of 
these unidentified multiple CAs. However, it should be borne in 
mind that identified CA-syndromes and CA-associations were 
excluded from this study material.
The so-called registry diagnosis was attempted in these 
unidentified MCAs on the basis of international literature
TABLE I
The data of twin index patients
SEX Component CAs Registry-diagnosis Birth weightиди llßH иди "В" "А" "В"
м F CCM /persistent ductus arteriosus/ + 
Hypospadias /glans/
LBW-association - 2.350 2.100
м F Hypospadias /penis/ + Cystic kidneys 
/bilateral/
- - 1.400 2.200
F M CCM /transposition of great vessels/ + 
Hypoplasia of lungs
- Hypoplasia of 
lungs
1.200 1.100
F F CCM /ventricular septal defect/ + 
congenital inguinal hernia /right/
LBW-association /Mental retardation/ 1.970 2.400
M F CCM /persistent ductus arteriosus + 
atrial septal defect/ + Hydrocephalus
- - 2.250 2.050
M M CCM /persistent ductus arteriosus/ + 
Congenital inguinal hernias 
/bilateral/
LBW-association 1.300 1.500
M M Spina bifida cystica + Exomphalos + 
Anal atresia
Extrophy of cloacc 1.670 2.050
M M CCM /persistent ductus arteriosus/+ 
Hydrocephalus + Undescended testes 
/bilateral/
LBW-association 1.500 1.750
M M Spina bifida cystica + Undescended testes 
/bilateral/
- - 2.250 2.000
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M F Limb reduction /aplasia of tibia, right 
clubfoot/ + poly-syndactyly of hand 
/right/
h Hypoplasia of tibia 
with polydactyly 
syndrome
3.000 2.700
F F CCM /atrial septal defect/ + Ear anomaly 
Adeafness/ + congenital inguinal 
hernia /left/
1.300 1.500
M M CCM /atrial septal defect/ + Congenital 
inguinal hernias /bilateral/
- - 1.450 1.750
M M Congenital dislocation of hips 
/bilateral/ + Undescended testes 
/bilateral/ /Mental retardation/
1.500 1.500
M M CCM /verticular septal defect/ + Teratoma 
/lipoma in temporal region, left/
- 1.700 2.000
F F Limb reduction /absence of metatarsus III., 
bilateral/ + CCM /ventricular septal defect/
Hydrocephalus 1.710 1.600
F F Limb reduction /hands, absence of finger
I-III., left, absence of II-IV.,
right/ + Other limb anomaly /elephantiasis,
/Mental and
somatic
retardation/1
1.800 1.500
foot, left/ + Congenital dislocation of hip 
/right/ + Clubfeet /bilateral/
Гм M Exomphalos /total/ + CCM /ventricular 's 
septal defect/ + Cystic kidneys /multi­
cystic, left/
'
Conjoined twin 
/ССМ-СК/ 
у association/
Exomphalds 
/persistent ductus 
arteriosus/ + Hydro­
cephalus + Cystic 
kidneys /bilateral/ 
/hydrops/
1.900
M
L
M Exomphalos + CCM /persistent ductus 
arteriosus/ + Hydrocephalus + Cystic 
kidneys /bilateral/ Ahydrops/
Exomphalos /total/ 
CCM /ventricular 
septal defect / +
950
Cystic kidneys 
/Multicystic, left/
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"A"
SEX 
1 "B"
Component CAs 
"A"
Registry-diagnosis
"B"
Birth weight 
"A" "B"
F F CCM /ventricular septal defect/ + 
Congenital inguinal hernia /right/
LBW-association - 1.250 1.750
F F CCM /persistent ductus arteriosus/ + 
Congenital inguinal hernias /bilateral/
LBW-association - 1.750 1.730
M F CCM /ventricular septal defect/ + 
Hydrocephalus
- - 1.900 1.600
У F M CCM /persistent ductus arteriosus/
+ Congenital dislocation of hips 
/bilateral/ + Teratoma /Cyst, of lig. 
testis/ + Congenital inguinal hernias 
/bilateral/
LBW-association Cleft palate 1.050 1.350
F F CCM /pulmonary stenosis/ + Dentatio 
praecox + /Umbilical hernia/
- - 1.980 1.620
y M M Hypospadias /glans/ + Congenital 
inguinal hernias /bilateral/ + 
umbilical hernia
GAM CCM /Ventricular 
septal defect/
2.100 2.220
M F Inguinal hernia /left/ + Undescended 
testes /left + aplasia testes/
GAM - 2.900 2.250
F F CCM /Ventricular septal defect/ + 
Congenital inquinal hernia /bilateral 
and umbilical hernia/ '
2.400 2.600
M F Congenital inguinal hernia /left/ + GAM - 2.750 2.400
Undescended testes /left + hydrocele/
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F F CCM /persistent ductus arteriosus/ + 
Megaloureter, left + Congenital inguinal 
hernia /left/
LBW-association 2 . 1 0 0 2.250
M M CCM /persistent ductus arteriosus/ + 
Congenital inguinal hernias /bilateral/ 
/+Mental retardation/
LBW-association 1 . 0 0 0 1 . 1 0 0
M M Cleft lips /bilateral +cleft palate/ + 
CCM /Tetralogy of Fallot/
- - 1.150 1.400
F F CCM /transposition of great vessels + 
aortic stenosis, valvular/ + Agenesis of 
kidneys /bilateral/
2.400 2 . 1 0 0
F F CCM /persistent ductus arteriosus + 
ventricular septal defect/ + Congenital 
dislocation of hips /bilateral/
LBW-association 1.650 1.650
F F CCM /persistent ductus arteriosis/ + 
Hypoplasia of abdominal muscles
Prune-belly defect - 1 . 2 2 0 1 / 2 0 0
F F Exomphalos + CCM /arterial septal 
defect, type II./
- Exomphalos 1.800 1 . 1 0 0
CCM = congenital cardiovascular malformation
LBW = Ca-association of newborn with low birth weight
GAM = genital anomalies of the male
CCM-CK = congenital cardiovascular malformation - cystic kidney association
X = concordant
X X  = semi-concordant
y = discordant
TABLE II
Sex ratio of twins A and twins В in the study sample
Twin M
Like-
F
sexed
Sex
ratio
M
Unlike-sexed 
F Sex 
ratio
M
Total
F 2 Sexratio
"A" 11 13 24 0.458 7 2 9 0.778 18 15 33 0.545
Affected "B" 2 2 4 0.500 2 0 2 1.000 4 2 6 0.667
Non-affected "B" 9 11 20 0.450 0 7 7 0.000 9 18 27 0.500
Subtotal 11 13 24 0.458 2 7 9 0.222 13 20 33 0.394
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TABLE III
Concordance in estimated MZ and DZ twin pairs based on sex
Twin pairs Unlike-sexed
DZ
Like-sexed 
D Z + M Z + DZ
Total
MZ V
P/F e/
Concordant 0 0 1 1 0 1 1 0.45 NS
Semi-concordant 1 1 0 1 2 0 2
Discordant 8 8 14 22 16 14 30 0.42 NS
Total 9 9 15 24 18 15 33
+Calculated on the basis of Weinberg method
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TABLE IV
Concordance in estimated MZ and DZ twin pairs based on sex
Twin pairs Unlike-sexed
DZ DZ +
Like-sexed 
MZ + V DZ
Total
MZ y
P/Fe/
Concordant 0 0 1 1 0 1 1 0.45 NS
Semi-concordant 1 1 0 1 2 0 2
Discordant 8 8 14 22 16 14 30
Total 9 9 15 24 18 15 33
+Calculated on the basis of Weinberg method
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(e.g., hypoplasia of tibia with polydactyly syndrome, CMcKusick 
catalog: No 18877D and extrophy of cloaca) and our previous 
studies /1, 2, 5/. Of the 34 twins with MCAs, 7 had CA- 
association and low birth weight /5/, 3 genital anomalies in 
the male /2 /, 2 congenital cardiovascular malformation-cystic 
kidney association / 1 /, one extrophy of cloaca and one 
hypoplasia of tibia with polydactyly syndrome. Thus different 
CA-entities were identified in 41.2% of twins with MCAs using 
registry diagnosis.
DISCUSSION
The occurrence of index twins "A" was significantly higher 
in our study sample of MCAs cases. Similar increases in MCAs in 
twins, (although non-significant) have also been reported in 
the literature /15, 16/. Differences in ascertainment and 
sample size may be responsible for differences between our 
studies and those of others.
The considerably higher rate of affected twins "A" among 
multimalformed babies (X^ = 7.1; 0.05 > p < 0.01) is suggestive 
of some causal connection between twinning and MCAs. There is 
an increased likelihood for CAs in twin gestation because they 
are actually two persons from the same pregnancy / 8 /. In this 
way, the relative population frequency of DZ versus MZ twins of 
2/3 to 1/3, may cause the incidence of any CA in twins which 
corresponds to 5/3 times incidence of singletons. To eliminate 
this problem, 34 cases of the study sample have to divide by 
5/3, so the number of index twins "A" became only 20.4. It is 
not significantly higher than that of the population at large 
(x 2 Cy□ = 0.05; P > 0.01).
Our analysis did not provide evidence for a role of 
mendelian factors or chromosomal aberration in the origin of 
unidentified MCA. It seems however that the excess of twins 
among unidentified MCA cases can be explained by the high 
occurrence of CA-association with low birth weight (LBW)
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newborns and genital anomalies of the male (GAM). The lower 
birth weight and preterm birth which are characteristic for 
twins may have a triggering factor in the pathogenesis of these 
CA-entities. All cases with CA-associations with LBW and GAM 
were discordant in our study sample which is another argument 
against genetic liability. After the exclusion of this CA- 
association (10 cases), GAM (3 cases) and conjoined twins (2 
cases), the occurrence of unidentified MCAs in twins is only 
1.83 per cent it is even slightly lower than the Hungarian twin 
birth rate of 2.1%. The point is that after the exclusion of 
the effect of lower birth weight and preterm birth there is no 
causal connection between the genesis of twinning and 
unidentified MCAs.
In conclusion, the unidentified MCAs in our study sample do 
not provide evidence for common cause with twinning but suggest 
that twinning can trigger the combination of some CAs due to 
lower birth weight and preterm birth.
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The study was undertaken to assess the influence of 
thyroxine given to improve respiratory adaptation in 
asphyxiated neonates on the recovery of compromised 
renal functions.
Two groups of infants with perinatal asphyxia were 
selected for the study. Group I consisted of 8  infants 
treated conventionally, while Group II included 7 
infants who in addition to standard therapy were 
administered 50 /ug thyroxine at admission and repeated 
24 hours later. Their respective mean gestational ages 
were 38.7 weeks (range: 34-42 weeks) and 37.4 weeks 
(range: 34-41 weeks). The studies were performed on 
days 1, 7 and 14 and the results compared to those 
obtained in 13 healthy neonates with the gestational 
age of 39.2 weeks (range: 38-41 weeks) (Group III).
Asphyxiated neonates had significantly higher plasma 
uric acid, xanthine, hypoxanthine and creatinine levels 
(p < 0.05), while their GFR proved to be markedly 
reduced (p < 0 .0 1 ) when compared to the values of 
healthy controls. Moreover, there was a significant 
elevation of urinary excretion of NAGA (p < 0.001), 
urine osmolality (p < 0.05), PENa, FECa, RFI (p < 0.05) 
in infants presenting with perinatal asphyxia. Renal 
tubular responsiveness to aldosterone measured as TTKG 
was also found to be depressed (p < 0.025). In response 
to thyroxine therapy renal functional recovery appeared 
to be accelerated as indicated by the lower plasma 
creatinine level, lower rate of fractional electrolyte 
and urinary NAGA excretion and improved reactivity to 
aldosterone on days 7 and/or 14 as compared to those 
obtained in neonates oresenting with asphyxia but 
without thyroxine therapy. The results seem to suggest 
that thyroid hormones may have an important role in 
the recovery of renal functions in newborn infants 
suffering from perinatal asphyxia.
Akadémiai Kiadó, Budapest
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INTRODUCTION
Newborn infants suffering from perinatal asphyxia may have 
compromised renal functions resulting from renal 
vasoconstriction/hypoperfusion, direct hypoxic cellular injury, 
or both. Ischemic, toxic and obstructive acute renal failure 
has been shown to be associated with depleted cellular ATP 
levels and thyroxine treatment has been demonstrated to 
accelerate recovery of renal functions and restoration of 
cellular ATP pool /5, 17, 22/. In addition to these 
experimental data, the beneficial effect of thyroxine on 
impaired renal functions has also been substantiated in 
pediatric patients with shock-related acute renal failure / 2 1 /.
Several reports indicate that newborn infants with hyaline 
membrane disease have biochemical hypothyroidism /7, 10, 13, 
15/, thyroid hormones enhance fetal lung maturation /3, 19, 20/ 
although thyroxine administration to neonates suffering from 
hyaline membrane disease and perinatal asphyxia does not 
appear to consistently improve respiratory functions / 1 , 2 , 
16/ .
In view of these clinical and experimental evidences the 
present study was undertaken to assess 1 ./ the influence of 
thyroxine treatment on the recovery of glomerular and tubular 
functions in newborn infants with perinatal asphyxia and 2 ./ to 
determine whether the accelerated recovery of renal functions 
if any, is the result of improved respiratory functions or 
rather it may be accounted for by the direct effect of 
thyroxine on the kidney.
P A T I E N T S  AND METHODS
Subjects
Two groups of newborn infants presenting with perinatal 
asphyxia and a group of healthy neonates were selected for the 
study. The diagnosis of perinatal asphyxia was made in infants 
who had Apgar score of 7 or less at five minutes of age. 
Asphyxiated infants received intermittent positive pressure 
ventilation through endotracheal tube or face mask and NaHCOj 
bolus in a dose of 1-2 mEq/kg of solution containing 4.2%
Effect of thyroxine administration 221
NaHCOj and 20% glucose in water. After this treatment in the 
delivery room they were transported to our perinatal intensive 
care unit where they were alternately assigned to either 
conventional therapy (supplemental oxygen and intravenous fluid 
administration, Group I) or to conventional therapy completed 
with thyroxine (Group II). 50 /Ug thyroxine was given on 
admission and repeated the same dose 24 hours later (L- 
Thyroxine, Henning, Berlin) as applied by Amato et al /1/.
Respiratory support, arterial blood pressure (Kontron 
Ultrasonic Blood Pressure Monitor), transcutaneous p0 2 and pC0 2 
value (Heilige Oxacapnomonitor) and acid-base balance 
(Radiometer ABL 330) have been routinely monitored. There was 
no statistically significant difference between the two 
asphyxiated groups with respect to pregnancy complications, 
instrumental delivery, birth weight, gestational age, one- and 
five-minute Apgar scores, age on admission, intravenous fluids 
received prior to and following entry into the study and need 
for respiratory support to maintain Pa0 2 greater than 50 Hgmm. 
The healthy neonates (Group III) were cared for in the
maternity unit. They were exclusively breast-fed and only 5% 
glucose in water was added to provide the required fluid 
intake. There was no significant difference between gestational 
age of the three groups of newborns. The clinical data of the 
patients studied are presented in Table I.
Study design
The study was carried out on days 1,7 and 14 to determine 
the perinatal asphyxia-related changes in renal functions and 
the influence of thyroxine administration on their postnatal 
course. For assessing the severity of hypoxic insult the
patients survived plasma levels of xanthine, hypoxanthine and 
uric acid /4/ were measured. To compare the postnatal
development of glomerular and tubular functions in the
different groups 24-hourt urine collection was performed and 
blood was taken at midpoint to determine glomerular filtration 
rate, fractional excretion of sodium, potassium and calcium, 
urine flow rate, as well as urine and plasma osmolality.
Laboratory assays and calculations
Plasma and urine sodium and potassium were determined by 
flame photometry, creatinine by the modified Jaffe method /11/ 
and osmolality by freezingpoint depression using Knauer 
osmometer. Calcium concentration in the plasma and urine was 
measured complexometrically. Endogenous creatinine clearance, 
fractional electrolyte excretion and renal failure index (RFI) 
were calculated using standard formulae. To estimate renal 
tubular responsiveness to aldosterone the recently introduced 
transtubular potassium gradient (TTKG) was calculated according 
to the formula of West et al /25/ as follows:
K urine: (U/P) osmolality
TTKG = ---------- :---------------plasma К
Urinary aldosterone excretion measured by radioimmunassay 
/23/ was used as an estimate of daily aldosterone excretion.
Hypoxic tubular injury was further defined by determination
Clinical characteristics of newborn infants with perinatal asphyxia receiving conventional (Group I) 
or conventional plus thyroxine therapy (Group II) and those of healthy control neonates (Group III) 
Data are given as means and ranges of individual values
TABLE I
Group П GA
weeks
BW
g
Apgar 
1 min
score 
5 min
positive
pregnancy
history
compli- age at 
cated admis- 
delivery sion hr
Oxygen
head
box
delivery 
CPAP PEEP
duration 
of O2  
therapy 
days
neurological 
symptoms at 
follow-up
I 8 37.1 2774 2 . 1 5.3 3 2 4.3 3 3 2 2.3 3
(34- (1900- (1-4) (4-7) (1-9) (1-5)
42) 3800)
II 7 37.4 3106 2.4 5.0 4 3 2.9 2 3 2 2 . 8 3
(34- (2350- (0-4) (3-7) (1 -6 ) (1-7)
41) 4300)
III 13 39.2 3652 9.0 9.2 1 0 - - - -
(38- (2710- (8 -1 0 ) (8 -1 0 )
41) 3750)
BV = birth weight
CPAP = continuous positive airway pressure 
GA = gestational age
PEEP = positive end-expiratory pressure ventilation
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of urinary excretion of NAGA, a lysosomal enzyme, which is 
released from the damaged proximal tubular cells / 8 /. For 
statistical evaluation the paired and unpaired Student's t- 
tests were used and the values were presented as means _+ SEM. 
Approval of the institutional ethical committee and informed 
parental consent were obtained for the study.
RESULTS
The time of supporting respiration was the same in both 
groups with asphyxia (3-7 days). In case of CPAP ventilation 
the PEEP was 4 F^Ocm, the FÍO 2 was 1.0 - 0.4 in both groups, 
respectively. The parameters of IPPV ventilation were the 
following: in the Group I: FÍO 2 : 1.0-0.4, PEEp: 4-1 F^Ocm, 
PIPm a x : ^5 F^Ocm, frequency: 60-20/min, in the Group II: FÍO 2 : 
1.0-0.35, PEEP: 4-2 Troern, Р1Р|пах: ^2 F^Ocm, frequency: 60- 
2 0 /min .
Plasma xanthine, hypoxanthine and uric acid levels as 
markers of hypoxic stress are shown in Table II. It can be seen 
that in response to perinatal asphyxia there was a marked 
increase in plasma xanthine level which was followed by a 
steady decline, the rate of decline, however, was more rapid in 
infants on thyroxine treatment. Similarly, plasma hypoxanthine 
level tended to be elevated in infants presenting with asphyxia 
on day 1 , it fell with advancing age, the fall being more 
pronounced in infants receiving thyroxine. Plasma uric acid 
level proved also to be higher in infants recovering from 
perinatal asphyxia, thyroxine therapy had no apparent influence 
on its subsequent fall.
Table III demonstrates that as a result of higher fluid 
intake urine flow rate was higher in infants of asphyxiated 
than in the control group and increased with age irrespectively 
of thyroxine therapy. Urine osmolality decreased accordingly 
without discernible difference between the groups with or 
without thyroxine administration. Plasma creatinine 
concentration was significantly elevated in asphyxiated 
neonates and it remained at about the same level all-over the 
study. In contrast, when thyroxine therapy was applied plasma 
creatinine concentration declined at a constant rate until the 
end of the 2 nd week to approach the values of healthy neonates.
Plasma xanthine, hypoxantine, and uric acid levels of newborn 
infants with perinatal asphyxia receiving conventional (Group I) 
or conventional plus thyroxine therapy (Group II) and those of 
healthy control neonates (mean +_ SE)
TABLE II
Group Postnatal age 
(days)
Xanthine 
(yumol/ 1  )
Hypoxanthine 
(jumol/ 1  )
Uric acid 
(/jmol/ 1  )
I 1 26.0 + 3.4 a 50.0 + 11.9 545.2 + 35 9a ,b
7 17.9 + 2.9 4 5 . 6 + 11.7 215.1 + 13.5b
14 1 0 . 0 +_ 1 .4 a 33.2 + 8 . 0 148.3 + 14.5a
II 1 23.5 + 1 .7a I b , A 56.0 + 9.4C 579.0 + 81 . 8 a >b
7 7.0 T  0 .9b 22.7 + 4. 0 C 215.8 + 40.2b
14 10.4 i  2 .0 a 22.9 + 3.7 136.6 + 31.8?
III 1 18. 0 + 1 .5A 42.9 + 2.3 504.5 + 34.Ie
7 16. 7 + 1.4 41.6 + 2 . 2 284.9 + 32.9C
14 - - -
Significant differences within groups (a,b,c) 
Significant differences between groups (A) 
a,b: p < 0 . 0 0 1
c ,A : p < 0.05
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TABLE III
Parameters of renal functions in newborn infants with perinatal asphyxia 
receiving conventional (Group I) or conventional plus thyroxine therapy 
(Group II) and those in healthy control neonates (means +_ SE)
Group Postnatal 
age (days)
Urine flow rate 
ml/kg
Urine osmolality 
mOsm/kgh^O
Plasma creatinine 
umol/1
GFR
ml/min.xl.73m^
I 1 2.0 + 0.3a,b,B 179.2 + 18.6a 'e 80.8 + 3.7d >B 21.6 + 2.8B
7 3.3 + 0.4b ’c 108.3 + 18.0c >C 107.6 + 11.3d ’L’’t 18.2 + 1.4c >C ’E
14 3.7 + 0.5a>c 73.2 + 8.0a 81.7 + 11.3 32.5 + 5.0e
II 1 1.4 + 0.4a,b,A 210.8 + 21.9a,c 74.9 + 8.9A 24.8 + 2.2 F
7 3.3 + 0.5b ’ü >ü 111.9 + 21.4c,C 66.7 + 9.Ie 30.2 + 3.7C
14 3.4 + 0.5a 74.3 + 20.4a 58.8 ±  5 -A 34.2 + 6.3
III 1 0.2 + 0.04b >A ’B 233.8 + 30.9b 52.4 + 1.9A,B 34.3 + 2.4F >B
7 1.6 + 0.2b,u 84.1 + 9.2b 50.3 + 4.2e 41.8 + 2.7E
14 “ — ” —
Significant differences within groups (a,b,c,d) 
Significant differences between groups (A,B,C,D,E,F) 
a,b,B,C,E,F: p < 0.001 
d,A: p < 0.025
C: p < 0.01
Effect of thyroxine administration 
225
226 К. Adamovich et al.
Approximately reciprocal changes were seen in endogenous 
creatinine clearance: i.e. it was depressed in asphyxiated 
neonates and appeared to recover earlier when thyroxine was 
g i v e n .
Table IV summarizes the results of determination of several 
markers of renal tubular functions. Urinary NAGA excretion was 
about three times higher and remained practically unchanged in 
infants presenting with asphyxia when compared with that of 
one-week-old healthy neonates (because of technical reasons we 
could not get values on the first day). Thyroxine 
administration had no influence on its postnatal course. The 
fractional sodium excretion in the asphyxiated newborns was in 
the normal range as well, but the decrease was faster in those 
treated with thyroxine. Fractional potassium excretion was 
about the same in all groups irrespective of age, perinatal 
asphyxia and thyroxine therapy. Fractional calcium excretion in 
asphyxiated neonates exceeded that of healthy controls, however 
its age-related changes were not significantly influenced by 
thyroxine. Essentially the same pattern was seen for renal 
failure index: it was elevated in infants with asphyxia and the 
rate of its decline remained unaffected by thyroxine.
Renal tubular responsiveness to aldosterone was estimated by 
calculating TTKG as reliable measure of aldosterone-induced 
distal tubular potassium secretion and by the simultaneous 
measurement of daily aldosterone excretion (Figure 1). When 
compared to healthy neonates TTKG in asphyxiated newborn 
infants indicated impaired distal tubular potassium secretion. 
In response to thyroxine treatment only a slight, statistically 
insignificant improvement occurred. The failure of the distal 
tubule to secrete potassium after perinatal asphyxia becomes 
even more evident when the simultaneous daily aldosterone 
excretion is considered. Infants suffering from perinatal 
asphyxia had significantly increased urinary aldosterone 
excretion, therefore higher TTKG could have been expected. In 
face of the increased urinary aldosterone excretion the 
markedly depressed TTKG in infants with asphyxia can be 
regarded as a clear evidence for the asphyxia-related severe 
impairment of this distal tubular function.
TABLE IV
Parameters of renal tabular functions in newborn infants with perinatal asphyxia receiving 
conventional (Group I) or conventional plus thyroxine therapy (Group II) and those in healthy
control neonates (means + SE)
Group Postnatal Urinary NAGA FENa FÉK FECa RFI
age (days) excretion (%) (%) (%)
(/jmol/day)
I 1 48.0 + 6.3r 0.48 + 0.17 6 . 1 + 0 . 6 0.7 + O.lB 1 . 1 + 0 .5a
7 49.3 + 7.8E 0.46 + 0.08h 4.7 + 0.7 1 . 0 + 0 .1 E 0 . 6 + 0 .2 C
14 52.9 + 1 0 . 8 0.24 + 0.09 4.3 + 0.7 0 . 6 + 0 . 1 0 . 2 + 0 .0 2 a,c
II 1 42.0 + 13.5_ 0.45 + 0 .1 0 b 5.5 + 1 . 0 0.5 + °.l 1 . 0 0.3a >A
7 56.9 + 1 1 .8 U 0.37 + 0.08 4.9 + 0.9 0 . 8 + 0 .1L 0 . 8 + 0 .2 d
14 47.7 + 17.1 0.14 + 0.05b 4.5 + 0.9 0 . 8 + 0.3 0 . 2 + 0.07a’d
III 1 _ 0.34 + 0.08 6.4 + 0.3 0.3 + 0 • ip , 0.3 + 0.07A
7 15.5 + 5.1d,E 0.23 + 0.03F 7.1 + 0.7 0.4 + 0 .1C >E 0.3 + 0.07
14 - — —
Significant differences within groups (a,b,c,d) 
Significant differences between groups (A,B,C,D,E,F)
a, A,D,E: p < 0.001
b, B,C: p < 0.02
d,F: p < 0.025
C: p < 0.01
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DISCUSSION
The results presented in this study provided evidence that 
thyroxine administration in the immediate postnatal period to 
neonates surviving perinatal asphyxia had no apparent influence 
on respiratory adaptation as judged by the unaltered oxygen 
requirement and respiratory support. On the other hand, 
thyroxine therapy was demonstrated to accelerate the recovery 
of GFR and some tubular functions. It seems reasonable to 
assume, therefore, that the beneficial effects of thyroxine on 
renal functions are unlikely the result of improved 
oxygenization but rather they may be accounted for by its 
direct stimulation of cellular metabolism within the kidney.
In spite of the fact that considerable body of evidence 
supports the view that thyroid hormones accelerate lung 
maturation, recent clinical study by Amato et al failed to 
demonstrate any beneficial influence of postnatal thyroxine 
administration on the course of idiopathic respiratory distress 
syndrome in premature infants /1/. The results of our present 
study are consistent with this observation and the experimental 
protocol we applied provided us the unique opportunity to get 
information about the possible role of thyroxine in the 
recovery of renal functions from hypoxic depression in 
asphyxiated human neonates. The hypoxic renal impairment caused 
by perinatal asphyxia was indicated by the significantly 
elevated plasma creatinine level and decreased GFR and by the 
increased urinary excretion of NAGA, increased fractional 
excretion of sodium and calcium and by the increase of RFI. In 
an attempt to define the effect of asphyxia on distal tubular 
function we calculated TTKG a reliable marker of renal tubular 
responsiveness to aldosterone. In agreement with several 
recent reports we could demonstrate that GFR and some indices 
of proximal tubular function recovered or approached to the 
control value earlier when thyroxine was given. Concerning the 
influence of thyroxine on the renal response to aldosterone 
apparent conclusion can not be drawn. The decrease of TTKG was 
similar in both groups of asphyxiated neonates, however, the 
daily aldosterone excretion in the thyroxine-treated infants
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was lower than in those without thyroxine. Nearly identical 
TTKG-values in face of reduced rate of aldosterone production 
may imply some improvement of renal tubular aldosterone 
r e a ctiv ity.
Great effort has been made to define the cellular mechanisms 
leading to ischemic renal damage and to accelerated recovery 
after thyroxine administration. Recent data from studies on 
pathophysiologic events during acute ischemic cell injury have 
reveaLed that, reduction of cell ATP, elevation of cytosolic 
Ca + + , phospholipid degradation and abnormal production of 
reactive oxygen metabolites are the major factors responsible 
of cellular level for the complex process of hypoxic acute 
renal failure /24/. It has been demonstrated that cellular high 
energy phosphate, in particular ATP pool is markedly depleted 
and the ability of the kidney to resynthesize ATP is diminished 
following acute renal injury /12/. ATP provides energy for 
vital cell functions including membrane-bound Na-K-ATP-ase 
activity which is responsible for regulating sodium and water 
transport across cell membranes and maintaining cellular 
integrity. Since treatment of acute renal failure with either 
ATP-MgCl 2 or thyroxine resulted in almost identical accelerated 
restoration of cellular ATP levels and recovery of renal 
function, it is reasonable to assume that this salutary effect 
of thyroxine is mediated through repletion of cellular ATP pool 
/18/. As an alternative possibility it has also been suggested 
that thyroxine stimulates incorporation of phospholipide into 
cell membrane /3/, therefore it may contribute to the 
maintenance of membrane stability and cellular integrity / 6 /.
In conclusion, our results show that thyroxine 
administration to neonates presenting with perinatal asphyxia 
may accelerate the recovery of compromised renal functions 
without significant influence on pulmonary adaptation. In view 
of this favourable effects of early thyroxine therapy further 
studies are needed to define more clearly the criteria for the 
■sslection of patients to and the optimal timing and dosage of 
thyroxine administration.
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Authors report on a Bicarnesine replacement therapy 
in an infant girl patient suffering from carnitine 
deficient myopathy diagnosed at 1 year of age. The 
hypotonic patient's motoric functions improved and she 
became able to walk as a result of therapy applied, but 
the pathological process generalized to 
encephalomyopathy. Free and esterified carnitine were 
determined from the serum and muscle biopsymaterial. 
After the Bicarnesine-supplementation the serum 
carnitine fractions elevated.
INTRODUCTION
Carnitine deficiency as a lipid storage myopathy was first 
published by Engel and Angelini /7/. Isolated muscle type /1/a, 
1/b, 13, 14, 6 / systhemic carnitine deficiency /12, 8 / and 
secondary carnitine deficient syndromes were differentiated.
The molecular weight of the quaterner amine carnitine is 162 
Dalton. That is synthetized in liver tissue and transported by 
carnitine acyltransferase to the cytosol taking part in the 
transport of the long chain fatty acids as a carrier through 
the mitochondrial membranes.
The case of a carnitine deficient girl patient will be 
published discussing the clinical chemical diagnostic methods 
and the therapeutic possibilities.
Akadémiai Kiadó, Budapest
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CASE REPORT
O.G. (b.29.A u g .1982) female patient's familial and perinatal 
history was negative (birth weight 3050 g). In the late newborn 
stage (from 12 tn day) she had apnoeic attacks, transitoric 
systolic heart murmur, hepatomegaly, generalized hypotonia, 
paradox ventillation movements, C O 2 retention. She was 
suspected to have metabolic myopathy.
Laboratory findings: serum CK 37 U/l, KN 3 mmol/1, uric acid 
317 yumol/1, Na 133 mmol/1, К 5.6 mmol/1, Cl 102 mmol/1, gamma- 
GTt 25 U/l, a l k .phosphatase 76 U/l, serum and urine aminoacid- 
chromatography normal.
Ophthalmological findings : strabismus convergens, epicanthus, 
fundus oculi -10.0 0 myopia. CSF tapping results were as
follows: Pándy negative, total protein, glucose in CSF normal,
lactic acid 0.6 mmol/1, pyruvate 34 yumol/l (normal), - se 
lactic acidosis and subacute necrotising encephalopathy 
(Leigh's) can be excluded. Serum lactate 1.1 mmol/1, pyruvate 
107 yumol/l (normal), NH 3 50 gamma%, arylsulphatase 33.6 U 
(normal).
EGG: monotonous fast theta activity without any specific
abnormality. The only sign of the maturation of her cortical 
activity during the last 6 years - between 3 and 9 years of age 
is an increased response (desynchronisation) for photic 
stimulation. - Electromyography: neurogen atrophy. ENG: n.
peroneus mcv 20 m sec on the left side, DL not measurable, 
without any denervation signs. - Muscle biopsy was made at 1 y. 
of age, after detecting the carnitine deficiency Bicarnesine 
(Labaz Laboratoire» solution 100 mg/kg/day) substitution was 
given. After 8 months of carnitine substitution the level of 
serum free and esterified carnitine was found elevated. Muscle 
biopsy: No 3365/1983: the diameter of the muscle fibers
decreased, 6 - 1 2  /j , these had normal polygonal shape, except 
some ovaloid or circle ones showing so-called acidophil 
necrosis. Hypertrophized muscle fibers were not found. Mild 
perivascular fibrosis was seen, polymyositis, malignancy and 
lipid storage myopathy can be excluded.
Dg: Muscle atrophy in early stage.
Echocardiography normal, no cardiomyopathy.
The girl is mildly retarded but has developed virtually no 
speech. Audiometry verified severe sensorineural hearing loss. 
A hearing aid was provided at three years without any success 
in speech. From four years on she attended special nursery 
class where she is being trained in the use of the Bliss 
symbolic language system to assist communication.
Biochemical investigations and results
The free and esterified carnitines (O-acylcarnitine) were 
measured from serum and muscle biopsy specimen according to 
Bieber's and Lewin's method /2/. The serum carnitine fractions 
were extremly decreased, the free carnitine was not detectable 
in the muscle tissue, while the esterified carnitine level 
diminished as comparad to the controls (Table I).
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TABLE I
Biochemical results
Carnitine
free
yumol/ 1
esterified 
/umol/g
Controls (n=10) 32.1 44.6
serum S.D. _+ 12.4 +. 15.1
muscle (n=5)
S.D.
1.25 
_+ 0.44
1 .3
+_ 0.56
0 . G . (patient) 
serum 2 . 1 1 1 1 . 2
muscle 0 . 0 0.32
O.G. (patient)
8 months after 
starting of Bicarnesine 
treatment serum 18.6 26.22
DISCUSSION
Our girl patient proved to be a case of primary type 
carnitine deficiency excluding the secondary types (hepatic 
fibrosis, haemodialysis). The initial muscle type carnitine 
deficiency in spite of the delayed introduction of carnitine 
supplementation progrediated, so generalized carnitine 
deficiency the so-called carnitine deficient encephalomyopathy 
has developed.
Ware et a l . 's /17/ case (14 у.о. male patient with systemic 
carnitine deficiency) showed hypoglycemia, hepatic laesion and 
progressive myopathy. In the primary carnitine deficient 
myopathic cases the muscle carnitine was under 2 0 % of the 
controls /4/. The carnitine supplementation may be particularly 
effective /3/.
Lipid storage myopathies might occur without any enzyme 
deficiency /11/. Laesion of the beta-oxidation of the fatty 
acids does not lead to lipid storage myopathy /16/.
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In our case lipid storage myopathy was not detected and 
carnitine acyl-transferase activity was not determined.
DiMauro and DiMauro /5/ have published muscle carnitine 
palmitoyltransferase deficiency with myoglobinuria, others have 
described / 1 0 / partial deficiency of the above mentioned 
e n z y m e .
Early diagnosis of the genetically determined carnitine 
deficiency would be important as prognostic factor.
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The erythrocyte glutathione metabolism of 11 
children with acute celiac disease (CD), 11 children 
under gluten free diet with CD and 5 children with 
cow's milk allergy was compared to that of 1 1  children 
with nutritive iron deficiency and to 2 2  healthy 
children as controls. Erythrocyte glutathione (GSH) 
content of celiac children was elevated and the 
glutathione disulfide (GSSG) level was significantly 
decreased as compared to normal controls. Erythrocyte 
GSSG/GSH ratio in acute CD differed also from the one 
in iron deficiency. In vitro oxidative load of 
acetylphenylhydrazine proved the impaired glutathione 
stability of the erythrocytes in acute CD and cow's 
milk allergy. A parallel rise of methemoglobin and 
hemichrome level of blood cells was seen. Further on, 
the selenium content of the red blood cells of CD 
patients decreased. All alterations of the erythrocyte 
tended to normalize during the dietetic period.
These data suggest a reduced protective capacity of 
erythrocytes in CD and in cow's milk allergy in 
childhood against oxidizing stresses.
INTRODUCTION
Several lines of evidence indicate an immunologic mechanism 
for the gluten sensitivity. The pronounced mucosal changes may 
develop a few hours after gluten challenge /5/ and during this 
process local inflammatory changes /9, 17/ take place, as well 
as a significant increase of neutrophil chemotactic activity 
of sera and a degranulation of mast cells /14/. Inflammatory 
cells are known to induce free radical production which in
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themselves can cause direct damage to biological compounds if 
protective mechanisms are impaired.
We wanted to study the relation between the tissue damage 
induced by gluten and the signs of oxidant injury of patients 
with celiac disease (CD). Understanding the role of toxic O 2  
metabolites in complex biological systems has been limited by 
the lack of direct methods for detecting this highly reactive 
compounds in vivo. Therefore we investigated the glutathione 
redox system, oxidative dérivâtes of hemoglobin (methemoglobin 
and hemichrome) and selenium content of erythrocytes of celiac 
patients in acute period, after gluten free diet and, gluten 
challenge parallel with histological examinations.
M AT ER IA LS  AND M ET HODS
22 children with CD (corresponding to the ESPGAN criteria) 
/18/, further on 5 patients with cow's milk protein 
intolerance, 1 1  children with nutritive iron deficiency and 26 
healthy children before minor surgical intervention were 
studied. Of 22 CD patients, 11 had active disease and 11 were 
in remission. In all CD patients and in 2 cases with cow's milk 
protein intolerance, small bowel biopsy was performed. At the 
same time a 2 ml blood sample, by adding EDTA, was taken for 
biochemical investigations.
To assess the selenium status, in another series of 
patients, altogether 24 children with CD on gluten containing 
diet and 25 CD patients on gluten free diet for at least 1 year 
and 15 matched healthy children were investigated.
The concentration of reduced glutathione (GSH) and oxidized 
glutathione (GSSH) was measured by specific glutathione 
reductase enzyme reaction immediately after blood sampling by 
the method of Tietze /27/. The value of GSSG was defined 
separately according to Akerboom and Sies /3/, after alkylation 
of GSH with N-ethyl-male-imide (NEM). The removal of NEM was 
performed by SephaçJex gel-filtration. The stability of GSH was 
measured by Beutler's original method / 8 /. The incubation of 
whole blood in /5 mg/ml acetyl-phenylhydrazine lasted for 1 
hour at 37°C. The oxidation state of hemoglobin was defined 
according to Szebeni et al /26/ by reading the light absorption 
spectra of the previously refrigerated haemolysate at 560, 600, 
630 and 700 nm. Haemolysate of washed erythrocytes was used to 
determine the selenium concentration by a fluorometric method 
using 2,3-diaminonaphtalene as the complexing agent /15/.
The statistical significance between the determined 
parameters was analysed by Student's "t" test. Differences at 
p <0. 05 were considered significant.
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These studies were approved by the Scientific Committee and 
the Ethical Council of the Szeged University, and by the 
Division of Clinical Pharmacology of the Hungarian National 
Pharmaceutical Institute.
RESULTS
The reduced glutathione levels of erythrocytes in control 
and celiac patients are presented in Fig. 1. The results are 
expressed in /jmol/g hemoglobin. GSH content was higher in red 
blood cells of CD patients and of nutritive iron deficiency 
cases, respectively, as compared to the healthy control group. 
Red cell oxidized glutathione (GSSG) also proved to be elevated 
in the nutritive iron deficiency group compared to normal 
controls, while patients with CD showed markedly lower values 
(Fig. 1/B). The erythrocyte GSSG/GSH redox ratio of children 
with CD also decreased significantly compared to the control 
groups during the course of the diet (Fig. 1/C).
In vitro treatment with acety1-phenylhydrazine (APH) caused 
a significant decrease in the glutathione content of 
erythrocytes of CD children on gluten challenge and of patients 
with cow's milk allergy, while during gluten free diet the 
values of CD children did not differ from those of controls 
(Fig. 2). During diet, the rise of erythrocyte glutathione 
stability could be proved in 6 patients with CD and in one case 
of cow's milk allergy (Fig. 3).
Gluten and milk load respectively induced an increase of the 
oxidation dérivâtes of hemoglobin. There was a marked elevation 
in the values of instable methemoglobin and hemichrome in 
blood, while these alterations disappeared during the diet 
(Fig. 4).
Fig, 5 presents the selenium (Se) content of the washed 
erythrocytes of CD patients and of healthy controls. The Se 
level of red blood cells of CD patients on gluten challenge 
was 51% lower than in the control group (228 +_ 158 ng/gHb and 
465 +_ 136 ng/gHb, respectively; p <0.001). During one year 
or more of gluten free diet, blood selenium increased by 15% 
(298 _+ 149 ng/gHb); however it did not reach the full normal
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blood Se level (Fig. 6).
Histological findings of CD patients in acute period and 
after gluten challenge showed subtotal atrophy.
DISCUSSION
Glutathione is the most abundant low molecular weight thiol- 
containing compound in living cells. Its reduced form
contributes to the viability of erythrocytes by stabilizing the 
thiol groups of membrane enzymes and hemoglobin /4/ and by 
acting as a reducing agent for hydroperoxides and free 
radicals, thus protecting the red cells against oxidative 
damage /19/.
Most of hydrogen peroxide is removed by reaction with
reduced glutathione to form oxidized glutathione and water 
catalyzed by the selenium containing enzyme glutathione 
peroxidase (GSH-Px) /25/:
2 GSH + H202 G5H P-X- -> GSSG + 2 H20
Therefore the investigation of the glutathione system is a 
sensitive index of the in vitro oxidative processes /1/.
Iron deficiency in itself may influence erythrocyte 
glutathione metabolism /16/. In nutritive iron deficiency, the 
increased function of glutathione synthetase enzyme is 
responsible for an elevation of the content for the red blood 
cells /22/. This process compensates for the deficient function 
of hemoglobin, as a redox system, present in a lower
concentration than the physiological one. As iron deficiency is 
a usual accompanying symptom of acute CD and cow's milk
allergy, we wanted to ascertain whether the changes of the
erythrocyte glutathione metabolism in CD are a consequence of
iron deficiency exclusively, or whether other factors may also
play a role. Thus a second control group of patients with
nutritive iron deficiency was formed. In our observation, 
erythrocyte GSH content elevated significantly in the CD group 
on gluten challenge and in nutritive iron deficiency, but the 
difference of GSSG values between the two groups emphasizes the
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role of factors other than merely iron deficiency.
Acute oxidant stress induces the decrease of GSH in the red 
blood cell and increases the GSSG level /7/. If, however, the 
oxidant stress is long lasting, the compensation process 
results in the increase of GSH. This phenomenon was observed - 
under laboratory conditions - by administering methylene blue 
to rabbits /20/. The same changes can be seen during human 
submaximal exercise /12/. Elevated blood sulfhydril levels 
provide an accessfully marker of increased oxidant exposure /6/. 
The elevated erythrocyte GSH of CD patients on gluten load can 
be regarded as a consequence of a permanent oxidant stress, as 
well. This explanation was supported also by the fact that 
the glutathione status of the red blood cells normalized during 
the diet.
The impaired defense of erythrocytes against oxidative 
stresses in CD and cow's milk allergy was proved by the in 
vitro acetylphenylhydrazine loading test of blood which showed 
a definitive decrease of erythrocyte GSH level compared to the 
controls. This type of glutathione in vitro instability of red 
blood cells improved during the diet.
During gluten and milk challenge the presence of instable 
methemoglobins and hemichrome is another evidence of decreased 
erythrocyte defensive capacity against oxidative stress. This 
instability of red blood cells against oxidative stress could 
also explain the frequent manifestation of methemoglobinaemia 
found in dermatitis herpetiformis patients treated by Dapson 
and by other medicaments with oxidative effect /2/.
Similar but milder metabolic changes of erythrocytes of 
cow's milk allergy patients suggest that the presence of 
chronic oxidative stress effects is not a unique phenomenon of 
CD: it probably occurs during mucosal destruction.
The definite decresae of erythrocyte GSSG/GSH ratio of CD 
patients on gluten challenge refers to the decreased activity 
of GSH-Px. This enzyme, besides removing hydrogen peroxide in 
v i v o , acts together with superoxide dysmutase (SOD) and 
catalase; but GSH-Px was found to be much more effective 
against oxygen-derived free radicals than catalase and SOD 
/21/. GSH in itself has a low grade reductive capacity. If
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GSH-Px decreases GSH protection is not significant, which 
leads to the destruction of the membranes /11/.
Since GSH-Px destroys H 2 O 2 , low levels of this enzyme may 
permit increased histamine release by mast cells, as well.
There is a synergic effect in the defence against 
peroxidation injury of the cell between vitamin E and GSH-Px 
/24/. In animal experiments tocopherol can only prevent 
haemolysis induced by peroxide, while GSH-Px prevents also the 
oxidation of hemoglobins by peroxides /23/. An accepted
screening method of vitamin E deficiency, the peroxide 
haemolysis test /10/ proved to be negative in acute CD /13/. In 
spite of this, we have to admit that in the results obtained in 
the present study a partial vitamin E deficiency might have 
some role.
The selenium deficiency in the presented patients can be 
regarded as a definite factor in the increased sensitivity of 
the erythrocytes against oxidative stresses in acute CD. The 
same biochemical alteration of erythrocytes were seen in 
children with selenium deficiency in China /29/. Selenium 
deficiency may lead to a decreased activity of GSH-Px and, on 
the other hand, Se also has a direct antioxidant property. Ward 
found reduced Se in serum in treated and untreated patients 
/29/. In our studies the selenium was determined in blood cells 
which is more reliable parameter of the true Se depletion of 
the body, and we obtained a gradual restoration of the Se 
deficiency during gluten free diet, which may indicate that Se 
deficiency can be - at least in part - a consequence of mucosal 
damage in CD.
Future studies would be needed to clear the exact role of 
free radicals in tissue damage. To lessen these pathological 
processes, the therapeutic use of antioxidants and scavangers
i.e. selenium and vitamin E should be a question of 
consideration.
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Ki-1 positive (anaplastic, large cell) lymphoma is a 
subgroup of non-Hodgkin lymphomas identified recently 
by Ki-1 (or BER-H2) (CD 30) monoclonal antibody. The 
clinicopathological features of two such pediatric 
cases of lymph node origin described here, and also the 
available literature emphasize the heterogenous nature 
of Ki-1 positive lymphomas, in almost every respect. 
Nevertheless, the Ki-1 antibody serves as an important 
diagnostic tool to differentiate lymphomas from other 
anaplastic, large malignancies.
INTRODUCTION
Probably, non-Hodgkin lymphomas (NHL) are the best examples 
how latest technologies (e.g. monoclonal antibodies for 
phenotyping, gene-rearrangement studies) can lead to the 
reclassification of malignancies, sometimes, with the 
identification of new subclasses. The value of any such attempt 
depends mainly on its relevance to prognosis. Recently, Ki-1 
monoclonal antibody (CD 30) was reported to be specific to 
neoplastic cells of Hodgkin's disease /41/, but the expression 
of Ki-1 antigen was also observed on a group of NHLs, showing 
reactivity to antibodies Ki-1 or BER-H2 (the latter is a 
paraffin-reactive Ki-1 analogue). Although, these Ki-1 positive 
(anaplastic, large cell) lymphomas are morphologically high 
grade malignancies /22, 28, 29, 43/, their appearance, in every 
respect, seems to be rather heterogenous. Here, we describe two 
pediatric cases and discuss some clinicopathological features 
of this entity.
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CASE REPORTS
Case 1. - V .A. 10 years old boy. Admission was necessary 
due to severe abdominal pain. Physical examination revealed a 
tumor, mainly in the left side of the abdomen. Accordingly, 
ultrasound showed inhomogenous solid area in connection with 
the intestinal tract. Besides, two métastasés of 2 cm 
of diameter appeared in the liver. Laboratory results, chest 
X-ray, bone marrow and liquor were negative. The abdominal mass 
(about 8 cm in diameter) has been removed with a segment of 
jejunum. - Histologically (2505/84), large neoplastic cells 
infiltrated the mesenterial lymph nodes, with only a small 
percentage of normal host cells. The large, oval or irregularly 
shaped nuclei contained one or more prominent nucleoli and were 
surrounded by pale cytoplasm. Mitotic figures, necrotic areas 
were not infrequent, while fibrosis was not obvious. Besides 
HLA-DR (Dako) and LCA (Bio-Genex) positivity, IgM and kappa 
light chain monoclonality suggested diffuse NHL of B-cell 
(possibly centroblastic) origin. Parts of the tumor has been 
xenotransplanted and fully characterized as established line 
/24/. The gene-rearrangement study showed bigenotypic character 
(haplotypes for IgH: R/R, IgL-kappa: R/D, IgL-lambda: G/R) 
/25/, but the tumor cells expressed only IgL-k mRNA 
(unpublished). Retrospectively, the tumor cells were highly 
positive with BER-H2 (Dako) monoclonal antibody (Fig. 2). - 
Patient has been treated as a В-cell lymphoma of stage III /30/ 
according to the protocol of POG (high dose Cyclophosphamide 
plus high-dose Methotrexate with coordinated intrathecal 
prevention - 35). The disease-free period now s u r p a s s e d '6 
y e a r s .
Case 2. - H.A. 8 years old boy. Four years earlier his 
nephrosis syndrome was treated effectively by steroid. 
Recently, he was vaccinated against rubella and two weeks later 
lymphadenomegaly developed in the ipsilateral axillar region. 
Although, the lesion histologically proved to be negative, it 
progressed towards the subclavicular region and within a month 
reached about 8 cm of diameter. Besides, a nut-sized tumor 
appeared in the submandibular area. Laboratory and clinical 
data showed normochrome anemia, increased sedimentation 
(40 mm/hr), a left-shifted granulopoiesis with preserved 
erythro- and thrombopoiesis in the bone marrow. Chest X-ray, 
abdominal ultrasound and bone-scintigraphy were negative. Total 
protein in the serum (83 g/1), as well as IgG fraction 
(15.4 g/1) increased, while IgA and IgM decreased. - Biopsy 
(2284/91) was taken from the axillary region. Normal lymph node 
structure was recognized only in small areas, since the lesion 
was diffusely infiltrated by tumorous tissue. Most of the tumor 
cells had large, rather irregular nucleus, loose chromatin, 
prominent nucleolus, and slightly basophilic cytoplasm. 
Multinuclear giant cells were inconspicuous, while mitotic 
figures were numerous. Host elements appeared as delicate bands 
of connective tissue, with limited extent of fibrosis, 
scattered small group of plasma cells and relatively few,
Ki-1 lymphoma 259
•  *
Fig. 1. Ki-1 positivity in large cell lymphoma (case 2) (x240)
Fig. 2. Ki-1 positivity in large cell lymphoma
(xenotransplanted tumor - HT 117 - from case 1) (x450)
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randomly distributed macrophages and lymphocytes. 
Electronmicroscopy could not find cell-connecting structures. 
Immunohistochemistry showed intensive granular cytoplasmic 
positivity with BER-H2 (Fig. 1), and positive staining with EMA 
(epithelial membrane antigen - Amershayi and pan-T (Dako). Pan- 
B, LCA, vimentin (Amersham), cytokeratin (wide spectrum, Dako) 
and lysozime (Dako) remained negative. IgH gene preserved 
germline configuration, while TCR gene indicated unexpected 
polyclonality. (ONA for gene-rearrangement study was isolated 
from AMeX-fixed, paraffin-embedded biopsy material - 39). 
Therefore, the exact geno- and phenotype is still obscure. - 
The treatment was designed for Ki-1 positive large cell 
lymphoma in stage II according to BFM protocol. 
(Cyclophosphamide and Prednisolone for 5 days followed by three 
cycles of combination chemotherapy - high-dose Ifosfamide and 
Cyclophosphamide, Cytozin arabinoside, Vumon, Adriablastin, 
Methotrexate, Prednisolone or Oradexon, including intrathecal 
prophylaxis with Cytozin arabinoside, Methotrexate and 
Méthylprednisolone). Complications (pancytopenia and 
infections) were successfully resolved. The boy is in disease- 
free remission since 4 months.
DISCUSSION
Ki-1 positive lymphoma represents 1-3% of NHLs /6, 11/, and 
can occur at any age group with peaks in second-third and 
fifth-seventh decades /7, 34/. In different reports the 
frequency of childhood cases ranged between 15 to 20% /7, 44/. 
In one-half of the cases the presenting complaint was 
1ymphadenopathy, in others the involvement of lymph nodes and 
skin appeared together, or extranodal origin (most frequently 
skin only) was observed /1, 7/. Infiltration of bone marrow can 
also be present /7, 8/.
The first impression of a large (anaplastic) cell tumor 
comes from histology. Typically, at the early stage, the 
affected lymph nodes are only partially involved by the 
neoplastic process invading preferentially sinuses and 
paracortical areas, sparing more-or-less the follicles, but in 
other cases, presumably in more advanced stage, diffuse 
infiltrate may afface the nodal architecture. Accompanying 
fibrosis (both interstitial and in bands) could be different. 
In general, the nuclei of tumor cells are indented or 
lobulated, with one or several prominent nucleoli. Eccentric 
lobated nuclei sometimes express a wreathlike configuration.
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The cytoplasm is usually abundant, finely granular, but 
occasionally may resemble "signet-ring cell" lymphoma, 
containing endocytotic vacuoles /1, 27/. Reed-Stenberg-like 
giant cells and mitoses are rather frequent. According to the 
morphological appearance two subtypes can be distinguished 
(relative polymorphy or monomorphy), without obvious 
relationship to immunophénotype /7, 8/.
Before the introduction of Ki-1 antibodies many of these 
cases were recognized as malignant histiocytosis, Hodgkin's 
disease (mainly the nodular sclerotic form), metastatic 
carcinoma, malignant melanoma /1, 44/, regressing atypic 
histiocytosis (nodulo-ulcerative proliferation of atypic 
histiocytes in the skin) /13/ or sinusoidal large cell lymphoma 
/32/. The list clearly indicates the differential diagnostic 
problems of morphologic evaluation, including in samples 
obtained by fine needle biopsy /46/.
If immunohistochemistry reveals Ki-1 positivity, the 
evidence for lymphoma is almost unequivocal. Among non-lymphoid 
tumors Ki-1 positivity was observed only in embryonal 
carcinomas /14/. (Sometimes, due to cross-reaction, diffuse 
cytoplasmic false positive staining may appear in pancreas or 
salivary gland carcinomas using BER-H2). It should be 
emphasized that only cases in which all or nearly all large 
cells express Ki-1 antigen could be regarded as Ki-1 positive 
lymphoma.
Concerning the most important clonal markers, clonal 
rearrangement of TCR- or Ig-genes were present in 70% of cases, 
the remaining showed null-cell genotype. Most of these 
lymphomas have T-cell, less have В-cell phenotype, but either 
both or none of the specific markers could also be expressed 
/10, 16, 19, 44/. Evaluation of other markers can be difficult. 
It is not infrequent, that LCA is negative and EMA is positive. 
Vimentin and S-100 may also show positivity, but cytokeratin, 
lysozime, melanocyte-specific antigen and desmin are always 
negative /10, 14, 16, 45/. Ki-1 positive lymphoma cells may 
express many antigens which are characteristic on histiocytes 
(vimentin, CD 68, alpha-antitrypsin, alpha-l-antichymotrypsin) , 
therefore in such cases gene-rearrangement study is essential
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to rule out true histiocytic origin /2, 3, 5, 6, 10, 17/. The 
distinction between Ki-1 lymphoma and Hodgkin's disease is made 
upon the later's LeuMl (CO 15) positivity /1, 21/. Fixation or 
embedding may denaturate Ki-1 antigen resulting in the failure 
to recognize Ki-1 lymphoma, when only paraffin-embedded 
material is available. Cytogenetic studies found association of 
Ki.-l lymphoma with a chromosomal translocation involving 5q35 
/t(2;5)(p23;q35)/ in most cases /12, 23, 28, 36/ but in 
others either this translocation was not present or different 
one /t(9;14)/ was described /22, 26/.
The clinical aspects of Ki-1 lymphoma are at least as 
heterogenous as the above discussed features. Some studies 
suggest that the prognosis in childhood and in elderly 
patients, respectively, and in adults with skin involvement is 
relatively good /1, 21/. The evaluations in reported cases are 
hampered by the short follow-ups. In one study the median 
survival time was 13 months for 41 patients /7/. Most of them 
received polychemotherapy (usually CHOP), some in combination 
with radiation, or radiation was given only. Young patients 
(age below 40), or those in stage I and II had better 
prognosis. Another group using combination chemotherapy 
achieved complete remission in two, and no remission in one 
child /40/. Similarly, chemotherapy (different in each cases, 
presumably due to the different initial diagnosis) led to 
complete remission in two out of six children (the longest 
survival was 30 months till the end of the observation period) 
/21/. Long survivals (14-25 yrs) were reported in a 
retrospective analysis for three patients (aged 2,28,49) /37/. 
Spontaneous remissions are extremely rare in large cell 
lymphomas /8, 15/. In another retrospective study of 31 
children, a disease-free survival of 74% was found using 
different protocols /18/. At evaluation it is important to 
prove the "de novo" nature of Ki-1 lymphoma, because both 
Hodgkin's disease and T-cell lymhoma with low malignancy can 
transform into Ki-1 lymphoma /45/. In one study the antecendent 
history of different lymphoproliférative diseases was apparent 
in 7 out of 24 patients /34/.
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The review of accumulated experiences suggests that Ki-1 
positive large cell lymphomas are characterized by clinical, 
morphologic, immunopheno- and genotypic heterogeneity. While 
more retro- and prospective studies are necessary to establish 
the clinical relevance and significance of the presence of Ki-1 
antigen on lymphoma cells, at the level of morphology, however, 
the Ki-1 monoclonal antibodies proved their diagnostic value, 
established their place in diagnostic protocols, especially in 
cases of large cell malignancies.
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ADOLESCENT MOTHERS: DO THEY BREAST-FEED LESS?
M. AMADOR, M.P. HERMELO, J.E. CANETTI, E. CONSUEGRA
Institute of Nutrition and Food Hygiene 
and William Soler Paediatric Hospital, 
La Habana , Cuba
Two groups of mothers with infants between sixty and 
eighty-nine days of age, from the same Health Area of 
the city of Havana were studied. The first group's age 
was nineteen years or less and members of the second 
one were twenty to twenty-five years old. The 
sociocultural level of the older group was 
significantly more favourable. The proportion of 
mothers exclusively breast-feeding was lower among the 
teenagers, and the frequency of complete weaning by the 
end of the third month was higher in their group. 
Duration of breast-feeding, either exclusive or 
combined with bottle-feeding was also shorter in the 
group of adolescent mothers, and frequency of diarrheal 
episodes was higher among their infants; body weight 
for age and body weight for length showed a shift 
towards lower percentile channels in these infants. 
Such differences were evident despite of that both 
groups of mothers had the same opportunity to receive 
information about the advantages of breast-feeding and 
there were no differences in the frequency and quality 
of prenatal care.
INTRODUCTION
Pregnancy among teenagers is frequently seen nowadays, 
though rates vary from country to country /5, 6, 16/. This fact 
has public health implications because early motherhood has 
been related to physical and psychosocial risks run by the 
children /29, 34/, a higher risk of death /7, 14,- 32/,
cognitive and behaviour problems /1/ and influence upon other 
developmental aspects /8, 11/ included. In addition, pregnancy 
may affect the nutritional status of the still growing
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adolescent mother who has increased needs for energy and 
protein /4, 18/ to face own and fetal needs for growth.
In several countries, the prevalence and duration of breast­
feeding remains low despite of all efforts made to promote this 
practice /33/, while in many others an increasing trend has 
been observed /13, 28/.
There is some evidence that adolescent mothers are less 
likely to b r e ast- feed/ 3 / , although with active counseling they 
are capable of successful lactation /19/.
The question whether this decline-' of breast-feeding is 
related with an increased incidence of pregnancies at earlier 
ages arises; the aim of the present study is to investigate 
this possibility by comparing infant feeding practices and 
several social, cultural and educational factors in mothers of 
two age groups, one of them being under twenty.
PATIENTS AND METHODS
Two groups of fifty mothers each, with infants between sixty 
and eighty-nine days of age were selected from the same Health 
Area of the city of Havana. The criteria for selection of the 
subjects appear in Table I.
Each mother was interviewed according to a previously 
designed protocol, and each infant was measured for body weight 
and length, according to the International Biological Programme 
/31/. Three anthropometric criteria were used for assessing 
growth and nutritional status: body weight and body length for 
age, and body weight for length. Cuban standards were used as 
reference values /12, 17/. The chi-square test was used for 
group comparison.
RESULTS
Figure 1 shows the distribution of the f a t h e r ’s age 
significant differences exist between the two groups, the 
proportion of teenagers being higher in the first one. The 
paternal schooling level also showed highly significant 
differences (Fig. 2): partners of teenagers have lower
educational levels. The maternal level of schooling, however, 
showed no differences. There were significant differences in
FATUMS Д&£.
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Fig. 1. Distribution of paternal age in the two study groups. 
Note the higher proportion of teenagers in Group 1
Fig. 2. Parental schooling. Fathers associated with teenager 
mothers have lower educational levels
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parental professions between the two groups, paternal and 
maternal alike (Table II). IWhen considering the couple s status, again significant 
differences were found: the proportion of unmarried and
divorced mothers was higher among adolescents (Table III).
Modes of feeding before the actual age of each infant were 
recorded in the same protocol by recall. Immediately after 
birth, there were no differences between the two groups, but 
they became significant at thirty, sixty and eighty-nine days: 
teenagers breast-feed less frequently and wean earlier (Fig. 3).
Causes of weaning differed between the two groups as shown 
in Table IV. It is of interest to observe that the majorIdifferences found correspond to: self decision« infant s
disease and the statement that the infant refused the breast.
No differences regarding prenatal care were observed: the 
mean number of prenatal consultations was 6.54 +_ 1.08 for
teenagers and 6.62 + 0.95 for the older group; the mean
gestational age at the first prenatal consultation was
15.02 + 4.11 and 14 .36 +. 3.67 wee ks, respectively. No
differences regarding first information about advantages of 
breast-feeding or regular information about breastfeeding 
practice or preparation for breast-feeding were found either, as 
can be seen in Table V and VI.
Diarrheal episodes were more frequent among teenagers* 
infants, but there were no differences regarding their number. 
More children from group 1 needed hospitalization because of 
diarrhoea (Fig. 4).
Hygienic and environmental conditions differred 
significantly: deficient and poor conditions were more frequent 
in the teenagers group (Fig. 5).
Differences in the percentile distribution of body weight 
and length for age, and for body weight for length were found. 
A shift towards lower channels is evident in the adolescent 
group (Fig. 6).
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TABLE I
Criteria of selection of the two groups of mothers
Criterion Group 1 Group 2
Mothers' age 19 years 20 to 25 years
Infants' age 60 to 89 days 60 to 89 days
Pregnancy and delivery Normal 
full term
Normal 
full term
Birth weight at least 2500 g at least 2500 g
Parity First delivery 
(only child)
First delivery 
(only child)
TABLE II 
Parents
Profession Fathers Mothers
occupation Group 1 Group 2 Group 1 Group 2
A) Worker 24 11 6 10
B) Student 8 11 9 14
C) Both 17 28 12 18
D) None 1 0 13 8
X2 = 9.60 X 2 = 10.35
p < 0.05 p < 0.05
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TABLE III 
Couple's status
Status Group 1 Group 2
Stable
Single
Divorced
28 (56%) 
16 (32%) 
6 (12%)
37 (74%) 
5 (10%) 
8 (16%)
Total 50 50
X2 = 11.12 
p < 0.005
TABLE IV
Reason for weaning (as referred by the mother)
Cause Group 
n = 26
1 Group 2 
n = 15
Not enough milk 26.9% 26.7%
Infant was unsatisfied 11.5% 26.7%
The infant refused breast 26.9% 13.4%
Doctor ' s prescription 3.9% 20.0%
Self decision 11.5% 0.0
Infant ' s disease 15.4% 6.6%
Mother ' s disease 3.9% 6.6%
X2 = 19.97
p < 0.05
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TABLE V
First information about the advantages of breast-feeding
Group 1 Group 2
Prenatal 45 47 X 2 = 2.03
WHEN ? At delivery 5 3 П  . s .
Never 0 0
Health Center 34 30 X 2 = 3.54
WHERE ? At home 13 14 П  . s .
In hospital 3 6
Obstetrician 5 8 X 2 = 2.94
WHO ? Pediatrician 2 2 n . s .
Nurse 32 27
Relative 11 13
TABLE VI
Regular information about breast-feeding and its
advantages
WHEN ? WHERE? WHO ? Group 1 Group 2
Prenatal consultations 5 8
Home visits 32 34
Radio/ TV Programs 11 23
Written Press 4 7
Mass Organizations talks 7 11
None 0 0
X 2 = 6.82
П  . s .
f a/munví P£fCíA/r)
Fig. 3. Modes of feeding up to the time of study in the two
study groups. The difference becomes significant after 
30 days of age. Teenagers breast-feed less frequently 
and wean earlier
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Fig. 4. Incidence of diarrhoeal episodes: higher in Group 1
278 
M. Amador et al.
Fig. 5. Hygienic and environmental conditions of the two study 
groups. The classification in four categories was based 
upon house conditions, degree of overcrowding, quality 
of water supply^ sanitary services, wastage disposal 
and presence of insects or rodents' ГО—J40
Adolescent mothers
Fig. 6. Percentile distribution of anthropometric measurements: 
a shift towards lower channels is observed in infants 
born to teenagers
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DISCUSSION
The results of this preliminary study show that infants of 
teenager mothers are breast-fed in a lower proportion than those 
of mothers aged 20 to 25 years. In Uruguay, Bauzá, Oiaz- 
Rosselló and Bielawski /3/ studied 239 mothers aged 12-19 years 
who attended Health Centers in Montevideo, and found that by 30 
days of age,45% of the children of teenager mothers and 34.3% of 
those of older mothers were completely weaned, while the 
proportions increased to 79.4 and 67.8 by the end of the third 
month. Mean duration of exclusive breast-feeding in children of 
adolescent mothers was 63.6 days and for those of older mothers
72.7 days. By analysing in an epidemiological approach the 
association between different variables to breast-feeding 
practices, Diaz-Rosselló and Bauzá found a significantIassociation between mother s age and failure to startbr east­
feeding /10/. In Mauritius, the age of the mother was found to 
be positively correlated with the length of lactation: the 
proportion of women still breast-feeding at any age of the child 
increases with increasing maternal age /25/.
The two study groups significantly differred in regard to 
several social, cultural, economical and environmental 
variables possibly influencing feeding practices. Lorenzo et al 
/20/ and Rivara /26/ found that the majority of teenagers’s 
husbands were of similar age but there was a sizeable group who 
were older, older fathers cohabiting with teenager mothers are, 
however, more similar to adolescent fathers than to men of 
their age living with women beyond twenty /24/.
A strong association between attained educational level and
the frequency and duration of breast-feeding has been found /22,л.23, 28/. The absence of a difference regarding the level of
schooling between the two groups could be attributed to the 
fact that girls are more stable in the educational system after 
they have completed the Junior High School (about 15 years of 
age). Similar results were obtained by Bauzá et al /3/. In our 
study, the educational level of mothers seems to have no 
influence on breastfeeding practice.
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The proportion of fathers exclusively doing physical work 
was higher in Group 1 while the proportion of teenager mothers 
who neither studied nor worked was higher. The educational 
level of men living with teenager mothers was significantly 
l o w e r .
A significant proportion of early pregnancies come from 
instable couples. In Britain, four fifths of pregnancies in 
teenagers are conceived out of a wedlock /6/. In Cuba, a study 
carried out in Havana showed that 56:4 % of pregnant teenagers 
were not married, 17.6 % lived alone and 6 % were divorced 
/14/. In this study the proportion of stable couples, whether 
legally married or not, was significantly lower in the 
adolescent group while the number of single mothers living 
apart from the i nf ant’s father, was significantly higher. There 
is evidence that the success of lactation is influenced by the 
c o u p l e ’s stability: when the father has a positive attitude to 
the pregnancy, maternal weight gain and the i nf ant’s birth 
weight are significantly higher /21/; on the contrary, 
illegitimate babies are less likely to breast-feed/ 1 5 / .
Most of the adolescent mothers express positive attitudes 
toward the fetus and the infant /8/, although many of them are 
psychologically immature and their identification with the 
maternal role is not firmly developed; this may influence 
attitudes toward breast-feeding. The difference between the two 
study groups in respect of reasons for weaning were mainly 
found in aspects attributed to the child.
General and specific prenatal care is usually worse among 
teenagers /3, 27/: many of them seek for medical care at 
advanced gestational age or do not regularly attend to prenatal 
clinics. However, in our study no differences were found in 
gestational age at the time of the first visit or in the number of 
visits or in the quantity or quality of the information about 
breast-feeding received before delivery, which reflects the good 
quality and availability of our Mother and Child Health 
P r o g r a m s .
Hygienic and environmental conditions were inferior for 
adolescents and their offspring. The interaction of these 
factors with the social, cultural and educational background
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characteristic of teenager mothers contributed to a higher 
incidence of diarrhoeal episodes. Poor families are less likely 
to breastfeed from birth on /2/? low socio-economic status 
rather than the adolescent m ot her’s young age itself has been 
considered as the major factor responsible for the intellectual 
deficit seen in children of teenagers /11/. This interaction 
results in the shift of body weight for age and body weight for 
length towards lower percentile channels, in this group higher 
rates of low birthweight, infectious and nutritional diseases; 
and infant mortality can be expected /14/.
Teenagers becoming parents seem to constitute a special 
group, not only from the biopsychological point of v i e b u t  
also because of a peculiar social and cultural background 
resulting in a lower frequency and duration of breastfeeding.
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BOOK REVIEW
Atlas of the Pediatric Ultrasound. Edi te d  by Reinhard D. S h u lt z, 
Ulrich V. Willi. Thieme Verlag, 1992. 204 pages, 1532 
illustrations.
This book is a translation of the German edition, 
published in 1990. The authors are well-known pediatric 
radiologists from all over the world (Fawer CL, Forster I, 
Gassner I, Jequier S, Schulz RD, Seitz K, Vergesslich К, Willi 
U V ) .
The atlas is organized on the basis of frequently encountered 
symptoms and typical clinical investigations. The case 
arrangement is not "encyclopedic" and is somewhat arbitrary. It 
is result of situations in which the indication for sonography is 
based not on a defined set of symptoms but on a more complex 
inquiry, of situations that require a differential diagnosis.
Cases that have the same diagnosis but a different morphologic 
presentation are shown side-by-side. The size of the pictures are 
small, but informative.
The atlas has 23 chapters, with a very short introduction 
before every chapter, and sometimes an examination-table of the 
indications of the investigation. The cerebral disease and the 
spinal tract chapters are illustrated not only by ultrasound, but 
by CT and MR pictures as well. In the chapter "Abnormal Thoracic 
Findings" there are only very few pictures about cardiac 
investigations. A separate chapter deals with ultrasound 
diagnosis of abdominal pain. There is a very rich illustration of 
the abdominal masses, it is a great help in the differentation 
between the different morphological pictures of the same 
histological tumors. A separate chapter deals with the ultrasound 
difference in blount abdominal traumas. In the chapter on the 
gastrointestinal disease the ultrasound pictures are completed by 
x-ray and pictures and drawings. The urinary tract diseases 
comprise a major part of the atlas. It is very useful to see 
pictures about the normal kidney in a separate chapter. The 
chapter about the neonatal and infant hip is a great help in
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everyday work.
The structure of the atlas is unusual, but the distribution 
according to symptoms is very useful in practical work. The 
comments on the pictures are detailed.
The well presented book is published by Thieme Medical 
Publishers. It is a great help for colleagues who have a special 
interest in pediatric ultrasound, but for pediatricians, and 
pediatric surgeons as well.
Éva Kis, MD
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Cerebrospinal fluid and plasma sodium, potassium, 
chloride, calcium and glucose concentration were measured 
parallel in 14 pathological newborn babies of gestational 
age and birthweight of 36.3+^4.3 wks and 2410+_890 g, 
respectively, at the age of 37.8+4.4 wks post- 
conceptionally. Whilst potassium, calcium and glucose 
level is much lower in the cerebrospinal fluid than in 
the plasma, similar sodium and higher chloride concentra­
tion was found in the cerebrospinal fluid. The 
significant positive correlation between plasma and 
cerebrospinal fluid glucose and sodium levels proves the 
lack of a functioning barrier for these compounds. On the 
other hand, cerebrospinal potassium level varied within a 
narrow range, independently of the plasma-concentration 
and the maturity of the studied babies. 
Pathophysiological implications of the results are 
further discussed in short.
INTRODUCTION
Cerebrospinal fluid (CSF), apart from its role in mechanical 
protection, serves as a metabolic pool and sink for the central 
nervous system. In spite of the fact that CSF is the third most 
commonly used body fluid for diagnostic evaluation, our present 
knowledge on the development and regulation of its homeostasis is 
still fragmentary. In principle, the composition of CSF depends 
on the plasmaconcentration of the various constituents and also 
the biochemical milieau of the brain. Transport between the 
different compartments is, of course, influenced by the function 
and/or maturity of the blood-CSF, blood-brain and the brain-CSF 
barriers.
It is known that potassium and calcium concentration in the 
brain interstitial fluid and CSF may well affect metabolism and
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electrophysiological activity of the nervous tissue cells and 
synapses /4, 6/. Increased CSF potassium concentration has been 
thought to be a possible causative factor in the pathogenesis of 
cerebral infarcts /4, 9/. Decreased relative CSF glucose level 
characterizes not only purulent meningitis, but can also be 
observed in case of other pathology, like in patients with 
subarachnoideal haemorrhage or posthaemorrhagic hydrocephalus, 
certainly due to disorders of transport mechanisms.
The objective of the present study was to collect more data on 
the regulation of CSF composition in newborn babies of various 
gestational ages, suffering from various perinatal pathology. 
Understandably, normal control values had to be missed.
PATIENTS AND M E T H O D S
Concentration of sodium, potassium, chloride, calcium and 
glucose have been measured simultaneously in plasma and CSF of 14 
newborn infants of 36.3 +_ 4.3 (29-41) weeks gestational age (+J3D) 
and 2410 _+ 890 (1270-3950) grams birthweight. All babies suffered 
from perinatal pathology, which was related to hypoxia-asphyxia 
in 9, major non-neurologic malformation in 3 and septicemia in 2 
cases. The lumbar puncture and blood sampling were parts of the 
diagnostic studies, performed at the postconceptional age of
37.8 +_ 4.4 (30-43) weeks. All CSF samples evaluated were
macroscopically clear. Bacterial meningitis could be excluded by 
culturing and cytology. For biochemistry routine laboratory 
methods were used. All babies in study were fed banked human milk 
or received glucose-saline drip infusion, according to their age 
or need at the time of the investigation.
For statistical analysis standard mathematical methods were 
used .
RESULTS
Results of the study are shown in the Table. It is seen that 
like in adults, in the CSF of the newborn babies a similar 
sodium, a higher chloride and much lower potassium, calcium and 
glucose level could be observed as an average, than that in the 
plasma. Furthermore, it is to be noted that the mean CSF glucose
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TABLE I
Electrolyte and glucose concentration in plasma and cerebrospinal 
fluid measured parallel in 14 pathological newborn infants
mean SD SE range
Sodium (mmol/1)
plasma 137 5.9 1.6 (130-147)
CSF 138 6.3 1. 7 (124-146)
R 1.01 0.04 0.01 (0.39-1.09)
Potassium (mmol/1)
plasma 4.4 0.6 0.1 (3.7 - 5.7)
CSF 3.0 0.3 0.1 (2.7 - 3.7)
R 0.68 0.09 0.03 (0.50- 0.81)
Chloride (mmol/1)
plasma 99 3.7 1.0 ( 91-105)
CSF 116 6.1 1.6 (103-124)
R 1.16 0.06 0.01 (1.04-1.23)
Calcium (mmol/1)
plasma 2.20 0.45 0.12 (1.5 - 3.0)
CSF 1. 52 0.37 0.10 (0.6 - 2.0)
R 0.71 0.20 0.09 (0.28-1.00)
Glucose (mmol/1)
plasma 5.1 1.1 0.3 (3.4 - 7.6)
CSF 2.5 1.2 0.3 (0.9 -4.8)
R 0.46 0.16 0.04 (0.22-0.65)
R = CSF/plasma concentration ratio
level was less than the 50 percent of the plasmaconcentration, 
what is more, in a few patients even much less concentrations 
were detected as shown by the lower range values.
On correlation analysis a significant positive correlationship 
(r=0.7806, p<0.001) was found between plasma and CSF glucose 
level, furthermore plasma and CSF sodium concentration 
(r=0.6627, p<0.01). No such relationship could be observed 
between the levels of any other parameters measured in the two 
bodyfluids. It has also been tested whether the maturity of the 
babies, as expressed by their postconceptional age, is related to 
the CSF/plasma concentration ratio of the electrolytes and 
glucose, but no such relationship was found.
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DISCUSSION
The composition of CSF is similar to an ultrafiltratum, which 
may, however, be modified by the active transport of various 
compounds. In healthy adults, sodium, chloride and magnesium 
concentration of CSF is higher, whilst potassium, calcium, 
phosphate and hydrocarbonate concentration is lower than that in 
the plasma, similarly to the lower organic crystalloid (glucose, 
amino acids) levels in the cerebrospinal fluid. Any changes in 
the composition of CSF may be due to alterations in 
plasmaconcentrations of the various constituents, or may reflect 
metabolic changes in the cerebral extracellular fluid. Both 
possible mechanisms largely depend on the functional maturity or 
damage of the various barriers.
In the present study a close relationship has been found 
between plasma and CSF glucose concentration in the 30-43 
postconceptional weeks old pathological babies, which shows that 
glucose transport is not influenced by the blood-CSF barrier. 
Another point to note is the lack of significant correlation 
between CSF/plasma glucose ratio and the maturity of the babies. 
This means that the lacking barrier function for glucose is 
probably not related to immaturity, at least in this age group. 
The mean glucose concentration in CSF was less than 50 percent of 
that in the plasma, what is more, in a few cases it was only a 
third or fifth of the blood glucose level, measured parallel. 
This observation proves that in pathological newborn infants 
relatively low CSF glucose level (<50 percent of blood glucose) 
not necessarily indicates purulent meningitis. This phenomenon 
may well be caused by transport disorders, as it was suggested by 
others /3, 9/ in case of posthaemorrhagic hydrocephalus or other 
kinds of intracranial pathology.
No difference between plasma and CSF sodium concentration was 
found. The lack of a higher CSF sodium level in comparison to 
plasma level, and also the significant correlationship found by 
us and previously by Stutchfield and Cook /9/ between plasma and 
CSF sodium concentration suggests in this age group at least that 
active transport does not influence CSF sodium concentration, it
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is primarily plasma level dependent. This observation may have 
practical importance in case of iatrogenic and any other kinds of 
hypernatraemias, considering suggested links between rised CSF 
sodium concentration and different types of cerebral 
haemorrhages.
Both CSF chloride concentration and CSF/plasma chloride 
concentration ratio were closely similar in the study babies to 
normal adult values. Increased CSF chloride level indicates a 
functioning active chloride transport mechanism, which must be 
fully matured at the range of postconceptional age of the babies 
studied by us.
It is well known that in the central nervous system 
extracellular potassium and calcium are important factors in 
neuron excitability and synaptic transmission. Disorders in their 
homeostasis result in pathological electric activity, cellular 
damage and abnormal clinical symptoms /5, 7/. Edvinson et al./4/ 
hypothesise that increased CSF potassium concentration causes 
persistent vasoconstriction of the piai arteliolae and small 
arteries, which is a pathogenic factor in the development of 
cerebral infarcts. In the adult, potassium concentration of brain 
interstitial fluid and CSF is well regulated and completely 
independent of the plasma concentration, due to an efficient 
blood-CSF and blood-brain potassium barrier /1, В/. The results 
of the present study prove that the CSF potassium regulation in 
the human newborn is already mature. Potassium level of the CSF 
was found to be not related to plasma potassium concentration and 
varied between narrower ranges than plasma potassium level. It is 
to be emphasized, however, that all study babies were 
normopotassemic, on the one hand, and we did not investigated the 
effect of acidosis on CSF potassium concentration, on the other 
h a n d .
Results of animal experiments showed a gradually decreasing 
calcium concentration in CSF and brain extracellular fluid, from 
the foetal to adult age /7/. In the foetus CSF passively reflects 
plasma calcium concentration, the function of blood-CSF barrier 
for calcium develops only later, with advancing maturation. In 
the adult CSF calcium level is normally half of the 
plasmaconcentration /8/. In the newborn infants we studied a
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relatively higher CSF concentration could be observed, as shown 
by the mean CSF/plasma concentration ratio of 0.71. At the same 
time, however, no statistically significant correlation could be 
found between CSF and plasma calcium levels, which means that the 
transport is limited by a functioning barrier.
The evaluation of the results of our study needs special care 
since the studied group of patients has not been homogeneous in 
reS'pect of gestational age or pathology. The reason of this is 
the principle that examination of CSF is rarely necessary on 
clinical ground even in seriously ill newborn infants. Another 
difficulty in the interpretation is the lack of normal control 
values. Nevertheless, the variable postconceptional age of the 
studied babies has provided a possibility to evaluate the 
findings in relation to functional maturity. In general, of 
course, the possible effect of pathology on the various 
parameters studied could not be excluded. But again, this would 
mean that our observations reflecting active regulatory functions 
are valid in the case of pathology, as well.
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Prolactin (PRL) has been detected in the cerebrospinal 
fluid (CSF) in humans and the absolute level appears to 
reflect the serum PRL concentration. Because PRL is 
thought to be involved in the regulation of brain water 
and electrolyte content attempt has been made to 
determine CSF and plasma PRL and dopamine (DA) 
concentrations, osmolality, and sodium level in 21 
newborn infants undergoing lumbar punction because of 
apneic spells, fever, or perinatal asphyxia. The mean of 
gestational age was 36.5 weeks (range: 31-41) and birth- 
weight was 2572 g (range: 1140-3550). The lumbar puncture 
was performed at the 8.3 postnatal day (range: 1-38). The 
plasma concentration of PRL was 106.52 +_ 14.43 ng/ml, 
significantly higher than the CSF PRL level (43.24 +_ 7.39 
ng/ml, p < 0.01). This elevated level was observed in all 
individual cases. DA concentration in the plasma was much 
higher than the value detected in the CSF (64.75 +_ 13.83 
vs 8.64 +_ 0.72 ng/ml, p < 0.01). No difference was observ­
ed between the sodium content of the CSF and plasma 
(138.94 +_ 1.28 vs 138.04 +_ 1.03 mmol/1), however, the 
osmolality of the plasma tended to be higher than the CSF 
osmolality (286.7 _+ 3.81 vs 276.76 +_ 2.19 mosm/kg, p < 
0.05). In the CSF osmolality, PRL, DA, and sodium 
concentrations did not show any correlation.
In conclusion: in the CSF PRL probably does not play a 
primary role in controlling the osmolality and sodium 
content. PRL in CSF seems to be independent from CSF DA 
concentration.
INTRODOCTION
Prolactin (PRL) together with 
been repeatedly detected in the
other pituitary hormones has 
cerebrospinal fluid (CSF) in
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humans /3, 19/ and several other mammalian species /6, 10, 16, 
18, 23 25/. The absolute CSF PRL level appears to reflect the 
serum concentration regardless of the cause of elevation in the 
serum PRL /5, 19/. Conditions of natural hyperprolactinemia, such 
as pregnancy and neonatal life, are accompanied by an increase in 
CSF PRL /3/. PRL does not cross the blood-brain barrier /29/ but 
enters the CSF by a specific PRL receptor-mediated transport 
mechanism /30/. The likely site of the transport mechanism is the 
choroid plexus /21, 30/. PRL receptors exist on the epithelial 
cells of this tissue /20, 30/, which interfaces between blood and 
CSF. Since binding to the choroid plexus decreases with age the 
effect of PRL on the choroid plexus function may be more 
important during the perinatal than later stages of development 
/20/. PRL may exert a physiological effect directly on the 
choroid plexus, which is the principal site of CSF production. 
The possibility that PRL has a significant role in the water and 
electrolyte balance of the brain of premature animals has been 
suggested by Coulter /7/. To investigate the role of PRL in the 
regulation of liquor composition, in the present study we decided 
to examine the PRL concentrations in the CSF and plasma during 
the neonatal period. The sodium concentrations together with the 
osmolality and dopamine (DA) levels of the plasma and CSF were 
also measured.
M AT ERIAL AND M E T H O D S
Twenty-one newborn infants were enrolled in the study. The 
mean of the gestational age was 36.5 weeks (range: 31-40) and the 
birthweight was 2572 g (range: 1140-3550). As a part of clinical 
examination spinal tap and CSF evaluation was indicated because 
of apneic spells, fever, perinatal asphyxia or intracranial 
haemorrhage. In the case of positive bacterial cultures, or blood 
in the CSF, the patients were excluded from the study. The 
clinical data are shown in Table I.
Plasma and liquor Na concentrations were measured by 
f1 amephotometry, the osmolality was detected by Knauer osmometer. 
The concentrations of PRL were determined by RIA method /4/. The 
plasma and CSF DA levels were measured by the method of Hahn 
/15/. Statistical analysis was performed using Student's t-test. 
The results are expressed as a mean +_ SEM.
M A G Y A RT U D O M Á N Y O S  A K A D É M I A
KÖNYVTÁRA
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TABLE I
Clinical data of the enrolled patients
Gestational age 36.5
(weeks ) (31-41)
Birth weight 2572
(g) (1140-3550)
Apgar score 8.1
1 minute (1- 9)
Time of lumbar puncture 8.3
(days) (1-38)
N 21
RESULTS
The plasma concentration of PRL was 106.52 _+ 14.43 ng/ml, 
significantly higher than the CSF PRL level (43.14 +_ 7.39 ng/ml, 
p < 0.01). This elevated level was observed in all individual 
cases (Fig. 1). DA concentration in the plasma was much higher 
than the value detected in the CSF (64.75 +_ 13.83 vs 8.64 +_ 0.72 
ng/ml, p < 0.01). No difference was observed between the sodium 
levels of the CSF and plasma (138.94 +_ 1.26 vs 138.04 _+ 1.03 
mmol/1), however, the osmolality of the plasma tended to be 
higher than the CSF osmolality (286.7 +_ 3.81 vs 276.76 _+ 2.19 
mosm/kg, p < 0.05). Results are listed in Table II.
DISCUSSION
The present study - in agreement with previous data (3,19) - 
provided further evidence that PRL is present in the CSF, however, 
in the plasma the concentration is significantly higher during
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Fig. 1. The individual plasma and CSF PRL values
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TABLE II
Plasma and liquor PRL, DA, Na concentrations and osmolality 
(mean +_ SEM). * p<0.01, 0  p<0.05
Plasma Liquor
PRL concentration 
(ng/ml )
106.52^14.43 * 
n = 16
46.65^7.39 
n = 21
*
DA concentration 
(ng/ml)
64.75+13.83 
n = 8
8.64^0.72 
n = 21
*
Na concentration 
(mmol/1)
138.04^1.03 
n = 13
138.94+1.26 
n = 18
Osmolality 
(mosm/kg)
286.70^3.81 
n = 8
276.76^2.19 
n = 21
0
the neonatal period. We found no correlation between PRL and DA 
concentrations of CSF. Exogenous DA exerts an inhibitory effect 
on the secretion of PRL even in sick preterm neonates /26/ and 
results in a significant elevation of CSF DA concentration /27/. 
The latter observation suggests that DA crosses the blood-brain 
barrier in the neonate.
Although PRL does not cross the blood-brain barrier /29/, it 
could be detected in the CSF. The accessibility of PRL to CSF is 
unique among polypeptide hormones. In comparison G H , LH, ACTH, 
and PTH, do not significantly accumulate in the CSF reflecting an 
increased hormone level in the blood /1, 6 , 10/. Walsh et al. 
demonstrated that PRL is transported from the circulation to CSF 
by a specific PRL receptor mediated process /30/. In the rat, 
hyperprolactinaemia results in an elevation in the concentration 
of CSF PRL /5, 19/, suggesting that CSF PRL is of pituitary 
origin. However, a recent report demonstrated that 
hypophysectomy, which suppressed concentration of PRL in the 
plasma, did not alter its baseline or cycling pattern of CSF / 8 /. 
CSF PRL may be derived from two sources:
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1. from the transport of PRL from the vasculature to C S F ,
2 . from prolactin-containing cells localized in the central 
nervous system.
Estradiol replacement to the hypophysectomized female rat 
normalized the CSF PRL suggesting that CSF PRL is regulated by an 
estrogen dependent mechanism at an extrapituitary site and that 
hypothalamic immunoreactive-PRL may be one source of CSF PRL / 8 /. 
The role of PRL in the CSF is far from clear. However, PRL has 
been suggested to regulate its own secretion by the anterior 
pituitary via short negative-feedback loop acting on the 
dopaminergic nerve terminals in the median eminence /2, 14, 24/.
During the neonatal period the PRL serves as a regulator of 
water and electrolyte homeostasis /11, 12/. Moreover, Coulter and 
Lorenzo et al. suggested that PRL regulates the water and 
electrolyte balance of the brain /7, 20/. One site of its action 
could be the choroid plexus which contains PRL receptors and is 
responsible for the CSF secretion /20, 30/. Besides PRL, other 
hormones like vasopressin and atrial natriuretic peptide (ANP) 
are involved in this process /9, 13/. Acute alteration of serum 
osmolality has an effect on both CSF formation rate and brain 
water content /17/. Recently Tulassay et al. demonstrated that 
ANP content of CSF correlated with CSF pressure but not with 
sodium concentration or osmolality /28/. In patients suffering 
from empty sella syndrome the impairment of CSF dynamics was 
found. A correlation between elevated intracranial pressure and 
hypothalamo-hypophyseal control of PRL secretion may exist in 
these patients / 2 2 /.
In conclusion: liquor PRL was found to be lower than 
plasma PRL. We could not demonstrate a correlation between the 
osmolality and PRL or DA concentrations in the CSF, however, the 
intracranial pressure was not measured. On the basis of these 
observations DA probably primarily does not control the PRL 
content of CSF. Further studies are needed to elucidate the 
possible role of CSF PRL in the regulation of CSF formation and 
in the control of water and electrolyte balance of brain during 
early human development.
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Authors analysed in an infant with primary 
intestinal lymphangiectasia the number of 
intraepithelial lymphocytes and the distribution of T 
lymphocyte subpopulations in the jejunal mucosa with 
immunohistochemical methods. It was established that 
the number of intraepithelial lymphocytes and of the 
cells belonging to the various T lymphocytes markedly 
decreased in the patient compared to controls, however 
the decrease of the CD4 cells was less than that of CD 8 
cells, thus the CD4/CD8 ratio increased. Authors 
conclude that the increase of CD/4/CD8 ratio in the 
jejunal mucosa may explain the absence of frequent gut 
infections in intestinal lymphangiectasia.
I NTRODUCTION
Intestinal lymphangiectasia (IL) is a rare disorder 
characterized by dilated lymphatics within the small intestinal 
mucosa, which can easily rupture and in consequence a protein- 
losing enteropathy occurs /1, 2/. This abnormality may be
primary or secondary to conditions such as tuberculosis, 
tumour, or retroperitoneal fibrosis /3, 4/.
In Hungary some case reports on this disease have also been 
published /5, 6 , 7/. Kósnai et al. through the presentation of 
their cases gave a very thoroughful summary of the diagnosis 
and therapy of IL /5/.
IL is sometimes associated with an immune deficiency state 
with abnormalities in both humoral and cellular immune system
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/ 8 , 9/ due to loss of immunoglobulins /10, 11/ and T cells /12/ 
into the intestinal lumen. Despite the primary abnormality of 
the gut as the cause of the immunodeficiency in IL, there is no 
increased susceptibility of gut infections / 8 /. This 
observation suggests that the local gut immunity is not 
impaired in this condition.
Earlier only surprisingly little attention has been paid to 
the local gut immunity in IL. Immunohistological analysis of 
the small intestinal mucosa in IL was reported only by Myszor 
et al. / 1 0 / who observed a decreased number of intraepithelial 
lymphocytes (IEL), but found the number of immunoglobulin 
containing cells in the lamina propria to be normal.
Until now the distribution of lymphocyte subpopulations was 
not analysed in this disease. In the present work we counted 
the number of IEL and the distribution of lymphocyte subsets in 
the small intestinal mucosa of our patient with IEL and the 
results were compared to those found in healthy controls.
P A T I E N T  AND METHODS
Case report
The six months old male infant was admitted to our 
department in 1991. From his family history it is remarkable 
that his brother was born with diaphragmatic hernia and despite 
the surgical correction he died at age of 13 days. The 
pregnancy was undisturbed with our patient, he was born with 
Caesarian section on term because of imminent foetal asphyxia 
with a birthweight of 3870 gram. He was exclusively breastfed 
until four months. Since that time he has got also cow's milk. 
Until his admission, gliadin-containing food was not 
administered. His development was quite normal, and he did not 
have any other disease. Two weeks before his admission he 
developed watery diarrhoea and then swelling of his eyelids and 
lower limbs was noticed.
Physical examination revealed oedema of his feet and 
eyelids. Organomegaly was not noted. Laboratory investigation 
revealed a very low serum total protein (31 g/1). Serum 
electrophoresis: albumin: 0.46, alpha^-globulin : 0 .1 , alphao- 
globulin: 0.19, beta-globulin: 0.17, gamma-globulin: 0.08. 
Immunoelectrophoresis: IgG: 1.2 g/1, IgA: 0.26 g/1, IgM: 0.46 
g/1. From his other laboratory findings: serum Ca: 1.98 mmol/1, 
serum P: 1.9 mmol/1, alkaline phosphatase: 45 U/l haematologi-
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cal status was normal, absolute lymphocyte count: 1840. 
Erythrocyte sedimentation rate was normal, proteinuria was not 
observed.
Abdominal ultrasonography revealed a small quantity of 
ascites, but otherwise showed a quite normal situation. The 
clinical and laboratory observations suggested the probability 
of a protein-losing enteropathy. A small intestinal biopsy was 
done at the ligamentum Treitz with a two ports Crosby capsule. 
The mucosal biopsy specimen revealed fenestration of the normal 
architecture of jejunal villi by large dilated lacteals (Fig. 
1), thus the pathological diagnosis of IL was established. As 
the secondary origin of lymphangiectasia was excluded, the 
diagnosis was primary IL.
Fig. 1. Jejunal mucosal biopsy specimen (haematoxy1 in-eosin, 
magnification x67). The normal architecture of jejunal 
villi is partially distorted by dilated lacteals
Rapid clinical improvement was observed beside feeding with 
formula containing exclusively medium-chain triglicerides 
(Humana MCT), oedema and diarrhoea were rapidly ceased. One 
year after onset of disease his total serum protein became 60 
g/l.
Methods
One of the two biopsy specimens was used for routine 
histology and the other one for immunohistochemical study. 
Serial frozen sections were cut at 5 micrometers from each 
tissue block, as it was published earlier /13/. Monoclonal 
antibodies and a sensitive immunoperoxidase method was used to 
determine the numbers of T lymphocyte subsets in the jejunal 
biopsy specimens /14/. A panel of commercially available mouse 
monoclonal antibodies was used. C03 positive T cells were
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determined by Leu 4 (Becton Dickinson, Mountain View, Ca, USA) 
monoclonal antibody. CD4 and CD 8 surface antigens were 
identified by T4 (Coulter Immunology, Hialeah, FI, USA) and OKT 
8  (Ortho Diagnostic Systems, Raritan, N. 3., USA) respectively. 
TCR delta 1 (T cells Sciences Inc., Cambridge, MA, USA) 
recognizing constant region of delta chain of T cell receptor 
(ICR) was used to identify all gamma/delta ICR positive I 
cells. Alpha/beta ICR positive 1 cells were detected by 
monoclonal antibody F 1 (I cell Sciences Inc.).
Ihe slides were evaluated using a Leitz-Ortholux light 
microscope. Ihe numbers of cells in the jejunal mucosa were 
counted at X900 magnification using a 0.045x0.045 mm graticule 
placed in the eyepiece of microscope. Ihe cell densities were 
expressed as cell per mm in the surface and crypt epithelium 
and as cell per mm^ in the lamina propria /15/. Ihe number of 
IEL was counted in the haematoxylin-eosin specimens which were 
done for routine histology. We compared the cell densities of 
our patients to those of our earlier reported controls /13, 
14/. Ihe control group consisted of 13 children with mean age 
of 8.2 years (range: 0.65 to 15.2) who were studied for growth 
retardation. Ihey had neither symptoms nor findings of 
gastrointestinal disease. Ihe jejunal mucosa was normal in each 
of them.
RESULÏS
Ihe number of IEL was very low in the patient, it was only 
about one tenth of the lowest value found in the controls 
(Table I).
The peroxidase-labelled cells were easily identified in the 
immunohistochemically stained slides. The distribution of 
lymphocyte subpopulations and the CD4/CD8 ratios in the surface 
epithelium and the Lieberkühn crypts are summarized in Table I. 
It is statable that in the surface epithelium the numbers 
of all different lymphocyte subsets with the exception of 
gamma/delta TCR positive T cells were lower than the lowest 
values found in the controls. In the patient the number of CD4 
positive cells was less decreased than that of CD 8 cells, thus 
the CD4/CD8 ratio was higher than that in any controls. In the 
crypts of patient the numbers of cells belonging to the 
different lymphocyte subpopulations were lower than the mean of 
those in the controls with the exception of CD4 positive cells. 
Consequently the CD4/CD8 ratio became elevated compared to the 
mean of controls.
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In the lamina propria of the patient the density of each 
lymphocyte subset was lower than the lowest value of that in 
the controls, and so the CD4/CD8 ratio was higher than the 
highest value of that observed in the controls (Table II).
TABLE I
The numbers of IEL and of cells belonging to different T 
lymphocyte subpopulations, as well as the C04/CD8 ratios in the 
intraepithelial spaces of jejunal mucosa of our patient and of
controls
Patient
mean
Controls 
+ SEM
( n = 13 )
range
Surface epithelium 
(cells/mm)
IEL 1. 5 30.0 + 3.3 16.5 - 56.2
CD3 1.4 29.9 + 3.6 15.4 - 54.0
CD4 0.4 1.5 + 0.4 0 . 6  - 3.6
CD 8 1 . 0 26.3 + 0 . 0 2 1 1 .6 - 5 4 . 6
alpha/beta TCR 0.9 19.9 + 4.1 15.8 - 58.2
gamma/delta TCR 0.3 3.5 + 1 . 2 0 . 0  - 6 . 2
CD4/CD8 ratio 0.45 0.066 + 0.019 0 .0 1 - 0 . 2 1
Crypt epithelium
CD3 2 . 2 7.1 + 1 . 1 2.4 - 1 2 .5
CD4 0 . 6 0.4 + 0 .1 0 . 0  - 1.5
CD 8 2 . 1 6.9 + 1 . 0 1.4 - 1 1 . 6
alpha/beta TCR 2 . 1 6 . 8 + 0 . 6 2 . 1  - 13 .1
gamma/delta TCR 0.3 2 . 1 + 1 .1 0 . 0  - 3.6
CD4/CD8 0.26 0.052 4- 0.024 0 .0 1 - 0.28
The sum of the alpha/beta and gamma/delta positive T cells 
was nearly similar to the number of CD3 positive cells in the 
intraepithelial spaces and in the lamina propria of both the 
patient and controls. The sum of the CD4 and CD 8 cells was 
similar to the number of CD3 cells in the intraepithelial 
spaces of the patient and of controls.
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TABLE II
The numbers of cells belonging to different T lymphocyte 
subpopulations and the CD4/CD8 ratio in the lamina propria of 
jejunal mucosa of our patient and controls (cells/mm^)
Patient Controls (n=13)
mean + SEM range
CD3 440 1970 + 189 889 - 2709
CD4 405 1502 + 160 837 - 2394
CD 8 131 919 104 219 - 1646
alpha/beta TCR 414 1770 + 176 920 - 2802
gamma/delta TCR 39 96 + 2 2 56 - 1 2 2
CD4/CD8 ratio 3.1 1.69 + 0 . 2 2 1 . 0  - 1 . 9
DISCUSSION
The systemic immunodeficiency in IL is due to low 
circulating T cell numbers and hypogammaglobulinaemia 
consequent on loss of lymphocytes and immunoglobulins into the 
intestinal lumen. The consequences include decreased cell 
mediated and humoral immunity / 8 , 9/. In patients with IL, 
however, there is no propensity to gut infection such as the 
chronical bacterial infections and giardiasis seen in patients 
with immunodeficiency states /10/. Our case also confirms this 
observation, namely in our patient despite marked 
hypogammaglobulinaemia no gastrointestinal infection was 
observed. These findings suggest that the local immune system 
of gut works satisfactorily in this disorder.
We confirmed the earlier report /10/ that the number of IEL is 
strongly decreased in IL. The absence of frequent infection 
despite reduction of IEL can be explained by the fact that the 
lymphocytes in the intraepithelial spaces are mainly suppressor
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type /16/ and are not playing a significant role in combating 
infection. The increase of CD4/CD8 ratio als helps the defence 
against gut infection.
Although in the lamina propria we observed a very marked 
decrease in all types of lymphocyte subsets, the elevation of 
CD4/CÜ8 ratio in concequence of the less decrease of CD4 than 
CD 8 cells, could explain that less CD4 positive cells can 
insure a suitable immune defence. With the elevation of CD4/CD8 
ratio in IL might be explained by the nearly normal density of 
immunoglobulin containing cells in the lamina propria of 
patients with IL, which was reported earlier /10/. A critical 
step controlling extravasation of lymphoid cells in the small 
intestinal mucosa is the binding of lymphocytes to vascular 
endothelium at sites of lymphocyte exit from the blood. Several 
adhesion molecules, both on the lymphocyte and endothelial cell 
surfaces, are required for this interaction /17/. In 
pathological state, expression of these molecules may change. 
It can be supposed that in IL the number of those endothelial 
determinants increase for which the CD4 T cells have receptors, 
and therefore the extravasation of these cells to the mucosa 
may increase, partly compensating the loss of them to the 
intestinal lumen.
The decrease of alfa/beta and gamma/delta TCR positive cells 
are nearly similar in IL which does not suggest a special role 
for gamma/delta positive cells in this disorder contrary to the 
observations in coeliac disease /14/.
On the basis of the immunohistological analysis of the 
jejunal mucosa of our patient, it can be concluded that the 
increase of CD4/CD8 ratio in both the lamina propria and 
intraepithelial spaces may explain the absence of frequent gut 
infections in IL despite the significant decrease of 
lymphocytes.
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Thirty-one 3 to 14 years old offspring of parents 
who had an acute myocardial infarction before age of 45 
and 42 healthy children without any family history of 
cardiovascular disease were investigated. A significant 
increase in plasma free serotonin concentration was 
seen in endangered children. From these results it may 
be supposed that vascular endothelium is dysfunctional 
in offspring of parents suffering from premature 
coronary arterial disease.
INTRODUCTION
Several recent studies show that the interactions of 
platelets with the vessel wall are obviously relevant both in 
the pathogenesis and in the clinical manifestation of 
atherosclerosis. Endothelial cells due to their critical 
anatomical position between the circulating blood and the media 
of the vascular wall, play an important regulatory role. 
Platelets remain inactivated in healthy blood vessels and do 
not adhere or aggregate. Aggregation of platelets leads to the 
release of their contents. Important among these substances is 
serotonin.
The present study was undertaken to determine whether the 
plasma free serotonin concentration altered in children whose 
parents had an unquestionable acute myocardial infarction 
before the age of 45.
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MATERIALS AND METHODS
Thirty-one 3 to 14 years old offspring, 16 girls and 15 
boys, of parents suffering from premature coronary arterial 
disease were involved in the study. In addition 42 healthy 
children of the same age, 26 girls and 16 boys, hospitalized 
because of various complaints for observation to the pediatric 
department, without any family history of cardiovascular 
diseases, as controls, were investigated. Blood samples were 
collected by venepuncture after fasting overnight at 7-8 a.m. 
after 15 minutes quiet bed-rest. None of the children were 
taking any medication before start of the study. Children 
affected by metabolic diseases, epilepsy, mental or motor 
retardation of any origin, were excluded. Plasma free serotonin 
determination was performed according to Shellenberger and 
Gordon's method /12/. Platelet count was studied by Medicor PS- 
5 analyser. All values are expressed as mean +_ SEM. Statistical 
significance between group means was assessed by Student's t- 
test.
RESULTS
The groups were not divided into subgroups because there was 
no statistically significant difference between the serotonin 
level in children whose both parents or one parent and 
grandparents had premature coronary arterial disease and in 
children whose one parents had an early acute myocardial 
infarction. As shown in Table I, a significant increase in 
levels of plasma free serotonin was seen in offspring of 
parents suffering from early coronary arterial disease compared 
to controls. There was no difference with respect to platelet 
count (Table II). No gender difference was seen in the examined 
p a r a met ers.
DISCUSSION
It is generally recognized that serotonin has complex 
actions on the cardiovascular system /2, 13, 14, 15/. It is 
accumulated in platelets by both active transport and passive 
diffusion from circulating plasma and stored in dense granules
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TABLE I
Plasma free serotonin levels in children (/jg/dl)
Control Endangered
Girls Boys Girls Boys
П 26 16 16 15
X 6 . 6 6.9 1 0 .1 xx 9 .5х
SEM 0.5 0.5 0.9 1 . 1
X = 
X X  =
p < 0.05
p < 0 . 0 1  compared to control
TABLE II
Platelet count in cildren (G/l)
Control Endangered
Girls Boys Girls Boys
П 26 16 16 15
X 258.7 265.0 219.6 2 2 2 .9
SEM 14.1 2 1  . 1 16.5 1 1 . 0
within the platelets. Serotonin is taken up by platelets, where 
it is stored, and by vascular endothelial cells, where it is 
inactivated enzymatically. An elevated serotonin concentration 
will be present if uptake mechanism are inhibited, and the 
turnover of platelets is accelerated or when the vascular 
endothelium becomes dysfunctional or damaged. We have shown a 
statistically significant increase in plasma free serotonin 
concentration in children with risk of cardiovascular disease. 
From this result it must be supposed that there is an 
endothelial dysfunction in children of parents suffering from 
premature coronary arterial disease. Endothelium appears to 
have a critical role in modulation of vascular responses to 
vasoactive substances that are released from aggregating
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platelets /1,8/. Platelets do not adhere to healthy, intact 
endothelium, however, the injured endothelium activities 
circulating platelets to adhere sub-endothelial structures of 
damaged vessel /1, 3, 6 , 7/. It has already been suggested that 
endothelium is dysfunctional in early atherosclerosis /5/. The 
platelet-aggregation leads to the release and local 
accumulation of serotonin that promotes further platelet 
aggregation, coronary artery vasoconstriction and reduction in 
coronary blood flow /2/. Atherosclerosis appears to increase 
responsiveness to s e r otoninergic vasoconstrictor responses, 
probably in part by producing a functional defect in 
endothelium /3, 5, 6 /. Many factors can damage the endothelium 
and contribute to the pathogenesis of atherosclerosis. Among 
them, oxygen-free radicals considered to be the most active 
/4/. It seems that both exogenous and endogenous oxygen-free 
radicals react with the endothelial membrane and damage the 
endothelium, as shown by an increase in malondialdehyde. Raised 
concentration of lipid peroxides, induced by free radical 
formation, have been found also in children of parents 
suffering from early acute myocardial infarction / 1 1 /.
From this study and by reason of our previous examinations 
/9,11/, we concluded that in children with high-risk of 
cardiovacular diseases, there is an endothelial dysfunction, 
which is equivalent to the early and critical stage of the 
atherosclerotic process.
Repeated injury of vessel-wall, caused by oxidation 
products of dietary lipids, smoking, diabetes, hypertension, 
stress, and materials originating from platelets, lead to the 
development of lipid-rich atherosclerotic lesions / 1 0 /. 
Therefore, it would be necessary to emphasize the importance of 
eliminating environmental influences and change life-style, as 
early as possible, in exposed families. If child has a parent, 
who had an acute myocardial infarction before the age of 45, 
all other risk factors should be altered.
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Insulin resistance was investigated in three obese 
boys with acanthosis nigricans and their results were 
compared to those obtained in non-acanthotic obese 
patients. Blood glucose immune reactive serum insulin 
and C-peptide during oral glucose tolerance test and 
1 Z 5 I-insulin binding investigated. Obese patients with 
acanthosis nigricans were more insulin resistant than 
simple obese controls. Insulin binding studies 
performed in two acanthotic patients suggested that one 
of them had insulin resistance type A, and the second 
patient had insulin resistance type B. According to the 
results acanthosis nigricans can serve as a marker for 
severe insulin resistance in obesity.
I NT RO DU CT IO N
Acanthosis nigricans (AN) is a dermatosis with unknown 
etiology characterized by a velvety, smooth thickening of the 
skin, accentuated skin markings and varying degrees of 
hypertrophy of the epidermis. Histologic findings are 
hyperkeratosis, papillomatosis and hyperpigmentation /10, 15/.
AN can occur at any age both in males and females but its 
exact incidence is unknown. The appearance of this dermatosis 
is a various omen in adults, in many of whom internal 
malignancy develops. However, malignancy associated with AN has 
not been reported in children /10, 11/. Some patients with AN 
in childhood and adolescence have been described as lean, 
whereas others were obese /16/. Children with AN often have 
different congenital syndromes and endocrinological 
abnormalities /10, 11/. AN may be associated with insulin
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resistance caused by a decreased number of insulin receptors, 
antireceptor antibodies and postreceptor defects /1, 5, 9/.
Recently three boys with obesity and AN were admitted to 
our department. Since the insulin resistance is also a common 
feature in childhood obesity / 8 , 13/, present work was 
performed to evaluate the insulin resistance of these obese 
acanthotic boys and to compare their results to those obtained 
from weight and age matched non-acanthotic obese boys.
P A T I E N T S  AND METHO DS
The clinical data from acanthotic obese patients (A01, A02, 
A03) are presented in Table I. They are 6 , 11 and 13 years old. 
The bone age was equal to chronological age in one of our 
patients, and it was accelerated in the two other cases. The 
degree of overweight was considerable in all of them. They had 
been obese for 2-4 years. The signs of puberty were presented 
in two of our cases. At the time of the study acanthotic skin 
lesions were observed in areas of neck and axillae and, in one 
of our patients, they could be seen in antecubital and inner 
thigh areas, too. The patients and their parents could not 
determine the exact time of the acanthotic lesions. Family 
occurrence of AN was not mentioned. The simple obese control 
group consisted of 7 children with obesity ranging in age from 
7-13 years with weight ranging between 160-190% of ideal body 
weight.
An oral glucose tolerance test (OGTT) with a 50 g/mz glucose 
load was performed after an overnight fast. Blood was sampled 
at 0, 30, 60, 90, 120 and 180 m after the glucose ingestion
and plasma glucose was determined by the glucose oxidase 
technique. Serum immune reactive insulin (IRI) and C-peptide 
were measured by commercial radioimmunoassay (RIA) methods 
(IR I : Izinta, Hungary, C-peptide: Serono). The study of 
insulin binding to red blood cells was performed by a 
modification of the method of Gambhir et al. /4/; non-specific 
binding was determined at 1 0  ^ ng/ml of insulin and subtracted 
from total binding. The presence of insulin receptor antibodies 
in sera of acanthotic patients was evaluated by determining if 
patient-serum could decrease the insulin binding to red blood 
cells obtained from normal persons.
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RESULTS
The results are summarized in Table II and in Fig. 1. In 
upper part of the table the basal blood glucose. IRI and CI­
TABLE I
Clinical data of patients with obesity and acanthosis nigricans
Age (year)
Bone age (year)
Height (cm)
Body weight (kg)
Body mass index - BM (kg/m^) 
Degree of obesity 
(percent of ideal b.w.) 
Puberty
A01 A02 A03
6 1 1 13
6 14 14
125 163 161
40 82 80
26 . 5 30.8 31
160 165 167
P0 P3 P4
peptide concentrations and I  glucose, E IRI and E C-peptide 
values during OGTT are demonstrated. Although the results 
obtained from acanthotic patients are individual values, a more 
marked reactive hyperinsulinaemia in all AO cases and a 
decreased glucose tolerance in two AO patients can be seen, 
compared to results of the simple obese group. The competition- 
inhibition curves of the ^ ^ I - i n s u l i n  binding studies are 
demonstrated in Fig.l. Specific radioactive insulin binding is 
decreased in A01 and A02 patients compared to nonacanthotic 
obese patients. Similarly, E C-peptide /Е IRI ratio is 
decreased in acanthotic obese boys compared to the controls 
(Table I). It is also shown that inhibition dose of unlabelled 
insulin required to decrease maximal binding by 50% ( I D j q )  is 
very high in A02 patient indicating a decreased hormonereceptor 
affinity. Serum of this patient could decrease reasonably (by 
54.2%) the specific labelled insulin binding to red blood cells 
obtained from a normal person shown the presence of insulin 
receptor antibodies.
TABLE II
Results of blood glucose, serum IRI and c-peptide measurements during OGTT and
insulin binding studies
Parameters
Simple 
(n = 7
obesity 
; X + SD)
Obesity
A01
with AN 
A02 A03
Blood glucose basal 4.88 + 0.16 5.2 5.9 6.3
(mmol / 1  ) I 33.1 + 3.1 30.7 36.9 41.7
IRI (pmol/1) basal 133.6 + 25 197 157 275
I 1892 + 275 5247 3864 4968
C-peptide basal 0.31 + 0.05 0.30 0.38 0.50
(nmol/ 1 ) I 4.51 + 0.42 5 . 90 5.18 6.60
I C-peptide/Г IRI 2.65 4 - 0 .7 1 . 1 2 1.34 1.33
(molar ratio)
Specific binding of
125_i_ insulin \ 5.10 4 - 1.38 1.98 1.14 -
Bound insulin
(pg/ 1 0  ^ blood red cells) 2.27 4- 0.61 0 . 8 8 0.51 -
Inhibition dose-IDjg
(1 0 -  ^ mol insulin) 3.5 + 0 . 5 4. 2 14 -
Percental inhibition
of AN sera (%) 1 1 . 2 54.2
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Fig . 1. Competition - inhibition curves of insulin binding studies in red blood 
cells obtained from patients with obesity and acanthosis nigricans and 
controls with simple obesity го40
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DISCUSSION
In the past decade there have been reported by several 
authors a severe insulin resistance in AN /9, 10, 14, 15/. It 
was also demonstrated that insulin resistance is a common 
feature in obese patients / 8 , 9/. Since insulin resistance can 
be seen in lean acanthotic patients /16/, the question arises 
whether the AN could account for the insulin resistance seen in 
obese subjects with AN.
In our acanthotic obese patients basal and reactive serum 
IRI concentrations were more increased than those of non- 
acanthotic obese controls. The decreased ration of C-peptide 
and IRI during ÜGTT (I C-peptide/Z IRI) is a further 
characteristic feature of insulin resistance in obesity /2/. A 
decreased Z C-peptide/Z IRI ration was found in our acanthotic 
obese patients compared to results obtained from nonacanthotic 
obese controls. These results suggest that insulin resistance 
is more severe in obesity with AN than in simple obesity. 
Recently several works have also reported a greater degree of 
insulin resistance in obese acanthotic subjects when compared 
with weight controls /14, 15, 16/. It was also demonstrated 
that insulin binding to skin fibroblast was significantly lower 
in the obese acanthotic subjects than in the simple obese 
patients /14/. It seems that AN can be considered as a marker 
for severe insulin resistance in obesity. In AN insulin 
resistance can be due to a receptor and a postreceptor defects 
/ 1 , 5/. The receptor defect can be either type A characterized 
by a decreased number of insulin receptor per cell or type В 
where the presence of antireceptor antibodies and decreased 
insulin binding can be demonstrated. The receptor affinity is 
normal in AN with insulin resistance type A and it is decreased 
in AN with insulin resistance type В /3/.
To assess potential defects in insulin at the cellular level 
insulin binding to red blood cells and a possible decreasing 
effect of sera from acanthotic patients on insulin binding were 
tested in our A01 and A02 patients /4/. A marked decrease in
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insulin binding to its receptor sites was found suggesting that 
the insulin resistance is due to alteration in insulin and its 
receptor interaction. Ihe difference found in IDjq values of 
ADI and A02 patients indicates a decreased receptor affinity in 
the latter case, since there is an inverse relationship between 
ID 5 0  and receptor affinity /3, 7/. Furthermore, in A02 patient 
the defect in the insulin-receptor interaction appears to be 
secondary to circulating antibodies which are directed at the 
insulin receptors and impair their functions, since his serum 
could decrease the specific insulin binding to red blood cells 
obtained from a normal person. Our results suggest that A01 
patient has insulin resistance type A, and A02 patient has 
insulin resistance type B. Unfortunately this characterization 
could not have been performed in A03 patient.
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Human recombinant erythropoietin (r-HuEPD, Eprex^) 
was administered to 8 children with chronic renal 
failure and high transfusion requirement. The hormone 
was given i.v. 2-3 times per week at the end of the 
dialysis. The selected initial dose (160 U/kg/week) was 
gradually raised up to a maximum of 400 U/kg/week. 
Anaemia normalised by the tenth week. The aimed target 
haematocrit was 0.33, the average maintenance dose was 
250-300 U/kg/week. The absolute reticulocyte count 
seemed to be a more sensitive indicator of the actual 
erythropoietin effect than the haematocrit level. No 
major adverse effects (convulsion, progressive 
hypertension, thrombosis) were observed during 
treatment with r-HuEP0.
The need for transfusions decreased dramatically, no 
transfusion was needed following the second week of 
treatment. The general condition improved 
substantially. In one hyperimmunized child the 
cytotoxic antibody titer decreased by 75 per cent.
INTRODUCTION
Renal transplantation is the treatment of choice of children 
with end stage renal failure. Even if this positive outcome 
occurs, it is usually preceded by a long period, sometimes 
years of chronic dialysis. Renal anaemia is one of the major 
problems encountered in children with chronic uraemia on renal 
replacement therapy.
The causes of renal anaemia in children are multiple:
1. The bone marrow of uraemic children is characterised by 
a significantly lower cellular density when compared to that of
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adults suffering from the same level of uraemia /12, 14/. It is 
hypothesized that the uraemic toxins inhibit the physiological 
development of the bone marrow. As a consequence renal anaemia 
of childhood is much more expressed as in later periods of life 
/12, 18, 19/.
2. Intestinal and extraintestinal blood losses can further 
accentuate the anaemia. Ihese losses can reach the level of 
2 . 6 - 6 .7 1/1.73 m 2/year /12-14/.
3. The half-life of erythrocytes is inversely correlated to 
the raise of the serum carbamid nitrogen level. The mean half- 
life of the erythrocytes is 60-70% of the normal /2, 12, 14/.
4. The major site of erythropoietin production is the 
kidney. In end stage renal disease renal erythropoietin 
production is decreased or even disappears (nephrectomy). Thus 
the physiological stimulus for the bone marrow is insufficient 
or absent /2, 3, 8 , 12/.
Until the introduction of erythropoietin treatment the 
management of the resulting severe anaemia consisted in 
repeated transfusions. Repeated blood transfusions not only 
account for transmission of blood-born infections (hepatitis, 
HIV, CMV), but can also lead to chronic iron overload and 
corresponding organ damage. Furthermore, multiple transfusions 
can lead to sensitization and development of cytotoxic 
antibodies reducing the probability of transplantation.
The introduction of erythropoietin offers a rational 
alternative for the treatment of renal anaemia. The hormone was 
first described by Paul Carnot in 1906. bince the late fifties 
it has been known that the major site of this hormone 
production is the kidney. In the early eighties the aminoacid 
sequence of the hormone was clarified, the gene was isolated 
and transferred in ovarian cells of the Chinese hamster. The 
cell cultures provided sufficient quantities of human 
recombinant erythropoietin (r-HuEPO) for clinical use /4, 5, 
8 , 9 /. The first clinical studies were performed in 1986 /4, 
5, 22/. The first Hungarian clinical trials began in 1989. We 
report about the results of the first paediatric administration 
of r-HuEPO in Hungary.
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PATIENTS AND M E T H O D S
We began to administer r-HuEPO (EprexR-Cilag) in October 
1989. The results of the treatment of eight children are 
summarized in this study. Mean age at the beginning of the 
study was 12.2 (range 5.5-18) years. The malerfemale ratio was 
2:6. Bilateral nephrectomy was performed in two patients 
because of uncontrollable hypertension. The underlying disease 
leading to renal failure and the main clinical data of the 
patients are listed in Table I. All patients were treated with 
chronic haemodialysis except patient 6 . Haemodialysis was 
performed three times weekly (4-5 hours per session). r-HuEPO 
was administered intravenously at the end of the dialysis. One 
patient (No. 6 ) was treated with chronic ambulatory peritoneal 
dialysis (CAPD). She received r-HuEPO subcutaneously.
The dose of EprexR was raised at intervals of one-two weeks 
until the desired haematocrit (НТО) level was reached (30-32%). 
The beginning dose was 160 0/kg/week. Later on the dose was 
adjusted according to the actual HTC level ("open-dose" study).
The dose of EprexR was calculated as U/kg/week. The 
laboratory parameters (HTC, reticulocyte count, creatinine 
level) were measured with routine laboratory methods once 
weekly.
The mean and SEM of the laboratory data of the same 
treatment phase (same treatment week) of the patients were 
calculated.
RESULTS
The initial dose of r-HuEPO was based on the review of the 
literature /1, 4, 6 , 10, 11, 13, 15, 16, 17, 20/. The initial 
dose of 1160 U/kg/week was gradually raised until the 6-7. 
week, to a maximal dose of 400 U/kg/week. The mean dose 
stabilised at 250-300 U/kg/week at about the fifth month of 
treatment. The data on the EprexR doses are represented on 
F i g . 1.
The mean basal HTC of our patients was 0.18 despite repeated 
transfusions. A substantial raise of the HTC level was observed 
after the sixth week of treatment, the highest values were 
observed at weeks 14-15. Later on the values stabilized at 0.33 
(Fig. 2).
Before beginning the treatment with r-HuEPO the absolute 
reticulocyte count of our patients was 0 -lxl 0 R signalling a
TABLE I
Data of the patients at the time of initiation of recombinant human 
erythropoietin (Eprex^) therapy
Number Age
(years)
Sex Basic disease Duration of 
previous dialysis 
(month)
Previous transfusion 
requirement 
(packed red cell)
l.x 18 0* chronic GN 57 1. 5 U/mo
2 .x 11.5 0* FSGS 32 2 U/mo
3. 13 $ FSGS 2 0 1.5 U/mo
4 . 1 0 interstitial
nephritis 18 2 U/mo
5. 1 2 2 juvenile
nephronophtisis 2 1 U/mo
6 .xx 13 £ RPGN 2 1 U/mo
7. 14.5 £ FSGS 1.5 3 U/mo
8 . 5.5 2 FSGS 1 2 U/mo
Remarks: x = after bilateral nephrectomy; "anephric patient"
xx = CAPD patient
FSGS = focal segmental glomerulosclerosis 
RPGN = rapidly progressive glomerulonephritis
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Fig. 1. Doses of EprexR during treatment (n = 8 , mean +_ SEM)
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Fig. 2. Evolution of the haematocrit value during Eprex^ treatment 
(n = 8 , mean +_ SEM)
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Fig. 3. Evolution of the reticulocyte count during Eprex^ treatment 
(n = 8 , mean _+ SEM)
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Fig. 4. Serum creatinine levels of Eprex^-treated uraemic children 
(n = 8 , mean _+ SEM)
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serious depression of the erythrocyte production. At the fifth 
week of treatment a one-hundredfold raise of the reticulocyte 
count was observed, reaching a two-three-fold normal level. 
After the 15th week of treatment the values stabilised at about 
the normal level (Fig. 3).
Fig. 4 shows the correlations between the Eprex^ dose, HTC 
level and reticulocyte count at the tenth week of treatment. A 
strong positive linear correlation was observed between the 
dose of hormone and reticulocyte count (y=0.67 x-0.46, r=0.88, 
p<0.01). A strong negative linear correlation was observed 
between HTC and the dose of r-HuEPO (y = 2.4 10^x+0.37, r = 0.77,
p < 0 . 0 1 )  .
The evolution of serum creatinine levels during treatment 
are shown on Fig. 5.
DISCUSSION
Erythropoietin is the treatment of choice of patients with 
end stage renal failure and the resulting severe anaemia /16, 
18/. The site of the hormone synthesis is the cortical tubular 
cell /9/. Erythropoietin is the most effective stimulus of the 
bone mar row erythrocyte production.
All of our eight patients needed regular transfusions prior 
to the introduction of the hormone. As a major advantage of r- 
HuEPO treatment the need for transfusions fell to zero after 
several weeks of administration. Only patients №  4 and 7 
needed one further transfusion during the first two weeks of 
treatment. The initial administration of 160 U/kg/week and its 
gradual increase up to 400 U/kg/week proved to be a safe 
dosage. No excessive raise of haematocrit level occurred. The 
target haematocrit value was set to 0.33 in order to prevent 
possible side effects (see later). The average maintenance dose 
was 250-300 U/kg/week.
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The absolute reticulocyte count (Fig. 3) was found to be the 
most sensitive indicator of the efficacy of Eprex^. The data 
summarized on Fig. 5 clearly indicate that the actual effect of 
the hormone is reflected by the evolution of the reticulocyte 
count rather than by haematocrit level.
Further complementary factors: iron, folic acid and vitamin 
В ^ 2 are needed to allow the full build-up of r-HuOPE effect 
/10/. Our previously poly transfused patients ( №  1-4) needed 
iron replacement following 1 0 - 1 2  weeks of treatment, whereas 
patients without multiple transfusions ( №  5-8) received iron 
supplementation after 5-8 weeks of treatment depending on their 
serum iron levels. Folic acid was routinely substituted because 
of the losses due to dialysis. Vitamin B]^ deficiency was not 
obs erve d.
The mean pre-dialysis serum creatinine levels of our 
patients were between 800-900 yumol/1. The raise of the 
haematocrit due to r-HuEP0 treatment could have a negative 
effect on the efficacy of the dialysis /16/. No such side 
effect was detected in our series, the average creatinin level 
remained stable.
Several further side effects are reported following 
treatment with r-HuEPO: deterioration of the underlying 
hypertension, hypertensive encephalopathy, seizures, thrombosis 
(occlusion of the Cimino arteriovenosus access) and allergic 
reactions ("flu-like" syndrome) /5, 6 , 17, 20/. None of the 
described complications were observed in our patients.
One further advantage of the treatment was observed in 
patient No. 1, who has been on haemodialysis for 6  years. His 
extreme levels of cytotoxic antibodies (nearly 1 0 0 %) fell to 
20% following eight months of Eprex^ administration.
In conclusion, erythropoietin administration in the current 
dosage proved to be a safe and effective alternative for the 
treatment of renal anaemia. The side effects of multiple 
transfusions could be spared, and the general condition and 
physical activity of the patients improved significantly.
344 P. Sallay and Gy. Reusz
REFERENCES
1. Bommer 3, Kugel M, Schoeppe W, Brunkhorst R, Samtleben W,
Bramsiepe P, Scigalla P: Dose-related effects of human
recombinant Erythropoietin on erythro poies is. Results of a 
multicenter trial in patients with end-stage renal disease. 
Contr Nephrol 6 6 : 85, 1988
2. Driieke T, Zins В, Moynot A, Naret C, Deschryver F, Varét В,
Jacquot C, Nayean Y: Kinetics of erythropoiesis in
hemodialysis patients on recombinant erythropoietin
treatment. Kidney Int 35: 245, 1989
3. Erslev AJ, Caro J, Miller 0, Silver R: Plasma
erythropoietin in health and disease. Ann Clin Lab Sei 10: 
250, 1980
4. Eschbach JW, Adamson JW: Guidelines for recombinant human 
erythropoietin therapy. Am J Kidney Dis vol. 14: (suppl. 1) 
2, 1989
5. Eschbach JW, Egrié JC, Downing MR, Browne JK, Adamson JW:
Correction of the anemia of end-stage renal disease with 
recombinant human erythropoietin: Results of a combined
phase I and II clinical trials. N Engl J Med 316: 73 , 1987
6 . Grützmacher P, Bergmann M, Weinreich T, Nattermann U,
Reimers E, Pollok M: Beneficial and adverse effects of
correction of anaemia by recombinant human erythropoietin 
in patients on maintenance haemodialysis. Contr Nephrol 6 6 : 
104, 1988
7. Kakuk Gy, Kárpáti I, Mátyus J, Újhelyi L: Behandlung der 
renalen Anämie mit humanem rekombinantem Erythropoietin. 
Nephrológiai Symposium, Debrecen, pp. 7. ed. Cilag AG 1990
8 . Kurtz A, Eckardt KD, Tannahill L, Bauer C: Regulation of 
erythropoietin production. Contr Nephrol 6 6 : 1, 1988
9. Lacombe C, Da Silva JL, Bruneval P, Camilleri JP, Bariety
J, Tambourin P: Identification of tissues and cells
producing erythropoietin in the anemic mouse. Contr Nephrol 
6 6 : 17, 1988
10. Macdougall IC, Hutton RD, Cavill I, Coles GA, Williams JD :
Treating renal anaemia with recombinant human 
erythropoietin: practical guidelines and clinical
algorithm. Br Med J 300: 655, 1990
11. Müller-Wiefel DE, Bosch A, Feist K: Erythropoietin (EP0) 
treatment in pediatric patients with renal anaemia: 
Application forms, dosage and response. Pediatr Nephrol 3: 
3C 69, 1989
Human recombinant erythropoietin 345
12. Müller-Wiefel DE, Scigalla P: Specific problems of renal 
anaemia in childhood. Contr Nephrol 6 6 : 71, 1988
13. Müller-Wiefel DE, Schärer К: Serum erythropoietin in
children with chronic renal failure. Kidney Int 15:
(suppl.) 70, 1983
14. Müller-Wiefel DE, Sinn H, Gilli G, Schärer K: Hemolysis and
blood loss in children with chronic renal failure. Clin
Nephrol 8 : 581, 1977
15. Offner G, Hoyer PF, Latta К, Winkler L, Brodhel J, Scigalla
P: One year's experience with recombinant erythropoietin in 
children undergoing continous ambulatory or cycling
peritoneal dialysis. Pediatr Nephrol 4: 498, 1990
16. Paganini EP, Latham D, Abdulhadi M: Practical
considerations of recombinant human erythropoietin therapy. 
Am J Kidney Dis 14: (suppl. 1) 19, 1989
17. Schaefer RM, Hörl WH, Massry SG: Treatment of renal anemia 
with recombinant human erythropoietin. Am 0 Nephrol 9: 353, 
1989
18. Schärer К, Müller-Wiefel DE: Hematological problems in
renal insufficiency; in Holliday, Barratt, Vernier, 
Pediatric Nephrology, pp. 880 (Williams & Wilkins, 
Baltimore) 1987
19. Schärer К, Müller-Wiefel DE: Renal anemia in children. A 
review. Int J Pediat Nephrol 3: 193, 1982
20. Sundal E, Kaeser U: Correction of anaemia of chronic renal 
failure with recombinant human erythropoietin: Safety and 
Efficacy of one year's treatment in a European Multicentre 
Study of 150 haemodialysis-dependent patients. Nephrol Dial 
Transplant 4: 979, 1989
21. Walter 0, Taraba I: Az erythopoietin haematogén hatása és 
következményei. Nephrológiai Symposium, Debrecen pp. 22 ed. 
Cilag AG, 1990
22. Winearls CG, Oliver D, Pippard MJ, Reid C, Dowing MR, Cotes 
PM: Effect of human erythropoietin derived from recombinant 
DNA on the anaemia of patients maintained by chronic 
haemodialysis. Lancet ii: 1175, 1986
P. SALLAY, MD
Bókay János u . 53.
H-1083 Budapest, Hungary

Acta Paediatrica Hungarica 32 (4), pp. 347-369 (1992)
A BEHAVIOURAL TERATOLOGIC STUDY ON OFFSPRING 
OF SELF-POISONED PREGNANT WOMEN
Ágnes LENDVAY, A. E. CZEIZEL
Department of Human Genetics and Teratology - WHO 
Collaborating Centre for the Community Control of 
Hereditary Disorders, National Institute of 
Hygiene, Budapest, Hungary
Received 13 October 1992
Ninety-three cases born from women who attempted 
suicide by taking large doses of chemicals and eight 
cases who had mothers affected by a chemical poisoning as 
accident during pregnancy were studied. Data of birth 
weight and gestational time, congenital anomalies and 
postnatal disorders were obtained in cases and matched 
controls (sociological twins). Test examinations were 
performed in both cases - controls and their mothers in 
the home of families. The mothers of index children had 
a lower socioeconomic : status and more were unmarried 
than the Hungarian pregnant population at large. The 
behaviour of index and control mothers showed some 
obvious differences. The bivariate analyses indicated 
some possible teratogenic effect of maternal poisoning, 
but it was not confirmed by multivariate analysis 
except lower birth weight. Thus differences between 
cases and control were explained mainly by the maternal 
behavioural factors.
INTRODUCTION
People who attempt suicide by taking large doses of 
chemicals or meet with an accident may provide an appropriate 
"experimental" epidemiological model for the study of the 
effects of chemicals in the human being /1, 2, 3/. Previously 
the self-poisoning model was used for the study of the 
mutagenicity of chemicals in humans /4, 5, 6 /. The present 
paper reports on the teratogenic effect of chemicals. Until now 
only case reports of self-poisoned pregnant women have been 
published /7, 8 /.
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We have examined the problem in three ways. First, a 
descriptive epidemiologic study was made in 142 self-poisoned 
pregnant women whose pregnancy outcomes were compared with 
their previous and subsequent pregnancy o u t c o m e s /9, 10/. Mental 
retardation occurred in 6.5% of 93 index children and 2.7% of 
144 sibs. Furthermore three of 78 index children past the age 
of 10 (i.e., 3.8%) had obvious behavioural deviations. (Two of 
them were in prison.) Similar conditions were not found among 
sibs. These findings prompted us to undertake a second 
approach, involving the behavioural study of offspring of self- 
poisoned pregnant women, the results are summarised in this 
paper. However, there is a third approach: a longitudinal 
prospective teratogenic study on the offspring of self-poisoned 
pregnant women / 1 1 /.
Our purpose is to examine two questions raised by our 
previous study. First, it is possible to confirm the previously 
detected behavioural effect on offspring after severe chemical 
intoxication in the pregnancy of their mothers? Secondly, if 
the previous results were confirmed, is it possible to separate 
the teratologic and maternal-social effects of self-poisoning 
in the origin of behavioural deviation?
MATERIALS AND METHODS
In 1985, 276 pregnant women (the so-called index mothers) 
were ascertained by scrutinizing case histories of all poisoned 
women between the ages of 14 and 50 hospitalized in the 
Inpatient Clinic of Toxicological Internal Medicine, Sándor and 
Frigyes Korányi Hospital, Budapest from 1980 to 1984. The 
diagnosis of pregnancy was based on information given by the 
women or ongynaecologic examination which were performed in all 
cases with a missed menstrual period or on any other signs of 
pregnancy. We planned to visit all index mothers at home. 
However, 40 had untraceable new addresses. Of 236 index mothers 
who were visited 52 were dropped from the research due to the 
misdiagnosis or uncertainty of 51 pregnancies (women denied 
being pregnant at the time of the home visit; probably these 
pregnancies were terminated) and one pregnant women was a 
foreigner. The distribution of 184 pregnancy outcomes evaluated 
was as follows: induced abortion 31, fetal death 17, and 
livebirth 136. However, in the latter group three mothers and 
two children died, 11 mothers were in prison (4.0%), 12 
children were adopted or in foster home and seven families
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refused to cooperate. Of 101 remaining index mothers, 8 had an 
accident or overdosage of drugs during pregnancy but they were 
not separated from women who had self-poisoning during 
pregnancy because of the low number of this subgroup.
Our purpose was to have both sibling and matched controls. 
However, 101 index children had 117 sibs and their distribution 
was uneven, because 44 index children had no sibs and the sibs 
of 57 remaining index children were of varying ages. Thus, this 
approach was abandoned and one non-relative healthy control was 
selected for each index child from the kindergartens of 
Budapest districts where index children lived. These 
"sociological twin" controls were matched to the index children 
by age (month of birth), sex and birth order, and families were 
matched to index mothers by age, marital status, education 
(number of school classes), occupation, income and housing 
conditions.
Test examinations were performed in the home of the families 
in 1985-1990; the number of home visits was between 2 and 5 
with a mean of 3.3. The Budapest Developmental Test /12/ was 
used for the estimation of the mental development of children 
under 5. The Behavioural Style Questionnaire /13/ was used for 
the examination of behavioural-temperament-scale in children 
aged 4-7 years. The drawing test was used for the study of 
performence in all children. The Home test /14/ was planned to 
estimate the family atmosphere and maternal behaviour in 
children with age under 3.5 years old. The personality of index 
mothers was examined by the colour-test of Liischer /15/, the 
tree test of Koch /16/ and the signature test of Bánáti /17/.
The statistical analysis was carried out by using ...‘2 and 
u test multivariate logit models modified to matched data.
RESULTS
a/ Personal data
The educational and occupational distributions of Г01 index 
mothers are shown in Table I, 56 (55.4%) index mothers were 
married at the time of poisoning, however, 72 (71.3%) were 
married at the time of the study.
Of 101 index children, 57 were boys and 44 girls. Their age 
distribution is shown in Table II. The distribution of birth 
orders was as follows: 1=51(46); 2=27(39); 3=14(11); 4=8(3); 
5=1(2). (Expected numbers based on Hungarian pregnant women 
having livebirths in the study period shown in brackets.)
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TABLE I
Educational and occupational distribution of index mothers 
(Expected figures of education based on Hungarian pregnant 
women having livebirths are shown in brackets)
Education
(Number of school classes)
Occupation
4 or less 8 (3) Unskilled 5
5-7 24 (4) Semiskilled 15
8 1 2 (51) Skilled 38
9-12 55 (31) Clerk 40
<13 2 ( 1 2 ) Professional 3
Total 1 0 1 ( 1 0 1 ) 1 0 1
b/ Toxicological data
Of 101 index mothers, 93 (92.1%) attempted suicide by drugs 
and 8  (7.9%) had accidents (noxious mushroom poisoning 2, 
intoxication of carbon monoxide 2 , pesticide 2 , sulphuric acid 
1 ) or an overdose of thrichlorethylene.
The maternal age and the gestational month at the time of 
poisoning are also shown in Table II. Self-poisoning occurred 
between the 7th week and the 32rd week of gestation.
The severity of poisoning is shown in relation to 
gestational trimesters in Table III. Familial and economic 
reasons were mentioned as a cause of self-poisoning by 39 and 
47 index mothers, respectively, while 7 did not give any 
e x p l a n a t i o n .
The list of drugs used for self-poisoning is shown in Table 
IV. Of 93 self-poisoned mothers, 6 6  (70.9%) used one drug, 15 
(16.1%) two drugs, 9 (9.7%) three and 3 (3.3%) four drugs. The 
most frequently used drugs are benzodiazepines (59 cases; 
58.4%).
TABLE II
Distribution of age of index children, maternal age-groups 
(expected figures based on Hungarian pregnant women having livebirths 
in the study period are shown in brackets) and gestational month at the time of
poisoning CO3CDСЛ
Age Gestational
of index No. 
children
0
0 Age-group 
of mothers
N o . 0,0 (%)
month N o .
0
6
1 - 2 15 14 ,. 9 15-19 24 23,. 7 (13 ,.9) 2 7 6 . 93 26 25 ,. 7 20-24 34 33 ,. 7 (38,.2 ) 3 2 2 2 1 ,. 84 13 1 2  . 9 25-29 26 25,. 7 (32..1 ) 4 2 2 2 1  ,. 85 16 15 . 8 30-34 1 1 1 0 ,. 9 (1 1 .8 ) 5 2 0 19,. 8
6 18 17 .8 35-39 4 4 ,. 0 (3,.3) 6 2 2 2 1 ,. 8
7 13 1 2  . 9 40-44 2 2 ,. 0 (0 .7) 1 CO 8 7.. 9
Total 1 0 1 1 0 0 . 0 Total 1 0 1 1 0 0  ,. 0 ( 1 0 0  .,0 ) Total 1 0 1 1 0 0 ., 0
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Table III
Distribution of severity of poisoning (how many 
times it exceeds the usual daily dose) at the 
function of gestational trimester
Severity of poisoning
I
T r imester 
II III
Total
mild ( 2-1 Ox ) 19 41 3 63x
moderate (ll- 2 0 x) 3 6 1 1 0
severe (20-49x ) 5 15 2 2 2 xx
very severe (>50x) 2 2 2 6
T otal 29 64 8 1 0 1
x including 2 accidents 
xx including 6 accidents
TABLE IV
List of most frequently used drugs 
for self-poisoning
Drug No 0,
Diazepam 42 31.1
Phénobarbital 2 2 16 .3
Promethazine 1 0 7.4
Nitrazepam 9 6 .7
Chlordiazepoxide 8 5.9
Mepr obomate 7 5.2
Glutemide 6 4 . 4
Others 31x 23.0
Total 135 1 0 0 . 0
x Human teratogenic drugs were not used for self-poisoning, 
however, drugs were combined with alcohol abuse in three cases
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с/ Clinical data
Pregnancy complications are shown in Table V; comparable 
data were not obtained in control mothers. The mean birth 
weight of index children was significantly lower than that of 
control children ( u = 1 . 8  4 ; p < 0.05) (Table VI). Duration of 
gestation of index and control cases was not significantly 
different (Table VII).
The rate of congenital anomalies documented by medical 
discharge summaries or personal examination did not show 
significant differences between the study group and two control 
groups (Table VIII). The expected total birth prevalence of 
congenital anomalies is about 6.5 in Hungary.
The occurrence of major postnatal diseases was somewhat, but 
not significantly higher in the group of matched controls than 
in index children (Table IX).
d/ Results of behavioural tests of offspring
The Budapest Developmental Test (Table X) indicated a 
significant decrease (p < 0.005) in the Development Quotient 
(DQ) of 70 index children with age under 5 years compared with 
that of matched controls. The difference is explained mainly by 
the predominance of lower values (< 1 0 0 ) in index children 
(52.9% vs 15.7%). However, the only three children with scores 
over 131 were index children.
The Behavioural Style Questionnaire (BSQ) was used in 
children aged 4-7 years (Table XI). This test is based on 100 
questions in order to evaluate nine features of development of 
children on a six-point scale. Table XI shows the summary of 
significant deviations between index children and their matched 
controls in features studied. Boys had significantly lower 
adaptability after the self-poisoning in all trimesters, while 
in girls the effect was seen only after self-poisoning in the 
first and third trimesters. A lower level of emotional behaviour 
(humour and depression) was seen in both sexes after poisoning 
in the second trimester (and in the first trimester of index
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TABLE V
History of 101 pregnancies studied
Events No . 0,"о
Physical trauma В 7.9
Smoking 36 35.6
Regular drinking 9 8.9
Disorders 6 5.9
(pneumonia, neurosis, lues)
Threatened abortion 6 5.9
Other pregnancy
complications 4 4.0
(EHP, cervical incompetency)
TABLE VI
Mean birth weight (g) of index and control children 
as well as of sibs born from previous and subsequent 
pregnancies of their mothers
Pregnancies
Group previous study subsequent
No . X No X No . X
Study 80 3077 1 0 1 3046 + 553 37 2808
Control 6 6 3101 1 0 1 3170 + 478 42 3233
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TABLE VII
Distribution of gestational time groups in index and control children
Children
No.
31
0,
a
32
No.
-36
0,
37
No.
-41
a
0
42-
No. %
Total 2 
No. % Д  3 p
Index 2 2.0 10 9.9 86 85.1 3 3.0 101 100.0
4.75 >0.05
Control 1 1.0 3 3.0 95 94.1 2 2.0 101 100.0
TABLE VIII
Distribution of congenital anomalies in index children, 
their sibs and matched controls
Congenital anomaly
Index 
children 
(N = 101)
Sibs of Matched
index children controls
(N = 117) (N = 101)
Cong, hydrocephalus 
Cong, cardiovascular
0 1 0
malformation 2 3 2
Diaphragm defect 1 0 0
Cong, dislocation of hip 2 1 1
Clubfoot 1 2 0
Undescended testis 2 0 1
Cong, inguinal hernia 1 1 2
Total 9 8 6
0,Q 8.9 6.8 5.9
У 1 - 0.32 0.65
p >0.03 >0.05
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TABLE IX
Distribution of disorders in index children, 
their sibs and matched controls
Disorder Index 
children 
(N = 101)
Sibs of
index children 
(N = 117)
Matched 
controls 
(N = 101)
Meningitis 1 2 X 0
Brain tumour 0 1 0
High myopia 0 1 0
Recurrent "cold" 4 1 4
Pneumonia 3 2 8
Bronchial asthma 0 2 0
Recurrent gastroenteritis 
Other disorders of
2 0 5
digestive system 0 1 0
Nephritis 0 1 0
Galactosemia 0 1 0
Jaundice 0 0 1
Drug allergy 1 0 0
Anaemia (severe) 2 1 2
IgA deficiency 0 0 1
Somatic retardation 1 2X 0
Total 14 14 21
0,
0 13.9 12.0 20.8
Y  2 - 0.17 1.69
* P - > 0.05 > 0.05
xone of these disorders occurred in one sib
boys' mothers). Girls showed some difference in the feature of 
advice and alienation after poisoning in the second trimester. 
Hyperactivity-hypermobility, which is a well-known symptom of 
minimal brain damage, was observed after self-poisoning in the 
second trimester in both sexes.
The drawing test is frequently used because it seems to be a 
playful exercise to children. Differences were not significant 
(Table XII) though the trend is obvious: control children had a 
higher proportion of results which were over average.
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TABLE X
Results of Budapest Development Test in 70(5) index 
cases and matched controls under the age of 5. 
(Numbers of accidents are shown in brackets)
Group 
of Dg
Cases
N o . % N o .
Controls
■'S
-80 2 2.9 0 0 . 0
81-90 1 2 17.1 2 2.9
91-100 23(1) 32.8 9 1 2 .9
1 0 1 - 1 1 0 1 0 (2 ) 14.3 28 40.0
1 1 1 - 1 2 0 1 0 14.3 19 27.1
121-130 1 0 (1 ) 14.3 1 2 17.1
131- 3(1) 4.3 0 0 . 0
Subtotal 70(5) 1 0 0 . 0 70 1 0 0 . 0
X 104.1 _+ 16.3 1 1 0 .03 +_ 10.2
u 2.62
p < 0.005
e/ Test results of mothers
The Home test data are summarized in Table XIII. There were 
significant differences between case and control boys on items I, 
IV, V and VI, and between case and control girls on items III, IV 
and VI. Overall differences were significant on all items except 
II. Thus, the familial environments of the study and control 
groups were significantly different.
Data from the test of Koch (Table XIV) showed a complicated 
pattern. While the proportion of infantilism was significantly 
more frequent in index mothers, traumasthenia was significantly 
higher in control mothers.
The results of the colour test of LLischer (Table XV) 
demonstrated significantly higher rate of immature emotions, 
anxiety, obstinate and vegetative tension in index mothers.
Summary of significant deviation of Behavioural. Style Questionnaire's features (I: activity, 
II: rythm of the biological function, III: advance and alienation, IV: adaptability, V: 
intensity, VI: humour and depression, VII: persistence, VIII: deviability and absent 
mindedness, IX: low threshold of response) in index children aged 4-7 years from matched 
controls as a function of sex and gestational trimesters
TABLE XI
Case boys Control boys Case girls Control girls
n o . X S.D. (N = 22) N o . X S.D. (N = 23)
First IV. 6 82.5 1 2 . 2 IV. 6 72.0 1 2 . 8
V I . 6 66.7 13.8
I . 50.8 +_ 4.4 I . 4 9 . 8 + 4.5
Second I . 14 40.3 6 . 2 IV.. 41.2 + 5.8 I . 14 40.9 6.7 Ill . 33.4 + 3.9
IV. 14 8 8 . 1 12.7 VI . 40.5 + 4.3 III. 14 38.8 5.4 IV. 37.7 + 7.7
V I . 14 91.6 34.7 V I . 14 103.4 32.2 V I . 40.0 + 4.9
Third V I . 2 108.0 26.0 IV. 3 104.0 8.5
3
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TABLE XII
Results of the drawing test in 101 index children and 101 control children
Results of test Index children Control children
Boy Girl Total Boy Girl Total
N o . 0,"o N o . 0,0 N o . 00 N o . 0,0 No 0,. 0 N o . 0,0
Under average 14 24.6 9 20.5 23 2 2 . 8 1 2 2 1 .1 8 18.2 2 0 19.8
Average 30 52.6 25 56.8 55 54.4 27 47 .4 23 52.3 50 49.5
Over average 13 2 2 . 8 1 0 22.7 23 2 2 . 8 18 34 .6 13 29.5 31 30.7
Subtotal 57 1 0 0 . 0 44 1 0 0 . 0 1 0 1 1 0 0 . 0 57 1 0 0 . 0 44 1 0 0 . 0 1 0 1 1 0 0 . 0
KV 1 . 1 2 7 Í I - 0.53 ? T i = 1 . 63
P = 0.58 P = 0.77 p = 0.44
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Results of home test in children under the age of 3.5 years
TABLE XIII
Index cases Matched controls Difference
Boy
Items of test (N=33)
Girl
(N=18)
Total
(N=51)
Boy
(N=33)
Girl
(N=18)
Total
(N=51)
Boy Girl Total
X S.O. X S.O. X S.D. X S.D. X S.O. X S.D. u u u
I. Emotional and verbal 
responsiveness of 
mother 8.09 2.04 8.17 2.71 8.12 2.28 10.00 0.83 9.12 2.32 9.67 1.38 -4.93XXXX -1.12 -4.09xxxx
II. Acceptance of
child's behaviour 5.70 1.64 6.06 1.47 5.83 1.58 5.59 1.70 6.00 1.33 5.74 1.56 0.26 0.13 0.28
III. Organization of the 
physical and tempo­
ral environment 4.91 1.0B 4.78 1.23 4.86 1.13 5.31 1.29 5.65 0.84 5.444 1.12 -1.31 2.46x -2.54XXX
IV. Provision of
appropriate play 
materials 5.85 2.44 5.83 2.24 5.84 2.37 7.31 2.05 7.65 1.53 7.44 1.86 -2.56xx -2.82XXXX -3.72xxxx
V. Maternal involvement 
with the child 4.12 1.70 4.22 1.69 4.16 1.70 5.00 1.44 5.53 1.09 5.20 1.31 -2.21XX 2.74XXX -3.39XXXX
VI. Opportunities
for variety 2.94 1.52 3.17 1.12 3.02 1.38 3.93 1.05 3.88 0.83 3.91 0.97 -3-Olxxxx -2.34XX -3.07XXX
X X  p <0.05 
X X X  p <0.01 
xxxx p <0.005
360 
Behavioural study on offspring
TABLE XIV
Results of the tree (Baum) personality test of Koch in 101(8) index mothers and 101 
control mothers. (Numbers of accidents are shown in brackets)
Items of test Index
N0.
mothers
%
Control 
No .
mothers
0,
0 Difference
Inhibition 52(4) 51.5 40 39.6
*
= 2.87; p = 0.09
Traumasthenia 1 2 (0 ) 11.9 30 29.7 Ц = 9.74; p = 0 . 0 0 1
Impression mobility 40(4) 39.6 38 37.6 4= 0.08; p = 0.77
Infantilism 49(3) 48.5 27 26.7 A= 1 0 .2 1 ; p = 0 . 0 0 0 1
ON
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Results of the colour (Farb) personality test of Liischer in 101 (8 ) 
index mothers anu 101 control mothers. (Numbers of accidents
are shown in brackets)
TABLE XV
Items of test Index 
N o .
mothers
0.
"0
Control 
No .
mothers
0,0
Differences
Immature emotions 40(2) 39.6 14 13.9 TTi = 17.09; P = 0 . 0 0 1
Anxiety 53(7) 52.5 36 35.6 9Ti = 5.01; P = 0 . 0 2
Obstinate 58(5) 57.4 26 25.7 щ  - 20.87; P = 0 . 0 0 1
Vegetative tension 52(5) 51 . 5 25 24.8 15.30; P = 0 . 0 0 1
Decreased vitality 52(3) 51.5 42 41.6 ?ri = 1.99; P = 0.16
Neurotic 38(0) 37.6 41 40.6 TTi = 0.19; P = 0 . 6 6
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Data from the signature test of Bánáti (Table XVI) indicated a 
higher rate of neurotic index mothers (which was not the case in 
the colour test). Intellectual performance did not show a 
significant difference; however, the trend indicates a lower 
level in index mothers.
Multivariate analysis
In the bivariate analysis of case-control studies a 
significant difficulty arises from the bias created by 
confounding factors. In order to rule out the confounding factors 
as much as possible, a multivariate analysis /18/ was performed. 
Adjusted relative odds and their 95% confidence limits were 
calculated from the estimates of model parameters and their 
standard errors /19/. The procedure for selecting variables to 
the final model was the following. First, the variables in the 
bivariate analysis were taken into a model. Second, those 
factors of which coefficient estimates were less than twice 
standard errors were excluded. Third, each one of these selected 
factors was added one at a time to the reduced model and included 
if the difference of déviances (between the two models) was 
greater than the 95% point of chi square distribution. Predictor 
variables were gestational age at the time of poisoning (I-II-III 
trimesters), severity of poisoning (mild and moderate - severe 
and very severe), type of drugs (benzodiazepines - barbitals - 
others), socioeconomic status of mothers (< 8 - > 8  class of schools) 
and maternal tests (under average - average - over average). The 
dependent variables were birth weight, gestation time and results 
of tests in offspring.
First, the maternal tests /15, 16, 17/ were evaluated and seven 
factors were developed on the basis of data from the study and 
control groups. These seven factors can explain 6 8 % of standard 
deviation of the original variables. After the rotation of 
factors studied, the differentiation of study and control groups 
was correct in 74% of analyses. In particular, the control group 
showed a more homogeneous pattern (84% of analyses were correct). 
The differentiation was correct in 54% of analyses in the study 
gro up.
Results of the signature personality test of Bánáti in 101(B) 
index mothers and 101 control mothers (Numbers of 
accidents are shown in brackets)
TABLE XVI
Items of test Index mothers Control mothers Differences
N o . 0,0 N o . 0,0
Irregular 19(1) 18.8 28 27.7 TTi = 2.25; p = 0 . 13
T raumasthenia 59(4) 58.4 64 63.4 r \ = 0-52; p = 0.47
Neurotic 36(3) 35.6 2 2 2 1 . 8 T i II -P
> '-J u II 0.03
Intellectual performance
Under average 2 0 19.8 2 2 2 1 . 8
Average 72(7) 71.3 61 60.4
r l I
I 4> О о TD II 0.13
Over average 9(1) 8 . 9 18 17.8
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TABLE XVII
Summary of multivariate analysis. Adjusted means show the 
figure after the reduction of "final maternal factor"
Parameters Index
Observed
X
children
Adjusted
X
Matched
Observed
X
controls
Adjusted
3?
P
Birth weight 3061 3061 3170 3169 < 0 . 0 1
Gestation time 39.2 39.1 39.6 39.6 > 0.05
DQ 72.3 72.6 74.1 73.7 > 0.05
BSQ 1 .79 1.79 1 .82 1.82 > 0.05
Drawing 1.93 1 .94 2 . 1 2 2 . 1 1 > 0.05
Home test 1 .49 1 .49 1.55 1.55 > 0.05
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Second, the results of Koch, Liichser and Bánáti tests were 
evaluated and later these were combined as a "final maternal 
factor". The latter showed a significant difference between index 
(3.43) and control (1.89) mothers (p < 0.01).
The multivariate analysis (Table XVII) indicated that after 
the exclusion of differences in mothers of the study and control 
groups, index children and controls showed a significant 
difference in birth weight 7-67; p < 0 .0 1 ) but not in the 
results of behavioural tests. The decreased birth weight in the 
study groups showed a correlation with the severity of poisonings 
during pregnancy.
DISCUSSION
The mothers of index children had a lower socioeconomic 
status (based on educational level and occupational background) 
and more were unmarried than the Hungarian pregnant population at 
large (about 7% in the study period).
The severity of self-poisoning was lower than in self-poisoned 
females in general but the distribution of drugs for suicide 
attempts was similar to the general pattern /9/.
Obvious teratogenic consequences of self-poisoning, during 
pregnancy were not apparent but the birth weight of index 
children was lower than that of matched controls. This indicates 
mil d intrauterine growth retardation because gestational time 
did not show any significant difference between index cases and 
mat ched controls. These data confirm our previous results because 
the birth weight of babies born from subsequent pregnancies of 
index mothers was significantly lower than that of both control 
children and of babies born from previous pregnancies of index 
mothers / 1 0 / .
The possible teratogenic effect of maternal self-poisoning 
dur ing pregnancy was indicated by / 1 / the somewhat lower 
intellectual performance based on developmental quotient, / 2 / 
hypermotility and /3/ lower adaptability in the bivariate 
analysis. All may be the symptoms of minimal brain damage or 
minimal cerebral dysfunction. However, no significant difference 
was found in multivariate analysis.
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The multifaceted personality assessment of mothers showed a 
higher rate of emotional immaturity, anxiety, obstinate, 
vegetative tension and infantilism which may have some connection 
with their suicide attempts and probably with their parental 
attitudes. A higher rate of neurotic personality was indicated by 
one test (Bánáti) but not by another (LLischer) in index mothers. 
The traumasthenia occurred at a significantly higher level in the 
control mothers. The Home test indicated some differences in 
mother-child connection e.g. the higher frequency of depressive 
character in index cases. Other significant differences in the 
items of the Home test between cases and controls may also be 
related to aspects of the mother's personalities. The point is 
that the behaviour of index and control mothers shows some obvious 
di f ferences.
The multivariate analysis of children's data indicated that 
the differences between index children and matched controls are 
caused mainly by the maternal behavioural factors. The interaction 
between these biological and familial-sociological effects needs 
further analyses.
It would be convenient if there was no need for this kind of 
human terato-epidemiologic research because the plethora of 
experimental systems that have been developed . over the past 
several years were so effective and widely used that people were 
not exposed to teratogenic chemicals. Unfortunately, this is not 
the case. Consequently, the harsh reality is that human beings 
provide indispensable information within teratology/ too.
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The head is a very rare primary site for Ewing's 
sarcoma which occurs most often in the long bones of 
the extremities and in the pelvis. This report 
describes an unusual case of Ewing's sarcoma arising 
from the occipital bone in a seven year old girl. The 
tumour compressed the venous sinuses, thus lowering the 
intracranial pressure resulted in temporary recovery 
which made the diagnosis difficult.
I NT RODUCTION
Ewing's sarcoma is a rare tumour of the bone. It accounts 
for approximately 1% of all childhood neoplasms /15/. This 
tumour affects children and young adults. It occurs most 
frequently in the early portion to midportion of the second 
decade of life. Primary tumours may arise in every part of the 
skeleton, but most often in the long bones of the extremities 
(the humerus and femur) and in the pelvic bones /21/. The head 
and neck are very rare primary sites for Ewing's sarcoma /1, 4, 
7, 11, 12, 18, 19/.
This case report describes a Ewing's sarcoma arising in the 
occipital bone of the skull, infiltrating the dura mater and 
causing the symptoms of raised intracranial pressure.
Akadémiai Kiadó, Budapest
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CASE REPORT
The seven year old girl was admitted to hospital at the end 
of April 1990 with a two-days history of headache, nausea, 
vomiting and abdominal pain. She had no complaints until 2 days 
before admission. The parents said that 3 weeks prior to 
admission she had fallen off her bicycle, but she did not lose 
c o n s c i o u s n e s s .
Physical examination findigs were normal, except for a 
slight abdominal pain in the right lower quadrant on deep 
palpation. There were no focal neurological findings. The 
abdominal pain soon disappeared, but on the 4th day of 
hospitalization intravenous fluids had to be administered for 
symptoms of mild dehydration. On the 6th day she began to 
complain about double vision. It was present looking in all 
directions. The fundoscopic examination revealed papillaoedema 
bilaterally. The patient was then transported to our 
d e p a r t m e n t .
On addmission she was somewhat tired. The findings of the 
physical examination were normal. The detailed neurological 
examination found a slight truncal ataxia, diplopia and 
bilateral papillaoedema /10/. The clinical features were those 
of space-occupying tumour. The plain skull X-ray, EEG, CT brain 
scan, routine haematological and biochemical tests were normal. 
Lumbar puncture was done carefully under the protection of 
Mannitol, because of the raised intracranial pressure. The 
cerebrospinal fluid was normal.
As the child improved, during the intracranial pressure 
reducing therapy, she became symptom-free. She did not have 
complaints and with our diagnostic procedures we could not 
prove neurological disease, so we discharged her. She was in 
good health for the next six weeks and there were no signs of 
p a p i l l a o e d e m a .
In July she was readmitted. She complained about a severe 
headache for 2 days with vomiting once or twice daily. The 
physical findings were normal with no focal neurological signs. 
The fundoscopic examination found bilateral papillaoedema 
again. Cerebral tumour was strongly suspected. The repeated CT 
scans of the head - with and without contrast enhancement - 
demonstrated cerebral oedema along with the obstruction of the 
ventricular system and a remarkable mass lesion round the 
sinuum confluens in the occipital area. The tumour was a 
slightly round mass, almost uniformly hyperdense, with a 
further enhancement after an injection of contrast medium 
(Figs 1-2). The magnetic resonance imaging of the head clearly 
showed the high-density space-occupying lesion in the occipital 
area (Fig. 3). Evaluation for extracranial manifestations 
revealed métastasés in the lung. Bone marrow was normal. No 
evidence of another primary lesion was found using isotop 
whole-body bone scan.
A suboccipital craniectomy was performed. In the area of the 
protuberantia occipitalis externa the bone was soft, livid and 
infiltrated with necrotic tumour mass. The patient underwent a 
suboccipital resection of the tumour, which had attached to the
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F í Q s 1, 2. Axial CT scans demonstrating the hyperdense tumour 
of the occipital bone in two different magnifica­
tions
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Fig. 3. Magnetic Resonance Imaging shows a high-density tumour 
in the occipital area
dura mater and infiltrated that. The location and the 
infiltrating extension of tumour did not allow radical 
extirpation.
The histological examination showed small round cell 
proliferation. The tumour cells had fairly wide, light stained 
cytoplasm, the nuclei were usually round and the structure of 
the nuclei was loose. The PAS (periodic acid - Schiff) reaction 
was positive. Immunohistochemical stain for LCA (leucocyte 
common antigen) was negative. Electronmicroscopical findings 
were not performed.
The patient received postoperative radiation therapy with 
4860 cGy in sections to the occipital bone of the skull and a 
three-drug regimen chemotherapy (Vincristine, Adriamycine, 
Cyclophosphamide). The CT scan performed shortly after the 
irradiation therapy did not show any evidence of tumour 
shrinkage .
The child is now 2 years postoperative. There is not 
evidence of local recurrence, but she has pulmonary métastasés.
DISCUSSION
Ewing's sarcoma is a rare, undifferentiated, small round to 
oval cell sarcoma of the bone. It represents about 10% of all 
the malignant primary bone tumours /13, 20/. This neoplasm
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affects children and young adults most frequently. Its 
histogenesis is uncertain, although many authors think on an 
undifferentiated, mesenchymal cell of origin. It occurs most 
often in the long bones of the extremities and in the pelvic 
bones. The head and neck are unusual sites for primary skeletal 
Ewing's sarcoma and most cases described in these locations 
have arisen from the maxilla and the mandible /6, 16/. In the 
literature only a few references specific to the flat bones of 
the skull are available. An extensive review of primary Ewing's 
sarcoma involving the bones of the head and neck was published 
by Siegal et al. in 1987 /19/. They reported on 29 patients 
with Ewing's sarcoma in the head and neck region. In this group 
11 patients had skull involvement, as the primary site of the 
tumour. Dahlin in a series of 299 Ewing's sarcoma found 2.3% to 
involve the bones of the head /5/. The occipital bone seems to 
be a very unusual site of origin of Ewing's sarcoma. If the 
cell of origin is an uncommitted mesenchymal cell, it is 
reasonable to assume that these mesenchymal stem cells exist 
throughout the body and reside in soft tissue as well as bone. 
This may help to elucidate such unusual primary sites as the 
occipital bone for Ewing's sarcoma.
This case report describes a Ewing's sarcoma arising in the 
occipital bone and infiltrating the dura mater in a 7 year old 
girl. In addition to location and age, also the clinical signs 
were uncommon and made this case unique. It took time to make 
the diagnosis. The most common presenting signs and symptoms of 
the Ewing's sarcoma were not present. We could not palpate the 
mass and/or swelling at the site of the tumour. As the 
appearance of the head Ewing's sarcoma differs in several 
respects from the so-called typical appearance, we could not 
find the characteristic X-ray findings of the Ewing's sarcoma 
(the distinct onion-ring appearance found in the long bones). 
The absence of the typical apperance was a pitfall for us. Only 
the second CT scan and the MRI helped us to make the diagnosis 
of an extradural space-occupying lesion.
A further unusual difficulty was that the tumour was located 
near the confluence of the sinuses and pressed by the mass,
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causing venous flow disturbance and signs of increased 
intracranial pressure (vomiting, diplopia, papillaoedema). In 
this way it is understandable, why the child became symptom- 
free after the intracranial pressure reducing therapy.
Ewing's sarcoma is a diagnosis of exclusion /15/. The tumour 
has no unique morphological markers that would allow reliable 
distinction from the other small round cell tumours. This may 
cause considerable difficulties in the diagnosis. In young 
patients all the common solid tumours of childhood must be 
considered, when they present in their primitive or 
undifferentiated form (Ewing's sarcoma, primary bone sarcomas, 
rhabdomyosarcoma, lymphoma, metastatic neuroblastoma and 
primitive neuroectodermal tumours) /2/. In most cases, however, 
a clear distinction on purely histological grounds is possible.
Prognostic considerations: the size and site of the primary 
tumour, the site and the extent of metastatic disease, the 
extent of the soft tissue extension of the primary tumour and 
the LDH level are at present believed to be the most important 
prognostic factors for patients with Ewing's sarcoma /3, 8, 9, 
14, 17/. There is a significant lower mortality for head and 
neck primaries compared with all other sites /19/. Patients 
with metastatic disease limited to the lung appear to far 
better, than those with metastatic disease in other sites.
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BOOK REVIEW
Atlas of rare chest diseases in c hi ld re n  Ed. by Rudnik Ű, 
Kurzawa R, National Research Institute of Mother and Child, 
1990, 192 pages, 69 figures, 160 X-ray pictures
The idea prompting the publication of this book was the 
fourth meeting of the European Paediatric Respiratory Society 
held in Krakow 1983. One section of this meeting discussed the 
rare pulmonologic diseases. On this occasion the participants 
of the meeting have been requested by Professor Rudnik, 
president of the Organizing Committee to put at the disposal of 
the publisher all documentation of rare diseases.
The publishing of the book was much delayed by the 
unexpected death of Professor Rudnik - it appeared 7 years 
later than planned. Finally the complication of the book was 
undertaken by Professor Kurzawa who let the book come out in 
1990. The presentation of the book satisfies every demand, it 
contains a great number of X-ray pictures and coloured 
histological figures of high quality. About two thirds of the 
material are coming from the Rabka Pulmonological Centre and 
the remaining one third from various countries of Europe.
The first chapter deals with the congenital malformations 
including 28 esse reports. One of them is a patient suffering 
from immotile cilium syndrome described by Marialigeti and 
Appel. Several articles deal with the pulmonary cysts of 
various origin as well as with the possibilities of their 
surgical solution. An interesting case report was written by 
Zuk et. al in which a relaxed diaphrgam made the impression of 
a right-side pulmonary tumour.
The second chapter reports on the congenital malformations 
combined with inflammatory or tumorous processes. In the case 
report of Latos and coworkers the patient suffered from Ehlers- 
□anlos disease and the abnormal pulmonary connective tissue 
resulted in a polycystic degeneration in the lung presenting 
clinically with severe spasmodic coughing. The pathogenesis of 
the disease is based on the lack of transformation of
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procollagen into collagen. This chapter includes also the 
history of a patient with multiple bone lymphangioma and 
chylothorax treated by Cserháti et al.
In the third chapter authors write about the primary 
pulmonary tumours in childhood dividing them into 3 groups 
considering their localization: pulmonary, bronchial and 
mediastinal tumours. Among the described cases especially rare 
diseases are the Castelman tumour and the malignant 
c h e mode ctoma.
The fourth chapter deals with pulmonary mycoses 
(actinomycosis and aspergilloma) while the fifth with chronic 
interstitial pneumonies of patients coming from the Helsinki 
Children's Hospital and Immunological Centre. The diseases are 
groupped according to clinical pictures:
a) no specific character, b) expressed bronchial obstruction, 
c) desquamative lymphoid type.
The short sixth chapter is devoted to BCG dissemination in 
imm u n o d é i icient states. In one of the interesting cases 
described by Schuster et al. exclusively the humoral 
immundeficiency (IgA and IgG) without cellular components 
resulted in BCG dissemination following live measles 
vaccination. Hódsági et al. report on BCG dissemination in 
chronic granulomatosis.
In the seventh chapter diseases of various etiologies are 
discussed. Poder et al. presented a case in which a pesticide 
called paraquat caused toxicosis at first right side 
infiltration, then emphysema occurred. Fifteen months after 
toxicity fibromatous alterations dominated the picture.
The book is rich in illustrations, therefore it is 
convenient for searching and also finding analogies for rare 
thorax deformities. The descriptions of clinical pictures are 
short which made possible the great number of case reports, 
however, the reader may be unsatistied with the profoundness of 
des cri p t i o n .
Endre Cserháti, MD
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